
<html lang="en"     class="pb-page"  data-request-id="7bf121ff-c054-4f9e-bb69-7c9cf9c35864"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm800386y;issue:issue:10.1021/jmcmar.2008.51.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer" /></meta><meta name="dc.Creator" content="Christopher D.  Cox" /></meta><meta name="dc.Creator" content="Paul J.  Coleman" /></meta><meta name="dc.Creator" content="Michael J.  Breslin" /></meta><meta name="dc.Creator" content="David B.  Whitman" /></meta><meta name="dc.Creator" content="Robert M.  Garbaccio" /></meta><meta name="dc.Creator" content="Mark E.  Fraley" /></meta><meta name="dc.Creator" content="Carolyn A.  Buser" /></meta><meta name="dc.Creator" content="Eileen S.  Walsh" /></meta><meta name="dc.Creator" content="Kelly  Hamilton" /></meta><meta name="dc.Creator" content="Michael D.  Schaber" /></meta><meta name="dc.Creator" content="Robert B.  Lobell" /></meta><meta name="dc.Creator" content="Weikang  Tao" /></meta><meta name="dc.Creator" content="Joseph P.  Davide" /></meta><meta name="dc.Creator" content="Ronald E.  Diehl" /></meta><meta name="dc.Creator" content="Marc T.  Abrams" /></meta><meta name="dc.Creator" content="Vicki J.  South" /></meta><meta name="dc.Creator" content="Hans E.  Huber" /></meta><meta name="dc.Creator" content="Maricel  Torrent" /></meta><meta name="dc.Creator" content="Thomayant  Prueksaritanont" /></meta><meta name="dc.Creator" content="Chunze  Li" /></meta><meta name="dc.Creator" content="Donald E.  Slaughter" /></meta><meta name="dc.Creator" content="Elizabeth  Mahan" /></meta><meta name="dc.Creator" content="Carmen  Fernandez-Metzler" /></meta><meta name="dc.Creator" content="Youwei  Yan" /></meta><meta name="dc.Creator" content="Lawrence C.  Kuo" /></meta><meta name="dc.Creator" content="Nancy E.  Kohl" /></meta><meta name="dc.Creator" content="George D.  Hartman" /></meta><meta name="dc.Description" content="Inhibition of kinesin spindle protein (KSP) is a novel mechanism for treatment of cancer with the potential to overcome limitations associated with currently employed cytotoxic agents. Herein, we d..." /></meta><meta name="Description" content="Inhibition of kinesin spindle protein (KSP) is a novel mechanism for treatment of cancer with the potential to overcome limitations associated with currently employed cytotoxic agents. Herein, we d..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 25, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800386y" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800386y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800386y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800386y" /></link>
        
    
    

<title>Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800386y" /></meta><meta property="og:title" content="Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0007.jpeg" /></meta><meta property="og:description" content=" Inhibition of kinesin spindle protein (KSP) is a novel mechanism for treatment of cancer with the potential to overcome limitations associated with currently employed cytotoxic agents. Herein, we describe a C2-hydroxymethyl dihydropyrrole KSP inhibitor (11) that circumvents hERG channel binding and poor in vivo potency, issues that limited earlier compounds from our program. However, introduction of the C2-hydroxymethyl group caused 11 to be a substrate for cellular efflux by P-glycoprotein (Pgp). Utilizing knowledge garnered from previous KSP inhibitors, we found that β-fluorination modulated the pKa of the piperidine nitrogen and reduced Pgp efflux, but the resulting compound (14) generated a toxic metabolite in vivo. Incorporation of fluorine in a strategic, metabolically benign position by synthesis of an N-methyl-3-fluoro-4-(aminomethyl)piperidine urea led to compound 30 that has an optimal in vitro and metabolic profile. Compound 30 (MK-0731) was recently studied in a phase I clinical trial in patients with taxane-refractory solid tumors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800386y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800386y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800386y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800386y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800386y&amp;href=/doi/10.1021/jm800386y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 4239-4252</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800168s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800177c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+D.++Cox">Christopher D. Cox</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+J.++Coleman">Paul J. Coleman</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Breslin">Michael J. Breslin</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+B.++Whitman">David B. Whitman</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+M.++Garbaccio">Robert M. Garbaccio</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+E.++Fraley">Mark E. Fraley</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carolyn+A.++Buser">Carolyn A. Buser</a></span><span class="author-xref-symbol "><sup>§</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eileen+S.++Walsh">Eileen S. Walsh</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Hamilton">Kelly Hamilton</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Schaber">Michael D. Schaber</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+B.++Lobell">Robert B. Lobell</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weikang++Tao">Weikang Tao</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Davide">Joseph P. Davide</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+E.++Diehl">Ronald E. Diehl</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc+T.++Abrams">Marc T. Abrams</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vicki+J.++South">Vicki J. South</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hans+E.++Huber">Hans E. Huber</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maricel++Torrent">Maricel Torrent</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomayant++Prueksaritanont">Thomayant Prueksaritanont</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chunze++Li">Chunze Li</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+E.++Slaughter">Donald E. Slaughter</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Mahan">Elizabeth Mahan</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++Fernandez-Metzler">Carmen Fernandez-Metzler</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Youwei++Yan">Youwei Yan</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+C.++Kuo">Lawrence C. Kuo</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nancy+E.++Kohl">Nancy E. Kohl</a></span><span class="author-xref-symbol "><sup>§</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George+D.++Hartman">George D. Hartman</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: +1-215-652-2411. Fax: +1-215-652-7310. E-mail: <a href="/cdn-cgi/l/email-protection#03606b716a705c606c7b436e667160682d606c6e"><span class="__cf_email__" data-cfemail="04676c766d775b676b7c44696176676f2a676b69">[email protected]</span></a></div><div class="corresp-fn" id="afn2">‡Department of Medicinal Chemistry.</div><div class="corresp-fn" id="afn3">§Department of Cancer Research.</div><div class="corresp-fn" id="afn1">†Current address: Department of Oncology Research, Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115.</div><div class="corresp-fn" id="afn4">∥Department of Molecular Systems.</div><div class="corresp-fn" id="afn5">⊥Department of Drug Metabolism.</div><div class="corresp-fn" id="afn6">#Department of Structural Biology.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800386y&amp;href=/doi/10.1021%2Fjm800386y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 4239–4252</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 25, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 April 2008</li><li><span class="item_label"><b>Published</b> online</span>25 June 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 July 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800386y" title="DOI URL">https://doi.org/10.1021/jm800386y</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4239%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BD.%2BCox%252C%2BPaul%2BJ.%2BColeman%252C%2BMichael%2BJ.%2BBreslin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D14%26contentID%3Djm800386y%26title%3DKinesin%2BSpindle%2BProtein%2B%2528KSP%2529%2BInhibitors.%2B9.%2BDiscovery%2Bof%2B%25282S%2529-4-%25282%252C5-Difluorophenyl%2529-N-%255B%25283R%252C4S%2529-3-fluoro-1-methylpiperidin-4-yl%255D-2-%2528hydroxymethyl%2529-N-methyl-2-phenyl-2%252C5-dihydro-1H-pyrrole-1-carboxamide%2B%2528MK-0731%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BTaxane-Refractory%2BCancer%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4252%26publicationDate%3DJuly%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800386y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4259</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">124</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800386y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;D. Cox&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;J. Coleman&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Breslin&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;B. Whitman&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;M. Garbaccio&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;E. Fraley&quot;},{&quot;first_name&quot;:&quot;Carolyn&quot;,&quot;last_name&quot;:&quot;A. Buser&quot;},{&quot;first_name&quot;:&quot;Eileen&quot;,&quot;last_name&quot;:&quot;S. Walsh&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Hamilton&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Schaber&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;B. Lobell&quot;},{&quot;first_name&quot;:&quot;Weikang&quot;,&quot;last_name&quot;:&quot;Tao&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Davide&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;E. Diehl&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;T. Abrams&quot;},{&quot;first_name&quot;:&quot;Vicki&quot;,&quot;last_name&quot;:&quot;J. South&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;E. Huber&quot;},{&quot;first_name&quot;:&quot;Maricel&quot;,&quot;last_name&quot;:&quot;Torrent&quot;},{&quot;first_name&quot;:&quot;Thomayant&quot;,&quot;last_name&quot;:&quot;Prueksaritanont&quot;},{&quot;first_name&quot;:&quot;Chunze&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;E. Slaughter&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Mahan&quot;},{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Fernandez-Metzler&quot;},{&quot;first_name&quot;:&quot;Youwei&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;C. Kuo&quot;},{&quot;first_name&quot;:&quot;Nancy&quot;,&quot;last_name&quot;:&quot;E. Kohl&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;D. Hartman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;4239-4252&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800386y&quot;},&quot;abstract&quot;:&quot;Inhibition of kinesin spindle protein (KSP) is a novel mechanism for treatment of cancer with the potential to overcome limitations associated with currently employed cytotoxic agents. Herein, we describe a C2-hydroxymethyl dihydropyrrole KSP inhibitor (11) that circumvents hERG channel binding and poor in vivo potency, issues that limited earlier compounds from our program. However, introduction of the C2-hydroxymethyl group caused 11 to be a substrate for cellular efflux by P-glycoprotein (Pgp). Utilizing knowledge garnered from previous KSP inhibitors, we found that β-fluorination modulated the pKa of the piperidine nitrogen and reduced Pgp efflux, but the resulting compound (14) generated a toxic metabolite in vivo. Incorporation of fluorine in a strategic, metabolically benign position by synthesis of an N-methyl-3-fluoro-4-(aminomethyl)piperidine urea led to compound 30 that has an optimal in vitro and metabolic profile. Compound 30 (MK-0731) was recently studied in a phase I clinical trial in patients &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800386y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800386y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800386y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800386y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800386y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800386y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800386y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800386y&amp;href=/doi/10.1021/jm800386y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800386y" /></input><a href="/doi/pdf/10.1021/jm800386y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1010 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800386y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800386y%26sid%3Dliteratum%253Aachs%26pmid%3D18578472%26genre%3Darticle%26aulast%3DCox%26date%3D2008%26atitle%3DKinesin%2BSpindle%2BProtein%2B%2528KSP%2529%2BInhibitors.%2B9.%2BDiscovery%2Bof%2B%25282S%2529-4-%25282%252C5-Difluorophenyl%2529-N-%255B%25283R%252C4S%2529-3-fluoro-1-methylpiperidin-4-yl%255D-2-%2528hydroxymethyl%2529-N-methyl-2-phenyl-2%252C5-dihydro-1H-pyrrole-1-carboxamide%2B%2528MK-0731%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BTaxane-Refractory%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D14%26spage%3D4239%26epage%3D4252%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0007.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of kinesin spindle protein (KSP) is a novel mechanism for treatment of cancer with the potential to overcome limitations associated with currently employed cytotoxic agents. Herein, we describe a C2-hydroxymethyl dihydropyrrole KSP inhibitor (<b>11</b>) that circumvents hERG channel binding and poor in vivo potency, issues that limited earlier compounds from our program. However, introduction of the C2-hydroxymethyl group caused <b>11</b> to be a substrate for cellular efflux by P-glycoprotein (Pgp). Utilizing knowledge garnered from previous KSP inhibitors, we found that β-fluorination modulated the p<i>K</i><sub>a</sub> of the piperidine nitrogen and reduced Pgp efflux, but the resulting compound (<b>14</b>) generated a toxic metabolite in vivo. Incorporation of fluorine in a strategic, metabolically benign position by synthesis of an <i>N</i>-methyl-3-fluoro-4-(aminomethyl)piperidine urea led to compound <b>30</b> that has an optimal in vitro and metabolic profile. Compound <b>30</b> (MK-0731) was recently studied in a phase I clinical trial in patients with taxane-refractory solid tumors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Advances in molecular biology and a better understanding of the mechanisms responsible for cancer formation and metastasis have led to a significant shift in focus toward <i>targeted therapies</i> for the treatment of neoplastic disease.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These efforts have resulted in the recent approval of innovative new drugs that show promise for extending the length and improving the quality of life for cancer patients.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, cytotoxic agents have been the mainstay of effective chemotherapeutic approaches for the past several decades, and they continue to play an important role in the battle against cancer, both as stand-alone agents and, more recently, as adjuvants with targeted therapies.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> It is therefore not surprising that the development of more effective and better tolerated cytotoxic agents continues to be an area of focus in the pharmaceutical industry.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Many successful cytotoxic agents currently in clinical use, such as the taxanes and <i>Vinca</i> alkaloids, operate during mitosis by interfering with the cellular machinery required for cell division and diverting the cell down a pathway of programmed cell death, or apoptosis. As defined by their mechanism of action, these antimitotic agents are <i>spindle poisons</i> in that they directly target the mitotic spindle by binding to tubulin, a protein required not only for mitosis but also for structural integrity and proper function of terminally differentiated cells.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">To avoid side effects attributed to the nonselective mechanism of action of spindle poisons, recent efforts have been focused on identification of new targets in the mitotic pathway that play a role only in dividing cells, or <i>targeted antimitotic therapies</i>.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> A leading candidate to emerge from these efforts is kinesin spindle protein (KSP<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a> or <i>Hs</i>Eg5), <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: KSP, kinesin spindle protein; MDR, multidrug resistant; Pgp, P-glycoprotein; hERG, human ether-a-go-go related gene; MTD, maximum-tolerated dose; GI, gastrointestinal.</p></div> a member of the kinesin family of molecular motor proteins. Kinesins bind to tubulin and utilize the energy generated from the hydrolysis of ATP to produce a directed force that can move cargo, regulate microtubule dynamics, or control chromosomal attachment.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> KSP is a <i>mitotic kinesin</i> that is only expressed in dividing cells and plays a critical role in the formation of a properly organized bipolar mitotic spindle.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Inhibition of KSP function results in mitotic arrest with a characteristic monoaster phenotype and subsequently leads to apoptosis.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">KSP inhibitors have several potential advantages over traditional spindle poisons as chemotherapeutic agents. Since their mechanism of action only affects dividing cells, KSP inhibitors are not expected to cause peripheral neuropathy, a side effect attributed to disruption of the tubulin network in neurons and leads to the discontinuation of taxane or <i>Vinca</i> alkaloid treatment in some patients.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Additionally, KSP inhibitors can be effective in cancer cells that are refractory to spindle poisons because of overexpression of P-glycoprotein (Pgp) or tubulin mutations.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Finally, a water-soluble KSP inhibitor will circumvent the onerous dosing regime employed for taxane administration, a nonaqueous vehicle that requires premedication to prevent vehicle-associated toxicities.<a onclick="showRef(event, 'cit10b'); return false;" href="javascript:void(0);" class="ref cit10b">(10b)</a> These promising characteristics have encouraged us, as well as others, to initiate clinical trials to evaluate KSP inhibitors for the treatment of taxane-refractory cancer.<a onclick="showRef(event, 'ref4 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref4 ref11 ref12">(4, 11, 12)</a></div><div class="NLM_p">In a series of recent publications, we disclosed our research efforts that began with a high-throughput screening (HTS) hit and culminated in the design of potent and selective KSP inhibitors <b>1</b> and <b>2</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Though these compounds illustrate that synthesis of water-soluble KSP inhibitors with antimitotic activity in a Pgp-overexpressing cell line is feasible, <b>1</b> had poor in vivo activity in a mouse xenograft assay,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> whereas <b>2</b> and related compounds demonstrated unacceptable levels of affinity for the human ether-a-go-go related gene (hERG) channel.<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> Herein, we disclose a new series of C2-hydroxymethyl dihydropyrrole KSP inhibitors derived by hybridization of <b>1</b> and <b>2</b>. This new series overcame the issues associated with our previous compounds and led to a clinical candidate for the treatment of taxane-refractory cancer.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0008.jpeg" id="gc1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Previously Reported KSP Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds in the 2,2-disubstituted dihydropyrrole series, including <b>1</b>, were synthesized by the route described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Following formation of the benzylimine of racemic phenylglycine methyl ester (<b>3</b>), alkylation with methallyl dichloride under phase transfer conditions provided the mono C-alkylated product (not shown or isolated). The benzylimine was hydrolyzed with aqueous HCl, and during workup, intramolecular N-alkylation occurred to furnish pyrrolidine <b>4</b>. The methyl ester of <b>4</b> was reduced with LAH to afford an amino alcohol that was treated with 1,1′-carbonyldiimidazole to provide oxazolidinone <b>5</b>. Ozonolysis of the exocyclic double bond generated bicyclic ketone <b>6</b>. This seven-step sequence can easily be carried out on mole-scale without the need to purify any intermediates and provides crystalline <b>6</b> by trituration from acetone in an overall yield of 15% from phenylglycine methyl ester.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0001.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClCH<sub>2</sub>C(CH<sub>2</sub>)CH<sub>2</sub>Cl, Bu<sub>4</sub>NHSO<sub>4</sub>, 10 M NaOH, DCM; (b) 1 M HCl; (c) Na<sub>2</sub>CO<sub>2</sub>/H<sub>2</sub>O; (d) LAH, THF, 0°C to room temp; (e) CDI, TEA, DCM; (f) O<sub>3</sub>, DCM, −78 °C, then DMS (15% yield from <b>3</b>); (g) NaHMDS, THF, −78 °C, then PhN(Tf)<sub>2</sub>; (h) 2,5-difluoroboronic acid, Na<sub>2</sub>CO<sub>3</sub>, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME (69% for two steps); (i) 10 M NaOH, EtOH, 60°C; (j) TBSCl, imidazole, 5% DMF in DCM (83% for two steps); (k) Chiralpak AD, 1% <sup><i>i</i></sup>PrOH in hexanes (0.1% DEA as modifier), first isomer to elute is the desired (<i>S</i>)-isomer; (l) triphosgene, TEA, THF; (m) NHMe<sub>2</sub>; (n) HF−TEA, CH<sub>3</sub>CN (78% for three steps).</p></p></figure><div class="NLM_p last">The triflate of ketone <b>6</b> was formed regioselectively with PhN(Tf)<sub>2</sub> and NaHMDS<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> and converted to <b>7</b> via Suzuki reaction with commercially available 2,5-difluorophenylboronic acid in 69% yield over two steps. The oxazolidinone ring was hydrolyzed with NaOH, and the resulting amino alcohol protected with <i>tert</i>-butyldimethylsilyl chloride provided <b>8</b> in 83% yield. As noted in our previous reports, only the (<i>S</i>)-antipode of compounds in this class of inhibitors exhibits KSP activity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Chiral HPLC separation was therefore carried out at this stage to provide optically pure (<i>S</i>)-<b>8</b>. Treatment with triphosgene, followed by addition of dimethylamine and subsequent deprotection, led to <b>9</b> in 78% yield from (<i>S</i>)-<b>8</b>. Elaboration of the primary alcohol in <b>9</b> to functionalized amino side chains, such as that in <b>1</b>, was carried out in a straightforward manner as previously described.<a onclick="showRef(event, 'cit13d'); return false;" href="javascript:void(0);" class="ref cit13d">(13d)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As discussed in the <a class="ref internalNav" href="#sec1" aria-label="Introduction">Introduction</a>, though compound <b>1</b> possessed an optimized in vitro profile, it displayed poor activity in an in vivo assay designed to measure mitotic arrest in a tumor xenograft (vide infra).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In an effort concurrent with these studies, we discovered compounds such as <b>2</b> wherein the solubilizing basic amine is connected to the dihydropyrrole core though an unsymmetrical urea linkage. These compounds, though more effective than <b>1</b> in vivo, demonstrated an unacceptable in vitro profile characterized by high affinity for the hERG channel.<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> Blockade of this ion channel has been implicated in drug-induced prolongation of the QT interval of the EEG, an event associated with a potential fatal polymorphic ventricular tachycardia, torsade de pointes.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">We ultimately discovered that it was possible to overcome the hERG channel binding in compounds related to <b>2</b> by reducing the basicity of the amine and restoring water solubility with a phosphate prodrug strategy.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Separately, we found that improved in vivo efficacy could be obtained in analogues related to <b>1</b> by replacing the dihydropyrrole urea with a dihydropyrazole acetamide.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, at the time of the initial work, we reached an impasse with these two series of compounds and thus began to search for structural alterations that would generate a new series with the potential to overcome the shortcomings of <b>1</b> and <b>2</b>.</div><div class="NLM_p">During the synthesis of compounds in the 2,2-disubstituted dihydropyrrole series, we recognized that incorporation of the C2-hydroxymethyl group preserved KSP potency, as revealed by comparison of <b>9</b> (KSP IC<sub>50</sub> = 78 nM) to the C2-H analogue <b>10</b> (KSP IC<sub>50</sub> = 38 nM) made earlier in our program (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>).<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> Though the potency of <b>9</b> was not in the range desired for leading compounds, we were encouraged by the discovery that a small, polar functionality with the potential to significantly alter physical properties is tolerated by KSP. We therefore decided to investigate the effect of C2-hydroxymethylation on the more potent inhibitor <b>2</b> and were pleased to find that the resulting compound (<b>11</b>) has potency similar to that of <b>2</b> in vitro, as well as superior activity in vivo (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>). Most interesting, however, was the order of magnitude decrease in affinity for binding to the hERG channel demonstrated by <b>11</b> relative to <b>2</b>.</div><figure id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0009.jpeg" id="gc2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Relevant Properties of KSP Inhibitors <b>10</b> and <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Extensive precedent exists for the circumvention of hERG activity by rational medicinal chemistry design.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Among the most successful reported approaches for diminishing binding to the hERG channel are modulation of lipophilicity, as measured by log <i>P</i>, and discrete structural modifications that disrupt the putative π-stacking and hydrophobic interactions between the drug candidate and the channel cavity. It is therefore not unexpected that installation of a polar, hydrogen-bond donating functionality at a central position within the core architecture of <b>11</b> results in a dramatic effect on hERG binding. The hydroxymethyl group decreased the experimental log <i>P</i> from 2.5 in <b>2</b> to 1.7 in <b>11</b>, and reduced hERG binding is a general trend observed for compounds in this series of C2-hydroxymethyl analogues (vide infra).</div><div class="NLM_p">Although introduction of the hydroxymethyl group had a favorable effect on hERG binding, it negatively impacted the Pgp profile. For example, whereas <b>2</b> is not a Pgp substrate, <b>11</b> is efficiently effluxed from cells by Pgp as indicated by its multidrug resistance (MDR) ratio, a measure of Pgp-mediated resistance to mitotic arrest that we have recently reported to be a reliable high-throughput approach to measure Pgp susceptibility of KSP inhibitors.<a onclick="showRef(event, 'cit13d'); return false;" href="javascript:void(0);" class="ref cit13d">(13d)</a> The MDR ratio is calculated by dividing the IC<sub>50</sub> for induction of mitotic arrest in a cell line that highly overexpresses Pgp by the IC<sub>50</sub> in the parental line that does not express Pgp. An MDR ratio of unity indicates that the KSP inhibitor is not effluxed by Pgp because it is equipotent in both cell lines. At the other extreme, paclitaxel [(1<i>S</i>,2<i>S</i>,3<i>R</i>,4<i>S</i>,7<i>R</i>,9<i>S</i>,10<i>S</i>,12<i>R</i>,15<i>S</i>)-4,12-diacetoxy-15-{[(2<i>R</i>,3<i>S</i>)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0∼3,10∼.0∼4,7∼]heptadec-13-en-2-yl benzoate] has a ratio of greater than 25 000, since it is devoid of activity in the overexpressing cell line. We considered compounds with a ratio of less than 10 to be acceptable for development, but <b>11</b> had a ratio of 21, with an EC<sub>50</sub> of only 150 nM in the Pgp-overexpressing cell line.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Pgp is encoded in the human MDR1 gene and has been extensively studied as a major feature of the multidrug resistant (MDR) phenotype. It plays an important role not only in the resistance of cancer cells to cytotoxic agents such as paclitaxel and the <i>Vinca</i> alkaloids but in other aspects of drug design and delivery as well.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Extensive efforts in recent years have been directed toward understanding the mechanisms of substrate recognition by Pgp, resulting in a number of models that attempt to explain the SAR of Pgp substrates.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, a complete understanding of the specific molecular elements required for recognition is complicated by the unusual promiscuity of Pgp and a lack of generalized assays that allow for direct comparisons between studies from different sources. Several successful efforts to rationally design drug candidates that circumvent Pgp efflux have been reported.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, the exercise remains mainly an empirical endeavor, albeit one that can be aided by several guiding principles such as increasing passive permeability, reducing molecular size, and removing or weakening hydrogen-bond donors and acceptors. The observation that hydroxymethyl substitution increased Pgp-mediated efflux in progressing from <b>2</b> to <b>11</b> is consistent with the recently reported finding that hydroxyl substitution at C11 in a series of structurally related glucocorticoids was responsible for enhanced Pgp affinity and cellular efflux.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">In recent publications, we demonstrated that it is possible to balance Pgp efflux potential (as measured by the MDR ratio) with KSP potency by careful modulation of amine basicity for two related series of KSP inhibitors.<a onclick="showRef(event, 'cit13d ref14'); return false;" href="javascript:void(0);" class="ref cit13d ref14">(13d, 14)</a> Specifically, we found that by constraining the p<i>K</i><sub>a</sub> to a range of 6.5−8.0, maximal KSP inhibitory activity is maintained, and the ability for the compound to induce mitotic arrest in Pgp-overexpressing cells is optimized. Interestingly, the p<i>K</i><sub>a</sub> of <b>11</b> is 8.8, which is consistent with its high MDR ratio. To determine if a similar trend holds for modulating basicity of the piperidine nitrogen, <i>N</i>-alkyl analogues of <b>11</b> with groups of varying electron-withdrawing ability were prepared and evaluated (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of <i>N</i>-Alkyl Group on Overall Compound Profile</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0004.gif" alt="" id="gr4" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0005.gif" alt="" id="_i8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Average from at least <i>n</i> = 3 expermints.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Values were determined with a Sirius GLpK<sub>a</sub> titrator, average of <i>n</i> = 3 determinations.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">Average from at least <i>n</i> = 2 experiments. n.t. = not tested.</p></div></div></div><div class="NLM_p">As we found for the previous series of KSP inhibitors, a good correlation between optimal profile and p<i>K</i><sub>a</sub> is observed: the inhibitor with p<i>K</i><sub>a</sub> < 6.5 (<b>16</b>) has reduced KSP potency, while those inhibitors with p<i>K</i><sub>a</sub> > 8 (<b>11</b>−<b>13</b>) lose appreciable activity in Pgp-overexpressing cells, as indicated by high MDR ratios. Notably, all analogues maintained favorable hERG binding profiles. The two inhibitors with a p<i>K</i><sub>a</sub> between 6.5 and 8.0, β-monofluorinated analogue <b>14</b> and cyclopropylamine <b>15</b>, possessed the optimal balance between KSP potency and MDR ratio and were chosen for further characterization.</div><div class="NLM_p">Cyclopropyl analogue <b>15</b> was found to be a potent time-dependent inhibitor of CYP3A4, a well-known liability of this structural motif,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and was not further pursued. In contrast, <b>14</b> demonstrated a promising overall profile, including excellent in vivo activity (EC<sub>90</sub> = 100 nM), good formulation properties, and the potential for suitable pharmacokinetic parameters. As part of our preclinical evaluation of <b>14</b>, we studied dose proportionality in the rat with iv bolus doses of 1, 4, and 12 mg/kg. As desired, a linear increase in exposure with dose was observed, with <b>14</b> achieving AUC levels of 0.5, 2.5, and 9.5 μM h<sup>−1</sup>, respectively; however, we were surprised to find mortality within 12 h postdose in 2 of 3 rats in the 12 mg/kg group.</div><div class="NLM_p">Acute toxicity is not an expected mechanism-based effect for inhibition of KSP and has not been observed in our preclinical program with any compound other than <b>14</b>. The dose-limiting, mechanism-based toxicity observed for KSP inhibitors both preclinically and in humans is neutropenia (depletion of white blood cells) and typically manifests in 4−10 days following compound adminstration.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In our search for a compound-specific source of toxicity, we identified the fluoroethylamine of <b>14</b> as a potential liability. If N-dealkylation of the piperidine ring were to occur in vivo, a likely byproduct would be fluoroacetate, a known toxin with acute pharmacology.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In fact, we discovered that N-dealkylated analogue <b>12</b> is the major metabolite generated in rat liver microsome and hepatocyte incubations, suggesting that formation of fluoroacetate is indeed the source of toxicity in vivo.</div><div class="NLM_p">Since <b>14</b> demonstrated the profile desired in a clinical candidate, we began a search for isoelectronic replacements of the fluoroethyl substituent that would maintain the overall properties of <b>14</b> and not impart toxicity in vivo. The most prudent choice was installation of fluorine directly on the piperidine ring. This strategy eliminates the possibility of forming a low molecular weight fluorinated acid as a metabolic byproduct and also provides the opportunity to carefully tune the p<i>K</i><sub>a</sub> of the piperidine nitrogen by controlling relative stereochemistry of the fluorine substituent. It has been shown that an axial 3-fluoro substituent lowers the p<i>K</i><sub>a</sub> of a piperidine nitrogen by approximately 1 log unit, whereas an equatorial 3-fluoro can lower the p<i>K</i><sub>a</sub> by nearly 2 units, a tactic that was employed in an effort to generate 5-HT<sub>1D</sub> receptor agonists with improved pharmacokinetic profiles.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> We thus turned our attention to synthesis of the required stereodefined fluorinated piperidine analogues to investigate this strategy.</div><div class="NLM_p">Utilizing a variant of the route reported by van Niel,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> we synthesized the four enantiomerically pure <i>N</i>-methyl-3-fluoro-4-(aminomethyl)piperidine analogues as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Formation of the TMS enolate of the protected 4-ketopiperidine <b>17</b>, followed by electrophilic fluorination with Selectfluor, afforded α-fluoroketone <b>18</b> in 90% yield. Reductive amination of <b>18</b> with methylamine in MeOH provided a separable mixture of trans and cis isomers <b>19</b> and <b>20</b> in a combined yield of 62%. The isomers were processed separately, beginning with Boc protection of the secondary amine, followed by resolution of the enatiomers with chiral stationary phase HPLC. Removal of the CBz group by transfer hydrogenation, reductive amination with formaldehyde, and Boc removal provided the four enantiomerically pure <i>N</i>-methyl-3-fluoro-4-(aminomethyl)piperidine analogues <b>25</b>−<b>28</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0002.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TMSCl, TEA, DMF, 80°C; (b) Selectfluor, CH<sub>3</sub>CN, 0°C (90% for two steps); (c) MeNH<sub>2</sub>, AcOH, NaBH<sub>3</sub>CN, MeOH (1.3:1 ratio of 19:20, 62% combined yield); (d)Boc<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>; (e) Chiralpak AD, 15% IPA/hexanes (45% yield of <b>21</b> and 49% of <b>22</b> from <b>19</b>); (f) 1,4-cyclohexadiene, 10% Pd/C, EtOH; (g) CH2O, AcOH, NaBH<sub>3</sub>CN, MeOH; (h) HCl(g),EtOAc, workup with Na<sub>2</sub>CO<sub>3</sub> (>90% yield for three steps); (i) Chiralpak AD, 20% IPA/hexanes (45% yield of <b>23</b> and 41% of <b>24</b> from <b>20</b>).</p></p></figure><div class="NLM_p">The four isomers were coupled to the dihydropyrrole core as illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> using enantiomerically pure <i>cis</i>-fluoropiperidine <b>28</b> as an example. Carbamoyl chloride <b>29</b> was first generated by treatment of (<i>S</i>)-<b>8</b> with triphosgene and triethylamine in THF. This intermediate was easily isolated in quantitative yield and is stable for months when stored in the freezer. Reaction of <b>29</b> with fluoropiperidine <b>28</b> provided <b>30</b> following removal of the TBS protecting group. Synthesis of the other three fluoropiperdine analogues was carried out by an analogous route with <b>25</b>−<b>27</b> to provide all four optically and diastereomerically pure isomers. The more potent cis isomer (<b>30</b>) and trans isomer (<b>31</b>) are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0003.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triphosgene, TEA, THF, 0°C (100%); (b) <b>28</b>, TEA, DMAP, THF; (c) TEA−HF, CH<sub>3</sub>CN, 37°C (63% yield over two steps).</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Fluorine Stereochemistry on Compound Profile<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0006.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">Average from at least <i>n</i> = 3 experiments, unless otherwise noted.</p></div><div class="footnote" id="tbl2-fn2"><sup>Table b</sup><p class="last">Values were determined with a Sirius GLpK<sub>a</sub> titrator, average of <i>n</i> = 3 determinations.</p></div><div class="footnote" id="tbl2-fn3"><sup>Table c</sup><p class="last">Value is from <i>n</i> = 1 determination.</p></div></div><div></div></div><div class="NLM_p">Because of the larger <i>A</i>-value of the amino group relative to fluorine, the urea substituent is expected to occupy the equatorial position of the piperidine ring, placing the fluorine axial in cis analogue <b>30</b> and equatorial in trans analogue <b>31</b>. This conjecture was subsequently confirmed by X-ray analysis (vide infra). As expected from precedent, the equatorial fluorine has a dramatic effect on p<i>K</i><sub>a</sub>, lowering it from 8.8 in nonfluorinated analogue <b>11</b> to 6.6 in <b>31</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). On the other hand, the axial fluorine results in a more modest effect on basicity, affording a p<i>K</i><sub>a</sub> of 7.6 in <b>30</b>. Compound <b>30</b> displayed superior potency in both the enzymatic KSP assay and a cell-based assay relative to <b>31</b>, and both compounds displayed little affinity for binding to the hERG channel. Importantly and consistent with its favorable p<i>K</i><sub>a</sub>, <b>30</b> also has significant activity in Pgp-overexpressing cells, with potencies of 4.2 and 18.9 nM in the parental and Pgp-overexpressing cell lines, respectively, resulting in an MDR ratio of 4.5. For comparison, the corresponding values for paclitaxel are 0.5 nM and >10 μM. Thus, <b>30</b> has the ability to induce a mitotic block with an IC<sub>50</sub> of 19 nM in cells that are refractory to paclitaxel due to Pgp-overexpression. On the basis of a favorable overall in vitro profile, <b>30</b> was selected for in vivo evaluation.</div><div class="NLM_p">The primary in vivo assay employed during lead optimization was a pharmacodynamic assay to determine mitotic arrest in tumors from nude mice bearing an A2780 human ovarian carcinoma xenograft. The minimum plasma concentration required to induce the maximum extent of mitotic arrest in the tumor is defined as the EC<sub>90</sub> for in vivo activity. We assessed mitotic arrest by determining the phosphorylation state of histone H3 on Ser-10, a residue that is phosphorylated exclusively in mitosis by the Aurora kinases,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and quantitated the results by immunohistochemical staining of resected tumors. For compound administration, subcutaneously implanted Alzet osmotic pumps were used for their ability to mimic a continuous iv infusion over the 22 h course of the experiment. We envision employing a continuous iv infusion in the clinic because mitotic arrest induced by KSP inhibition must be maintained for a minimum of 16−24 h to induce the apoptotic response.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This protocol provides the best opportunity to maintain plasma exposure for the required length of time without exposing the patient to high levels of drug following a bolus infusion.</div><div class="NLM_p">For the in vivo study, aqueous solutions of <b>30</b> were administered to A2780-xenografted mice via minipump at doses of 2.5, 5, 10, 20, and 40 (mg/kg)/day. As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>30</b> exhibited a dose-proportional increase in both exposure and mitotic arrest in tumors, and the maximal level of mitotic block (EC<sub>90</sub>) occurred at a minimum plasma level of 94 nM from the 10 (mg/kg)/day dose. The degree of maximal mitotic arrest induced by <b>30</b> was similar to that of a historical KSP inhibitor that served as a positive control. Subsequent studies in a large cohort of nonxenografted mice revealed that the maximum-tolerated dose (MTD) of <b>30</b> when administered via minipump is 12 mg/kg over the course of 24 h.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Thus, <b>30</b> provides a maximal pharmacodynamic effect in tumors at its MTD in our in vivo assay.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Induction of mitotic block by <b>30</b> in tumors from a mouse xenograft assay at doses of 2.5, 5, 10, 20, and 40 (mg/kg)/day. Levels of phosphohistone H3 were measured in the tumor 22 h postdose and plotted relative to vehicle and a known KSPi positive control. Steady-state plasma concentrations were determined at the time of sacrifice by cardiac puncture and also showed a dose dependent increase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From a retrospective analysis, we believe that the superior in vivo activity of compounds in the C2-hydroxymethyl series, such as <b>11</b>, <b>14</b>, and <b>30</b>, is reflected by the combination of increased potency in both cell-based and serum-shifted biochemical KSP assays relative to <b>1</b>. As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, key compounds in the C2-hydroxymethyl series are approximately 4-fold more potent in the cell-based assay and 2- to 3-fold more potent in the KSP assay in the presence of 30% mouse serum. A similar explanation of improved in vivo potency holds across other series of KSP inhibitors recently reported from our group.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Correlation between Cell Potency, Serum Shift, and in Vivo Efficacy<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">KSP IC<sub>50</sub>(nM)</th><th align="center" valign="bottom" char="±">cell EC<sub>50</sub>(nM)</th><th align="center" valign="bottom" char="±">KSP + serum IC<sub>50</sub> (nM)<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a></th><th align="center" valign="bottom" char=".">in vivo EC<sub>90</sub> (nM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>1</b></td><td align="left" valign="top">5.2 × 0.8</td><td align="char" valign="top" char="±">22.5 ± 5.6</td><td align="char" valign="top" char="±">84.2 ± 6.0<a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a></td><td align="char" valign="top" char=".">1425</td></tr><tr valign="top"><td align="left" valign="top"><b>11</b></td><td align="left" valign="top">6.2 ± 2.9</td><td align="char" valign="top" char="±">5.6 ± 1.3</td><td align="char" valign="top" char="±">29.1 ± 6.5</td><td align="char" valign="top" char=".">125</td></tr><tr valign="top"><td align="left" valign="top"><b>14</b></td><td align="left" valign="top">5.0 ± 1.4</td><td align="char" valign="top" char="±">4.8 ± 0.8</td><td align="char" valign="top" char="±">38.8 ± 19</td><td align="char" valign="top" char=".">100</td></tr><tr valign="top"><td align="left" valign="top"><b>30</b></td><td align="left" valign="top">2.2 ± 1.2</td><td align="char" valign="top" char="±">5.3 ± 2.3</td><td align="char" valign="top" char="±">29.1 ± 12.2<a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a></td><td align="char" valign="top" char=".">94</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Average from at least <i>n</i> = 3 experiments, unless otherwise noted.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">KSP assay run in the presence of 30% mouse serum.</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last">Value is from <i>n</i> = 2 determinations.</p></div></div></div><div class="NLM_p">On the basis of the ability of <b>30</b> to induce mitotic arrest in tumors in vivo, we were encouraged to test its antitumor efficacy in xenograft models. In the clinic, cytotoxic chemotherapeutic agents are typically administered at their MTD on schedules designed to accommodate the induction and recovery from mechanism-based hematopoietic and gastrointestinal (GI) toxicities.<a onclick="showRef(event, 'cit4a'); return false;" href="javascript:void(0);" class="ref cit4a">(4a)</a> Typical regimes are once every 3 weeks, once weekly for 3 weeks, or once daily for 5 consecutive days. Thus, we wanted to test dosing protocols in our preclinical model that mimic these likely clinical schedules.</div><div class="NLM_p">First, studies were undertaken in naive mice to determine the MTD of <b>30</b> in protocols that varied the dose, vehicle, and frequency of administration, monitoring survival as an end point. In all cases of lethality following administration of <b>30</b>, death is observed at least 6 days after the start of dosing, suggesting that mechanism-based toxicity in hematopoietic and/or GI tissues is the causative factor. To provide support for this hypothesis, peripheral blood counts were determined during these studies to assess the myelosuppressive activity of <b>30</b>. Of the different blood cells, neutrophils are most strikingly and consistently depleted, with a nadir in counts on day 4 postdose and recovery to greater than predose levels by day 11 in surviving animals. The severity of neutrophil depletion is directly related to the dose of <b>30</b> and suggests that neutropenia may be the dose-limiting toxicity in mice.</div><div class="NLM_p">Over the course of a large number of experiments, we found that the schedule for administration of <b>30</b> that consistently provided the best efficacy is a q4d × 3 regime, where the MTD of <b>30</b> is 100 mpk in pH 4 saline given subcutaneously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As indicated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, <b>30</b> produced statistically significant inhibition of A2780 tumor growth under these conditions. In this experiment, the efficacy of <b>30</b> appears statistically superior to that of paclitaxel when given on its optimal schedule of qd × 5 at 20 mpk ip.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0011.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of A2780 tumor growth in mice. Both paclitaxel and <b>30</b> were dosed at their MTD on the schedule indicated. The data are plotted as the change in tumor volume relative to its starting volume, versus days following initial dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further our understanding of the potential for <b>30</b> to treat refractory tumors, we developed xenograft models utilizing paclitaxel-resistant cell lines. For this purpose, we choose the PTX10 cell line that carries a tubulin mutation at the taxane binding site,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> as well as the Pgp-overexpressing KB-v cell line utilized in our assay to determine MDR ratio. In order to provide a direct comparison of the in vivo efficacy of <b>30</b> and paclitaxel from the same study, we designed the assay as a dual flank xenograft model, wherein animals were implanted on contralateral flanks with both a taxane-sensitive cell line (A2780 or KB-3-1) and a taxane-resistant cell line (PTX10 or KB-v).</div><div class="NLM_p">As pictured in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, <b>30</b> maintains excellent efficacy against the paclitaxel-resistant PTX10 cell line that carries a tubulin mutation at the taxane binding site. In contrast, paclitaxel treatment produces no growth inhibition relative to vehicle in these tumors. Notably, the tumor growth inhibition pictured in Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> was obtained from the same animals in dual flank mode. In a similar vein, we were able to show that <b>30</b> inhibits the growth of KB-v tumors that highly overexpress Pgp, whereas paclitaxel has no effect (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Thus, <b>30</b> provides significant antitumor efficacy at its MTD in a mouse xenograft assay and is efficacious in tumors that are resistant to paclitaxel because of either tubulin mutation or Pgp overexpression.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0012.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of growth in PTX10 tumors that are paclitaxel-resistant because of a tubulin mutation. Both paclitaxel and <b>30</b> were dosed at their MTD on the schedule indicated. The data are plotted as the change in tumor volume relative to its starting volume, versus days following initial dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0013.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of growth in KB-v tumors that are paclitaxel-resistant because of Pgp overexpression. Both paclitaxel and <b>30</b> were dosed at their MTD on the schedule indicated. The data are plotted as the change in tumor volume relative to its starting volume, versus days following initial dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Studies were carried out with <b>30</b> to confirm that no undesired changes in overall profile or mechanism of action occurred during our lead optimization process. First, we determined that inhibition of KSP by <b>30</b> is not competitive with either ATP or microtubules. We also found that <b>30</b> is >20000-fold selective for KSP over a panel of eight structurally and functionally related kinesins (CENP-E, MKLP-1, Kif3A, Kif1B, uKHC, nKHC, KIF14, and MCAK; IC<sub>50</sub> > 50 μM in every case). These mechanistic observations suggest that <b>30</b> binds in the <i>induced-fit</i> allosteric site previously defined by our group.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This mode of binding nicely explains not only the lack of competition with microtubules and ATP but also the selectivity of <b>30</b> for KSP over other kinesins, since the binding site is adjacent to the L5 loop that is unique to the motor domain of KSP. Binding in this allosteric site has subsequently been confirmed for a number of structurally diverse KSP inhibitors, though several recent reports have identified ATP-competitive inhibitors that bind in the nucleotide binding site.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">The X-ray structure of the KSP−<b>30</b>−ADP ternary complex was determined to 2.3 Å resolution and confirms that <b>30</b> does indeed bind in the allosteric site of KSP (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Also of note is the conformation of the piperidine ring, wherein the fluorine is axial and the urea substituent occupies the equatorial position, as expected.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0014.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure of the active site of the KSP−<b>30</b>−ADP ternary complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Three general features present in the KSP−<b>30</b>−ADP ternary complex have been identified in progenitor compounds:<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (1) the difluorophenyl moiety of <b>30</b> occupies a large, hydrophobic area of the allosteric binding site (eastern pocket) made up of lipophilic residues L214, A218, F239, and I136; (2) the unsubstituted phenyl ring of <b>30</b> sits orthogonal to the core in a second, smaller region (western pocket) sandwiched between residue P137 (back) and the alkyl side chain of R119 (front); (3) the polar <i>N</i>-methyl-3-fluoro-4-(aminomethyl)piperidine moiety of <b>30</b> extends toward the solvent-exposed region located above the W127/Y211 π-stacking interaction that seals the protein cavity. The unique and most interesting interaction is the 2.5 Å hydrogen bond formed between the C2-hydroxymethyl group and the backbone carbonyl oxygen of residue G117 located at the roof of the cavity. The G117 carbonyl is the same functionality responsible for hydrogen-bonding to the side chain propylamino group of structures such as <b>1</b>.<a onclick="showRef(event, 'cit13c'); return false;" href="javascript:void(0);" class="ref cit13c">(13c)</a> Few polar regions are present in the allosteric binding site of KSP, and the hydroxymethyl group in <b>30</b> provides an optimal way to utilize the polarity offered by the G117 carbonyl without compromising any of the favorable hydrophobic interactions present in the previously investigated structural series.</div><div class="NLM_p">Compound <b>30</b> also behaves as expected in several assays that, collectively, strongly suggest that KSP inhibition is the mechanism of mitotic arrest and antitumor efficacy. Unlike taxanes and the epothilones, <b>30</b> has no effect on microtubule polymerization in vitro at 20 μM. Additionally, a cell-based assay measuring caspase-3 activation indicates that <b>30</b> induces apoptosis in A2780 cells with an EC<sub>50</sub> of 2.7 nM. Finally, monoaster formation, the phenotype characteristic of KSP inhibition, occurs in ∼90% of A2780 cells following a 16 h incubation with 50 nM of <b>30</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0015.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Immunofluorescence pictures of A2780 ovarian carcinoma cells treated with vehicle (left) or 50 nM of <b>30</b> (right) for 16 h (blue = DNA, green = microtubules). In the vehicle control image, cells in interphase, metaphase, and anaphase/telophase are visible.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Importantly, the physical properties and pharmacokinetic profile of <b>30</b> are consistent with that desired for a development compound. The free-base of <b>30</b> is a crystalline solid that is stable for 4 weeks at 80 °C open to air. The aqueous solubility of <b>30</b> is >50 mg/mL at pH 4.3, and if kept below room temperature, it has sufficient stability under these conditions to provide an acceptable clinical formulation. The metabolism and pharmacokinetic properties of <b>30</b> were studied in three preclinical species, and as illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, moderate-to-high plasma clearance with a half-life of 1−2 h was observed. The metabolic turnover of <b>30</b> is more rapid in animal liver microsomes and hepatocytes than in human, and all metabolites detected in human preparations are found in preclinical species. On the basis of a metabolic scaling method, <b>30</b> is predicted to be a low-to-moderate clearance compound in humans (1.4−7 (mL/min)/kg) with a half-life of 2−10 h. These parameters are supportive of continuous iv infusion in man.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetics of <b>30</b> in Preclinical Species<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">species</th><th align="center" valign="middle" char=".">iv dose</th><th align="center" valign="middle" char="±">Cl ((mL/min)/kg)</th><th align="center" valign="middle" char="±"><i>V</i><sub>dss</sub> (L/kg)</th><th align="center" valign="middle" char="±"><i>T</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">rat</td><td align="char" valign="top" char=".">1</td><td align="char" valign="top" char="±">66.7 ± 12</td><td align="char" valign="top" char="±">3.0 ± 0.6</td><td align="char" valign="top" char="±">1 ± 0.1</td></tr><tr valign="top"><td align="left" valign="top">dog</td><td align="char" valign="top" char=".">0.4</td><td align="char" valign="top" char="±">15.1 ± 6.4</td><td align="char" valign="top" char="±">1.6 ± 0.8</td><td align="char" valign="top" char="±">2 ± 0.2</td></tr><tr valign="top"><td align="left" valign="top">rhesus</td><td align="char" valign="top" char=".">0.4</td><td align="char" valign="top" char="±">23.1 ± 6.4</td><td align="char" valign="top" char="±">2.3 ± 0.4</td><td align="char" valign="top" char="±">1 ± 0.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Values are mean ± SD, <i>n</i> = 3.</p></div></div></div><div class="NLM_p">The overall safety profile of <b>30</b> is also acceptable for an antimitotic agent. Unlike <b>14</b>, no acute toxicity is observed in the rat with an iv bolus dose of 15 mg/kg (9.6 μM h<sup>−1</sup>), and <b>30</b> demonstrates >3000-fold selectivity for KSP over a panel of 160 enzymes, receptors, and transporters in a Panlabs screen at MDS Pharma. Gratifyingly, no QT interval prolongation was seen in preclinical cardiovascular safety studies, consistent with the optimized hERG profile achieved during the discovery effort. On the basis of its favorable efficacy, pharmacokinetic, and safety profile, <b>30</b> (MK-0731) was accepted for development and advanced into clinical trials.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p last">In a phase I open-label clinical trial to test safety and pharmacokinetic parameters in patients with taxane-refractory tumors, <b>30</b> was well-tolerated and exhibited dose-proportional exposure following a 24 h continuous infusion. As predicted, <b>30</b> is a low clearance compound (100−250 mL/min on average) with a half-life of 4−10 h in humans. At the MTD of 17 (mg/m<sup>2</sup>)/day every 21 days, <b>30</b> was well-tolerated with the anticipated dose-limiting toxicity of neutropenia.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We demonstrated herein that installation of a hydroxymethyl group at C2 of the dihydropyrrole core provided <b>11</b>, which had an optimized hERG profile relative to its progenitor, <b>2</b>. However, this change also engendered Pgp susceptibility. By carefully modulating the p<i>K</i><sub>a</sub> of the basic amine in <b>11</b>, we discovered fluoroethylated KSPi <b>14</b>, which had an optimal in vitro profile but was acutely toxic in vivo. Placement of the fluorine in a strategic, metabolically benign location on the piperidine ring allowed us to simultaneously avoid toxic metabolite formation and tune the p<i>K</i><sub>a</sub> of the nitrogen to provide <b>30</b> with an optimized in vitro and in vivo profile. In mouse xenograft assays, <b>30</b> induced dose-dependent mitotic arrest in tumors and inhibited tumor growth comparable to paclitaxel. Compound <b>30</b> also inhibited tumor growth in cell lines that are resistant to paclitaxel because of either tubulin mutations or Pgp-overexpression. The overall safety and pharmacokinetic profile supports the use of <b>30</b> for the treatment of cancer via continuous iv infusion. In clinical trials, <b>30</b> exhibits low systemic clearance and is well-tolerated at its MTD, resulting in the expected dose-limiting toxicity of neutropenia.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (A) Biology</h3><div class="NLM_p last">All animal studies were performed according to the NIH Guide for the Care and Use of Laboratory Animals, and experimental protocols were reviewed by the Merck Animal Care and Use Committee.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> KSP ATPase Assay</h3><div class="NLM_p last">The primary assay for KSP activity is based on a colorimetric determination of inorganic phosphate released from ATP. The KSP motor domain (1−367) was expressed in bacteria with a His<sub>6</sub> tag for purification. Microtubules are polymerized from tubulin at 37 °C, in the presence of 1 mM GTP and 10 μM paclitaxel, and are then separated from unpolymerized tubulin by centrifugation. Assays were performed in a 96-well plate, with each well containing 4 μL of a DMSO solution of test compound. Compounds were tested as an 11-point titration series, with 3-fold dilutions between each step, ranging from a concentration of 2 μM (in assay) to 34 pM. The reaction was started by adding 156 μL of the reaction buffer to each well; final reaction conditions were 80 mM K-HEPES (pH 6.8), 40 mM KCl, 1 mM EGTA, 0.01% BSA, 1 mM DTT, 2 mM MgCl2, 1 mM ATP, 0.5 μM tubulin (as polymerized microtubules), 2.5% DMSO, and 0.25 nM KSP. After incubation at room temperature for 3 h, reactions were quenched by addition of 240 μL/well of a solution containing 65 μg/mL quinaldine red, 0.093% polyvinyl alcohol, and 4.1 mM ammonium molybdate in 0.38 M sulfuric acid. After 5 min for color development, plates were read for optical absorbance at 540 nm. A serum-shifted assay was also run on selected compounds and was performed similarly. Serum was prepared for the assay by extensive dialysis against the primary reaction buffer, using dialysis membranes with a 12−14 kDa cutoff.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> KSP ATPase Selectivity</h3><div class="NLM_p last">Other kinesins assayed were isolated motor domains, cloned from the corresponding human sequences, and expressed and purified similarly to the procedure used for KSP (CENP-E:1−340, uKHC:1−337, nKHC:1−340, Kif1B:1−350, Kif3A:1−350, MKLP-1:1−435, Kif14:342−720). MCAK motor domain was purchased from Cytoskeleton. Assays were run similarly to the KSP assay described above except that 1 μL of <b>30</b> in DMSO was placed in a well to which 39 μL of reaction buffer was added. The reaction buffer used here was identical to that described above except that the tubulin concentration was 1 μM. After 50 min of incubation at room temperature, reactions were quenched by the addition of 40 μL of a solution containing 50 mM EDTA and 1.8 M KCl. Reactions were visualized by the addition of 120 μL of the quinaldine reagent described above. Compound <b>30</b> was tested at 50 and 5 μM. Enzyme concentrations varied depending on the enzyme tested: CENP-E, 5 nM; uKHC, 1.5 nM; nKHC, 10 nM; Kif1B, 5 nM; Kif3A, 2 nM; MKLP1, 50 nM; Kif14, 50 nM; MCAK, 50 nM. Compound <b>30</b> displayed an IC<sub>50</sub> > 50 μM against each kinesin tested.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Kinetic Competition Studies</h3><div class="NLM_p last">Assays used a method similar to that described for the primary KSP ATPase assay, with the exception that both ATP and microtubule concentrations varied. Compound <b>30</b> was tested at eight different concentrations, including a no compound control, from 0 to 12.5 nM. Either ATP or microtubules were varied independently from the compound over 12 different concentrations; ATP was varied from 10 to 400 μM, while microtubules were varied from 100 to 4000 nM. When ATP was varied, microtubule concentrations were fixed at 1 μM. When microtubules were varied, ATP concentration was fixed at 1 mM. The enzyme concentration tested was 0.5 nM. Reactions for each condition were initiated in a total volume of 700 μL. Eighty (80) μL aliquots were quenched by addition of an equal volume of a solution containing 50 mM EDTA and 1.8 M KCl at 4, 8, 14, 22, 30, 40, 55, and 70 min and held on ice. Phosphate was detected by addition of 240 μL of the quinaldine red reagent and incubated for 25 min before reading the absorbance at 540 nm. The data were first analyzed as a function of time to derive linear rates for each reaction condition. The velocity data were then analyzed with respect to the Michaelis−Menten or MM fit equation describing mixed inhibition using a nonlinear least-squares method. The data were also analyzed using an alternative model, which incorporates a correction for the reduction in compound concentration in the assay by the enzyme, as a function of enzyme concentration. This model gave essentially identical results to the Michaelis−Menten fit, indicating compound <b>30</b> is not competitive with either ATP or microtubules.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cell-Based Assay</h3><div class="NLM_p last">Mitotic arrest was measured by assessing the mitosis-specific phosphorylation of nucleolin using an antibody-coated, bead-based assay. In this assay, total nucleolin is captured on a streptavidin-coated paramagnetic bead coupled with biotinylated nucleolin monoclonal IgG1 antibody 4E2 (Research Diagnostics, Inc.). Nucleolin phosphorylation is detected by an antibody complex consisting of a phospho-specific nucleolin IgM monoclonal antibody, TG3 (Applied NeuroSolutions, Inc.) and a goat antimouse IgM labeled with a ruthenium Tris-bipyridyl complex (BV-TAG Technology, BioVeris Corp.). A2780 cells were seeded at 10 000 cells/well in 96-well plates and grown overnight. Cells were treated in triplicate with vehicle (DMSO) or test compound for 16 h. The final concentration of compound in the assay ranged from 300 to 0.3 nM in a 7-point, half-log dilution series, and the final DMSO concentration was 0.1% v/v. Cells were incubated with compound for 16 h, and then plates of cells were centrifuged at 1500 rpm for 5 min to collect floating cells, followed by lysis via shaking at 4 °C for 20 min in RIPA buffer (50 μL/well) that contained a complete set of protease inhibitors, 1 μL/mL DNase I, 1.0 mM sodium orthovanadate, and 1.0 μM microcystin. The following procedures were all done at room temperature. Streptavidin-coated paramagnetic Dynabeads (10 μg/well) were premixed with biotinylated 4E2 antinucleolin antibody (50 ng/well) in the assay buffer (pH 7.3 phosphate buffered saline, 1% BSA, and 0.5% Tween-20). The cell lysates (25 μL/well) were subsequently incubated with the premixed beads/4E2 antibody (25 μL/well) in 96-well plates by shaking for 30 min. The antiphosphonucleolin TG3 antibody was then added (50 ng/well), followed by shaking for another 30 min. Finally, a ruthenylated goat antimouse antibody (prepared immediately before use) was added (6 ng/well) and mixed by shaking plates for 2.5 h. The sample plates were read on an IGEN M-series M8 analyzer.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Tubulin Polymerization Assay</h3><div class="NLM_p last">Tubulin polymerization was monitored using the light-scattering properties of polymerized microtubules. The assay was carried out in a 96 well plate, using tubulin at a final concentration of 2.5 mg/mL, with 0.5 mM GTP, in a buffer of 80 mM K-PIPES, pH 6.8, 1 mM MgCl<sub>2</sub>, 1 mM EGTA. Compound <b>30</b> in DMSO (2 μL, final concentration of 20 μM) was added to 198 μL of reaction buffer, and the mixture was incubated at 37 °C. The optical density was measured at 320 and 340 nm every 30 s for 75 min. Assay plates contained controls for microtubule stabilization (paclitaxel, 20 μM) and inhibition of polymerization (colchicine, 20 μM).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Monoaster Formation</h3><div class="NLM_p last">The formation of monoastral spindles was detected by immunofluorescence microscopy in cultured A2780 cells. Cells were grown in microscopy slide chambers, exposed to <b>30</b> (5 or 50 nM) or vehicle (0.1% DMSO final concentration) for 16 h, and then permeabilized and fixed with 100 mM Pipes buffer (pH 6.8) containing 10 mM EGTA, 1 mM MgCl2, 0.2% Triton X-100, and 4% formaldehyde, for 10 min at room temperature (RT). The fixed cells were treated with 2% bovine serum albumin (BSA) in TBST (Tris-buffered saline containing 0.1% Tween-20) for 1 h to block nonspecific antibody binding. Subsequently, cells were incubated with an anti-α-tubulin monoclonal antibody (clone DM1, Sigma) (1:500) for 12 h at 4 °C, followed by an incubation with a FITC-conjugated donkey antimouse IgG (15 μg/mL) for 1 h at RT in the dark. Cells were then treated with the DNA stain Hoechst 33342 (10 μg/mL) for 10 min, and slides were mounted with an antifade kit. Between staining steps, cells were washed 3 times with TBST. Mitotic spindles were visualized by a fluorescence microscope.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Caspase-3 Assay</h3><div class="NLM_p last">A2780 cells were seeded at 20 000 cells /well in 96-well plates and grown overnight. Cells were treated in triplicate with vehicle (DMSO) or <b>30</b> for 48 h. The final concentration of compound in the assay ranged from 300 to 0.415 nM in a 7-point, 3-fold dilution series, and the final DMSO concentration was 0.1% v/v. Cells were lysed and the capase-3 activity in cell lysates was determined using the ApoAlert caspase fluorescent assay kit according to the manufacturer’s protocol. For compound <b>30</b>, EC<sub>50</sub> = 2.7 ± 0.4 nM (<i>n</i> = 6).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> hERG Binding Assay</h3><div class="NLM_p last">The binding assay was performed on membrane preparations from human embryonic kidney (HEK) cells constitutively expressing hERG. The membranes were prepared by homogenization of the HEK cells in Tris-EDTA buffer (50 mM Tris, 1 mM EDTA, pH 7.5) and centrifugation at 45000<i>g</i> for 20 min at 4 °C. The pellet containing membrane was resuspended in Tris-EDTA and stored at −70 °C. In the binding assay, hERG membranes were diluted into assay buffer (60 mM KCl, 71.5 mM NaCl, 1 mM CaCl<sub>2</sub>, 10 mM Hepes, pH 7.4) to a final concentration of 4.16 μg per 400 μL well volume. Radiolabeled ligand (<sup>35</sup>S-MK-499, specific activity of ∼1000 Ci/mmol) was then added to a final concentration of 50 pM, and 400 μL of membrane−ligand mixture was added per well to 96-well assay blocks containing 4 μL of 100× stocks of tested drugs or 100% DMSO (maximum binding control) or 100 μM cold MK-499 (nonspecific binding control). Membranes were incubated at room temperature for 75 min, filtered through GF/B Unifilters presoaked in 0.1% BSA, and washed 5 × 500 μL with wash buffer at 4 °C (10 mM Hepes, 131.5 mM NaCl, 1 mM CaCl<sub>2</sub>, 2 mM MgCl<sub>2</sub>, pH 7.4). Filters were dried at room temperature, 50 μL Microscint-20 was added to each well, and Unifilters were counted for 1 min. Dose−inhibition curves and inflection points were determined by curve-fitting the equation response = ((max − min)/(1 + ([I]/IP)<i>s</i>) + min, where I is the concentration of inhibitor, max is the maximum response (DMSO control), min is the minimum response (excess, cold ligand control), IP is the inflection point, and <i>s</i> is the slope. Generally, the inflection point is similar to the concentration of drug that inhibits 50% of radiotracer binding. Compounds were tested as an 8-point titration series, with 4-fold dilutions between each step, ranging from a concentration of 100 μM (in assay) to 6 nM.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> MDR Ratio</h3><div class="NLM_p last">The human KB-3-1 tumor cell line and a multidrug-resistant derivative that overexpresses MDR1 (KB-V-1) were used to evaluate the MDR ratio. The KB-V-1 cell line was originally derived by culturing KB-3-1 cells in vinblastine and displays cross-resistance to multiple cancer drugs.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Relative to KB-3-1, KB-V-1 expresses >500-fold higher levels of MDR1 mRNA. Compounds were evaluated for their ability to induce mitotic arrest in KB-3-1 and KB-V-1 cells by the phospho-nucleolin/mitotic arrest assay essentially as described above except that the final concentration of compound in the assay ranged from 10 000 to 0.1 nM in an 11-point, half-log dilution series. The MDR ratio is calculated by dividing the IC<sub>50</sub> in KB-V-1 cells by the IC<sub>50</sub> in KB-3-1 cells. Coadministration of verapamil, a competitive inhibitor of Pgp, restores the activity of paclitaxel and KSP inhibitors in the KB-V-1 cell line to nearly that observed in the parental KB-3-1 line, confirming that Pgp efflux is responsible for the observed resistance to drug-mediated mitotic arrest.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> In Vivo Mitotic Arrest Assay</h3><div class="NLM_p last">Subcutaneous (sc) xenograft tumors were formed by injection of the human A2780 ovarian carcinoma cell line in the hind flank of 8−12 week-old female immunodeficient nude mice (Crl:NU/NU-nuBR strain). Typically, animal weight ranged from 25 to 30 g. To facilitate tumor formation, cells were injected in media containing Matrigel, a solubilized basement membrane preparation extracted from the EHS mouse sarcoma. A2780 cells were grown in cell factories in RPMI medium + 10% serum, harvested by trypsinization and centrifugation, and resuspended in a 60:40 mixture of ice cold Matrigel/serum-free RPMI. Mice were lightly anesthetized via CO<sub>2</sub> inhalation, and 0.5 mL of cells (9 million) was injected sc into their hind flanks. On day 14 after tumor cell implantation, tumors were calipered and mice whose tumor volumes ranged typically from 300−900 mm<sup>3</sup> were selected for study. Mice were randomized according to tumor volumes and distributed into treatment groups of 6 mice with approximately equivalent ranges of tumor volumes between treatment groups. On day 15 after tumor implantation, mice were implanted with Alzet 2001D osmotic pumps containing vehicle, positive control (compound <b>19</b> from ref <a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">13b</a>), or varying concentrations of <b>30</b> solubilized in water acidified to pH 4.0 with HCl. The dose groups (7 mice per group) of <b>30</b> were 40 (mg/kg)/day (5.78 mg/mL), 20 (mg/kg)/day (2.89 mg/mL), 10 (mg/kg)/day (1.45 mg/mL), 5 (mg/kg)/day (0.72 mg/mL), and 2.5 (mg/kg)/day (0.36 mg/mL). Pumps were primed for 3 h at 37 °C in 0.9% saline bath prior to implantation. For pump implantation, mice were anesthetized by intraperitoneal (ip) injection of ∼0.1 mL of 7.7 mg/mL ketamine/0.46 mg/mL xylazine/0.9% saline mixture per 10 g body weight (typically, ∼25−28 g). Implantation involved cranial-caudal incision on the right dorso-lateral flank, and incisions were sutured with surgical staples. Mice were euthanized 22 h after pump implantation by CO<sub>2</sub> inhalation, tumors were excised for PD analysis (see below for method), and blood was removed by cardiac puncture using heparinized 20-gauge needles. Plasma was prepared from heparinized whole blood by centrifugation at 3000 rpm for 15 min at 4 °C and stored frozen prior to analysis for levels of <b>30</b>. Tumors were excised during necropsy and fixed for 24−48 h in 10% formalin (saline buffered). Tissues were paraffin-embedded, thin-sectioned (5 μm), and subject to antigen retrieval by heating (8 min, 20% microwave power) in target retrieval solution. Sections were immunostained with 1:200 diluted rabbit polyclonal anti-phosphohistone H3-Ser10 antibody followed by incubation with biotinylated goat antirabbit IgG [H + L] and then avidin-HRP. Signal was detected by development with HistoMark Black HRP substrate, followed by counterstaining with light-green counterstain. Immunostained tumor sections were quantitated by automated image acquisition and analysis. Images were captured using an inverted microscope fitted with a motorized stage and a digital camera. The percent of tumor area positively immunostained with phosphohistone H3-Ser10 was quantitated from the acquired images using Image Pro Plus software equipped with a custom macro. Necrotic regions of the tumor and regions with sporadic cellularity consisting primarily of Matrigel were excluded from the analysis. To eliminate subjectivity, data analysis using the Image Pro software was performed in a blinded fashion by two scientists. For each analyst’s data set, percent phosphohistone H3 stained tumor area in each drug treated tumor was normalized to the mean percent phosphohistone H3 stained tumor area in the vehicle control group to determine the fold induction in mitotic arrest (phosphohistone H3 staining) for each drug treated tumor. Fold-induction values for each tumor from the two analysts were averaged, and the mean ± SEM for each drug treatment group was calculated. The minimum plasma concentration required to induce the maximum amount of mitotic arrest in the tumor is defined as the EC<sub>90</sub> for in vivo activity.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Tumor Growth Inhibition Assay</h3><div class="NLM_p">The mice for the dual flank xenograft were generated as described above for nude mouse xenograft formation but were raised by subcutaneous injection of either 9 million A2780 and 6 million PTX10 cells (method A) or 2.5 million KB-3-1 and 9 million KB-v-1 cells (method B) on contralateral flanks. On day 13−14 after tumor cell implantation, tumors were calipered and mice whose tumor volumes ranged typically from 250 to 500 mm<sup>3</sup> were selected. Mice were randomized and distributed into treatment groups with approximately equivalent ranges of tumor volumes. For sc injection, <b>30</b> was formulated as a solution in acidified saline at pH 4.0, 100 μL was administered for a dose of 100 mpk on the q4d × 3 schedule (A2780/PTX10 experiment) or as a suspension in 0.5% w/v methylcellulose, and 100 μL was administered for a dose of 40 mpk on the qd × 1 schedule (KB-3-1/KB-v experiment). Paclitaxel was solubilized in a 1:1 (v/v) mixture of ethanol and Cremaphor-EL and then diluted in saline just prior to injection to make a working stock solution with final vehicle composition being ethanol/cremaphor/saline (10:10:80). Then 200 μL of this working solution was injected ip in mice daily for 5 consecutive days (qd × 5), delivering a dose of 20 mg/kg per day.</div><div class="NLM_p last">For efficacy evaluation, groups of 10−12 mice were dosed as indicated and their tumors were manually calipered on multiple days over the course of the study. Tumor volumes were evaluated for at least 10−11 days from the start of dosing. Tumor volumes were calculated according to the formula for volume of a prolate ellipsoid, (<i>W</i>2 × <i>L</i>)/2, where <i>W</i> (width) and <i>L</i> (length) are in millimeters and <i>L</i> ≥ <i>W</i>. The mean tumor volume change Δ<i>V</i>, for treatment (<i>T</i>) and control (<i>C</i>) groups was calculated by subtracting the initial tumor volume (<i>T</i><sub>i</sub>), obtained either the day prior to start of treatment (<i>d</i> − 1) or on the same day as the start of treatment but prior to administration of compound, from the tumor volume on the day of testing, 3−14 days after start of dosing. Percent change in tumor volume in the treatment group relative to control group (% <i>T</i>/<i>C</i>) was calculated as follows: <span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/jm-2008-00386y_m001.gif" alt="" /></img></span><span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/jm-2008-00386y_m002.gif" alt="" /></img></span> The error for each data point was determined by the following equation, where StdDev is the standard deviation and <i>n</i> is the number of animals in the given treatment group: <span class="NLM_disp-formula" id="eq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/jm-2008-00386y_m003.gif" alt="" /></img></span></div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (B) Chemistry</h3><div class="NLM_p last">All solvents used were commercially available “anhydrous” grade, and reagents were utilized without purification unless otherwise noted. Nonaqueous reactions were carried out in oven- or heat-gun-dried glassware under a nitrogen atmosphere. Magnetic stirring was used to agitate the reactions, and they were monitored for completion by either TLC (silica gel 60, Merck KGaA) or LC/MS (Waters 2690 separations module with a YMC Pro 50 mm × 3 mm i.d. C-18 column interfaced with a Waters Micromass ZMD spectrometer) utilizing a gradient of 0.05% TFA in water/acetonitrile with detection at 215 or 254 nm. A SmithCreator microwave from Personal Chemistry was used for microwave heating, and a CombiFlash system utilizing RediSep cartridges by Teledyne Isco was utilized for silica gel chromatography with fraction collection at 254 nm. Reverse phase HPLC purification was carried out on a Waters HPLC (XBridge Prep C-18 5 μM 19 mm × 150 mm column) utilizing a gradient of 0.1% TFA in water/acetonitrile with sample collection triggered by photodiode array detection. The reported yields are for isolated pure compounds unless otherwise noted and were not extensively optimized. Analytical HPLC was carried out on the above-mentioned LCMS system with a nine minute gradient (method A) and on a Hewlett-Packard 1100 series HPLC with a Sunfire C-18 5 μM 4.5 mm × 50 mm column and a gradient of 0.1% H<sub>3</sub>PO<sub>4</sub> in water/acetonitrile (method B). Both methods provided purities as measured by UV detection at 215 nm. Proton NMR spectra were recorded on a Varian INOVA 500 MHz spectrometer, and all chemical shifts are referenced to an internal standard of tetramethylsilane. High resolving power accurate mass measurement electrospray (ES) and atmospheric pressure chemical ionization (APCI) mass spectral data were acquired by use of a Bruker Daltonics 7T Fourier transform ion cyclotron resonance mass spectrometer (FT-ICR MS). Optical rotations were determined at 23 °C on a Perkin-Elmer 241 spectrometer in the solvents and concentrations specified.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl 4-Methylene-2-phenylpyrrolidine-2-carboxylate (<b>4</b>)</h3><div class="NLM_p last">To a suspension of phenylglycine methyl ester hydrochloride (1.0 kg, 4.96 mol), anhydrous Na<sub>2</sub>SO<sub>4</sub> (1.2 kg, 8.5 mol), and benzaldehyde (520 g, 4.91 mol) in 7.0 L of CH<sub>2</sub>Cl<sub>2</sub> in a 20 L jacketed reactor was added triethylamine (518 g, 5.13 mol). After the mixture was stirred for 6 days, the solids were filtered off and rinsed with an additional 4.7 L of CH<sub>2</sub>Cl<sub>2</sub>. The filtrates were combined and used as is for the following reaction. To the solution of crude imine in a total of 11.7 L of CH<sub>2</sub>Cl<sub>2</sub> was added tetrabutylammonium hydrogen sulfate (178 g, 0.52 mol, and methallyl dichloride (2.0 kg, 16 mol). Rapid stirring was initiated, and 7.8 L of a 10 M NaOH solution was added. After the mixture was stirred at room temperature overnight, the layers were split, and the bottom aqueous layer was removed. To the reactor was added 6 L of 1 M HCl, stirring was carried out for 2 h, the layers were separated, and the aqueous layer was basified to pH 8 with Na<sub>2</sub>CO<sub>3</sub> and extracted three times with EtOAc. The combined EtOAc extracts were concentrated to dryness, dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated aqueous NaHCO<sub>3</sub> and water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide 375 g of crude <b>4</b> that was carried into the next step without further purification.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 6-Methylene-7a-phenyltetrahydro-1<i>H</i>-pyrrolo[1,2-<i>c</i>][1,3]oxazol-3-one (<b>5</b>)</h3><div class="NLM_p last">A 20 L reactor was charged with 6.8 L of 1 M LAH in THF (6.8 mol) and cooled to 0 °C. A solution of crude <b>4</b> (375 g, 1.73 mol) in 2.0 L of THF was added to the reactor over 40 min, cooling was removed, and stirring was maintained for 1 h at room temperature. The reaction was carefully quenched with 257 mL water, followed by 257 mL of 15% NaOH, and then 770 mL of water. To the reactor was added 1.2 kg of Na<sub>2</sub>SO<sub>4</sub>. Stirring was maintained overnight, and the solids were filtered and washed with THF. The combined filtrates were concentrated to provide 320 g of a crude oil that was used in the next step without purification. This material was dissolved in 12 L of CH<sub>2</sub>Cl<sub>2</sub>, and to the mixture was added triethylamine (350 mL, 2.5 mol) and 1,1′-carbonyldiimidazole (357 g, 2.2 mol). After the mixture was stirred overnight at room temperature, the reaction was quenched with 1 M HCl, the layers were split, and the organic was washed with water. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to provide 336 g of <b>5</b> as a crude oil that was used in the next step without purification.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 7a-Phenyldihydro-1<i>H</i>-pyrrolo[1,2-<i>c</i>][1,3]oxazole-3,6(5<i>H</i>)-dione (<b>6</b>)</h3><div class="NLM_p last">Crude <b>5</b> (336 g, 1.56 mol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and split into two equal portions to process separately. The solution was cooled to −78 °C and purged with O<sub>2</sub>, and then ozone was bubbled through the solution at a rate of 5 L/min until a pale-blue color persisted (∼4 h). The mixture was purged of excess ozone, quenched dropwise with excess dimethyl sulfide (500 mL, ∼10 equiv), and allowed to slowly warm to room temperature overnight with stirring. The two runs were pooled, the solvents were removed by rotary evaporation, and the solid was triturated with acetone to provide 160 g of <b>6</b> (15% from phenylglycine methyl ester) as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.4 (m, 4H), 7.35 (m, 1H), 4.85 (d, <i>J</i> = 8.9 Hz, 1H), 4.30 (d, <i>J</i> = 8.9 Hz, 1H), 4.0 (d, <i>J</i> = 18.3 Hz, 1H), 3.55 (d, <i>J</i> = 18.3 Hz, 1H), 3.35 (d, <i>J</i> = 17.4 Hz), 2.90 (d, <i>J</i> = 17.4 Hz, 1H) ppm. LC/MS: <i>t</i><sub>R</sub> = 2.35 min (98% pure). LRMS = 218.0 (M + H).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 6-(2,5-Difluorophenyl)-7a-phenyl-5,7a-dihydro-1<i>H</i>-pyrrolo[1,2-<i>c</i>][1,3]oxazol-3-one (<b>7</b>)</h3><div class="NLM_p last">A suspension of <b>6</b> (12.5 g, 57.5 mmol) in 500 mL of THF was cooled to −78 °C. With rapid stirring, a 1 M solution of NaHMDS (69 mL, 69 mmol) was added dropwise and allowed to age for 30 min before warming to 0 °C for 1 h. The solution was cooled back to −78 °C, and solid <i>N</i>-phenylbis(trifluoromethanesulphonimide) (24.7 g, 69 mmol) was added in one portion. The mixture was allowed to warm slowly to room temperature overnight and quenched with a saturated solution of NH<sub>4</sub>Cl. The organic layer was separated, and the aqueous phase was extracted twice with EtOAc. The combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. This residue was dissolved in 400 mL of 1,2-dimethoxyethane, and to this was added 100 mL of water, LiCl (7.3 g, 172 mmol), Na<sub>2</sub>CO<sub>3</sub> (18.3 g, 172 mmol), and 2,5-difluorophenylboronic acid (16 g, 101 mmol). The solution was degassed with N<sub>2</sub> for 2 min, charged with tetrakis(triphenylphosphine)palladium(0) (3.5 g, 3 mmol), and heated to 90 °C for 3 h. After the mixture was cooled to room temperature, most of the DME was removed by distillation and the crude reaction was dumped into a separatory funnel with 500 mL of CH<sub>2</sub>Cl<sub>2</sub> and 200 mL of water. The layers were cut, and the aqueous layer was extracted twice more with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic phase was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated by rotary evaporation. The residue was dry loaded on silica and purified by column chromatography with a gradient of 0−100% CH<sub>2</sub>Cl<sub>2</sub> in hexanes to provide semipure <b>7</b> as a white solid. This material was triturated with 150 mL of Et<sub>2</sub>O, stirred overnight, and filtered to provide 12.5 g (69%) of <b>7</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.4 (m, 4H), 7.35 (m, 1H), 7.05 (m, 1H), 6.95 (m, 2H), 6.80 (d, <i>J</i> = 1.0 Hz, 1H), 4.85 (d, <i>J</i> = 15.0 Hz, 1H), 4.75 (d, <i>J</i> = 8.7 Hz, 1H), 4.50 (d, <i>J</i> = 8.7 Hz, 1H), 4.20 (m, 1H) ppm. LC/MS: <i>t</i><sub>R</sub> = 4.56 min (96% pure). LRMS = 313.9 (M + H).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(2,5-Difluorophenyl)-2-phenyl-2-[(1,1,2,2-tetramethylpropoxy)methyl]-2,5-dihydro-1<i>H</i>-pyrrole (<b>8</b>)</h3><div class="NLM_p last">To a suspension of <b>7</b> (12.2 g, 38.9 mmol) in 120 mL of EtOH was added 3 M NaOH (77.9 mL, 233 mmol). The mixture was heated to 60 °C for 4 h, cooled to room temperature, and added to a separatory funnel containing 250 mL of CHCl<sub>3</sub> and saturated brine. The layers were separated, and the aqueous phase was extracted twice with 2:1 CHCl<sub>3</sub>/EtOH. The combined organic layers were washed with brine and concentrated. This residue was suspended in 100 mL of CH<sub>2</sub>Cl<sub>2</sub> and 40 mL of DMF. Imidazole (10.6 g, 156 mmol) and TBSCl (12.3 g, 82 mmol) were added. The mixture was allowed to stir overnight, and it was added to a separatory funnel containing water and CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was washed several times with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to an amber oil. This crude material was dissolved in 100 mL of MeOH and treated with ∼100 mL of 2 M methylamine in MeOH for 4 h at room temperature (to cleave the <i>N</i>-TBS group on the core). Following concentration by rotary evaporation, the residue was purified by column chromatography with a gradient of 0−40% EtOAc in hexanes to provide 12.9 g (83%) of <b>8</b> as a white solid. LC/MS: <i>t</i><sub>R</sub> = 4.03 min (100% pure). LRMS = 402.0 (M + H).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (2<i>S</i>)-4-(2,5-Difluorophenyl)-2-phenyl-2-[(1,1,2,2-tetramethylpropoxy)methyl]-2,5-dihydro-1<i>H</i>-pyrrole [(<i>S</i>)-<b>8</b>]</h3><div class="NLM_p last">Resolution of the enantiomers of <b>8</b> was carried out chromatographically using a Chiralpak AD 10 cm × 50 cm column with 1% isopropanol in hexanes (containing 0.1% diethylamine as a modifier) at 175 mL/min. Injection of 20 g per run was determined to be optimal, with retention times of 35−55 min for peak 1 and 60−95 min for peak 2 and recovery of >95%. Analytical HPLC analysis of the eluent, carried out on a 4 mm × 250 mm Chiralpak AD column with the same eluent as above at a flow rate of 1 mL/min, indicated that the first enatiomer to elute (<i>t</i><sub>R</sub> = 7.97 min) was >99% ee and the second peak to elute (<i>t</i><sub>R</sub> = 10.0 min) was ∼99% ee. The first enatiomer to elute is the desired (<i>S</i>)-isomer as determined by KSP activity and X-ray analysis of subsequent analogues (see US2005/0038074 for small-molecule X-ray analysis of <b>30</b>). Data for (<i>S</i>)-<b>8</b>: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.55 (m, 2H), 7.37 (m, 2H), 7.28 (m, 1H), 7.05 (m, 1H), 6.95 (m, 2H), 6.75 (d, <i>J</i> = 1.6 Hz, 1H), 4.42 (d, <i>J</i> = 14.0 Hz, 1H), 4.10 (dd, <i>J</i> = 14.0, 1.6 Hz, 1H), 3.94 (d, <i>J</i> = 10.2 Hz, 1H), 3.74 (d, <i>J</i> = 10.2 Hz, 1H), 2.57 (bs, 1H), 0.85 (s, 9H), 0.02 (s, 3H), 0.00 (s, 3H) ppm. LC/MS: <i>t</i><sub>R</sub> = 4.03 min (100% pure). LRMS = 402.0 (M + H). [α]<sub>D</sub> +28.4 (<i>c</i> 1.0, chloroform).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (2<i>S</i>)-4-(2,5-Difluorophenyl)-2-(hydroxymethyl)-<i>N</i>,<i>N</i>-dimethyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (<b>9</b>)</h3><div class="NLM_p last">To a suspension of triphosgene (3.7 g, 12.5 mmol) in 400 mL of THF at 0 °C was added a solution of (<i>S</i>)-<b>8</b> (10 g, 24.9 mmol) and triethylamine (5.2 mL, 37.4 mmol) in THF over ∼2 min. After the mixture was warmed and stirred for 1 h at room temperature, a 2 M solution of dimethylamine in THF (50 mL, 100 mmol) was added and stirring was continued for 2 h. The mixture was added to a separatory funnel containing 100 mL of 1 M HCl, and the mixture was extracted twice with EtOAc. The combined organic layers were washed again with HCl and then with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was dissolved in 300 mL of THF and cooled to 0 °C, and 4 M HCl in dioxane (25 mL, 100 mmol) was added dropwise. The mixture was allowed to warm to room temperature and was stirred for 2 h before being added to a separatory funnel containing 5% aqueous Na<sub>2</sub>CO<sub>3</sub>. The mixture was extracted twice with EtOAc, washed with saturated brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by column chromatography with a gradient of 2−100% EtOAc in hexanes to provide 7.0 g (78%) of <b>9</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.35 (m, 4H), 7.25 (m, 1H), 7.05 (m, 1H), 6.95 (m, 2H), 6.28 (s, 1H), 5.46 (m, 1H), 4.86 (d, <i>J</i> = 13.8 Hz, 1H), 4.63 (d, <i>J</i> = 13.8 Hz, 1H), 4.42 (m, 1H), 4.00 (d, <i>J</i> = 12.2 Hz, 1H), 2.98 (s, 6H) ppm. HPLC purity: method A = 100%; method B = 98.5%. HRMS calcd for C<sub>20</sub>H<sub>20</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M + H): 359.1566. Found: 359.1564. [α]<sub>D</sub> −66.4 (<i>c</i> 1.0, chloroform).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (2<i>S</i>)-4-(2,5-Difluorophenyl)-2-(hydroxymethyl)-<i>N</i>-methyl-<i>N</i>-(1-methylpiperidin-4-yl)-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (<b>11</b>)</h3><div class="NLM_p last">To a suspension of triphosgene (982 mg, 9.7 mmol) in 100 mL of THF at 0 °C was added a solution of (<i>S</i>)-<b>8</b> (2.6 g, 6.5 mmol) and triethylamine (1.35 mL, 9.7 mmol) in THF over ∼2 min. After stirring for 1 h at 0 °C, the mixture was warmed to room temperature and stirred for an additional 2 h. The reaction was quenched with saturated aqueous brine, added to a separatory funnel containing EtOAc, and the layers were cut. The aqueous phase was extracted again with EtOAc and the combined organic layers were washed with saturated brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide the intermediate carbamoyl chloride. This material was dissolved in 100 mL of CH<sub>2</sub>Cl<sub>2</sub>, and 4-methylamino-<i>N</i>-methylpiperidine (1.67 g, 13 mmol) and triethylamine (2.7 mL, 19.4 mmol) were added, followed by a catalytic amount of DMAP. After being stirred overnight at room temperature, the mixture was added to a separatory funnel containing saturated aqueous NaHCO<sub>3</sub>, and the mixture was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by column chromatography with a gradient of 0−50% 20:1:1 EtOH/H<sub>2</sub>O/NH<sub>4</sub>OH in EtOAc to provide a colorless oil. This residue was dissolved in 150 mL of THF. The mixture was cooled to 0 °C, and 4 M HCl in dioxane (6.5 mL, 26 mmol) was added dropwise. The mixture was allowed to warm to room temperature and was stirred for 2 h before being added to a separatory funnel containing 5% aqueous Na<sub>2</sub>CO<sub>3</sub>. The mixture was extracted twice with EtOAc, washed with saturated brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. An attempt to purify the residue by column chromatography with a gradient of 0−50% 20:1:1 EtOH/H<sub>2</sub>O/NH<sub>4</sub>OH in EtOAc provided ∼2 g of <b>11</b> (70%) as a white solid but with only 87% purity. Analytically pure material was obtained by reverse phase HPLC purification of a portion of this material and free-basing the fractions with NaHCO<sub>3</sub>. The basic fractions were extracted with EtOAc, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide 380 mg of <b>11</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.35 (m, 4H), 7.25 (m, 1H), 7.05 (m, 1H), 6.95 (m, 2H), 6.29 (s, 1H), 5.40 (m, 1H), 4.83 (d, <i>J</i> = 13.7 Hz, 1H), 4.57 (d, <i>J</i> = 13.7 Hz, 1H), 4.42 (m, 1H), 4.00 (d, <i>J</i> = 12.0 Hz, 1H), 3.71 (m, 1H), 2.95 (m, 2H), 2.90 (s, 3H), 2.29 (s, 3H), 2.10 (m, 2H), 2.0 − 1.8 (m, 3H), 1.65 (m, 1H) ppm. HPLC purity: method A = 100%; method B = 100%. HRMS calcd for C<sub>25</sub>H<sub>29</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub> (M + H): 442.2301. Found: 442.2300. [α]<sub>D</sub> −41.9 (<i>c</i> 1.0, chloroform).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Benzyl 3-Fluoro-4-oxopiperidine-1-carboxylate (<b>18</b>)</h3><div class="NLM_p last">To a solution of benzyl-4-oxo-1-piperidinecarboxylate (50 g, 215 mmol) in 225 mL of DMF was added triethylamine (90 mL, 644 mmol) and then chlorotrimethylsilane (38.1 mL, 300 mmol). The mixture was heated at 80 °C overnight, cooled to room temperature, and then dumped into a separatory funnel containing hexanes. The mixture was partitioned with water, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated by rotary evaporation. The residue was dissolved in 1000 mL of CH<sub>3</sub>CN, cooled to 0 °C, and treated with Selectfluor (79.8 g, 225 mmol) in three portions over 5 min. After the mixture was stirred at room temperature overnight, most of the solvent was removed by rotary evaporation and then partitioned between EtOAc and water, separated, washed with saturated brine solution, dried over MgSO<sub>4</sub>, filtered, and concentrated by rotary evaporation. The residue was purified by column chromatography with a gradient of 33−66% EtOAc in hexanes to provide 48.5 g (90%) of <b>18</b> as a white solid. LRMS = 252 (M + H).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (±)-<i>trans</i>-Benzyl 3-Fluoro-4-(methylamino)piperidine-1-carboxylate (<b>19</b>) and (±)-<i>cis</i>-Benzyl 3-Fluoro-4-(methylamino)piperidine-1-carboxylate (<b>20</b>)</h3><div class="NLM_p last">To a solution of <b>18 (</b>10 g, 39.8 mmol) in 100 mL of MeOH was added acetic acid (∼5 mL) and a 2 M solution of methylamine in THF (60 mL, 120 mmol). After the mixture was strirred for 3 h, NaCNBH<sub>3</sub> (3.76 g, 60 mmol) was added. After the mixture was stirred overnight, the reaction was quenched with saturated aqueous NaHCO<sub>3</sub>, partitioned with CH<sub>2</sub>Cl<sub>2</sub>, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated by rotary evaporation. The residue was loaded onto a silica gel column and eluted with EtOAc, then 80:10:10 CHCl<sub>3</sub>/EtOAc/MeOH to provide 3.7 g (35%) of <b>19</b> (100% pure) and 2.9 g (27%) of <b>20</b> (100% pure) as colorless oils. Data for <b>19</b>, first to elute (confirmed by NOE analysis at −35 °C): <sup>1</sup>H NMR (500 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 7.4−7.3 (m, 5H), 5.1 (m, 2H), 4.4−4.1 (m, 2H), 3.9 (m, 1H), 3.15−3.05 (m, 2H), 2.75 (m, 1H), 2.4 (s, 3H), 2.0 (m, 1H), 1.25 (m, 1H) ppm. Data for <b>20</b>, second to elute (confirmed by NOE analysis at −35 °C): <sup>1</sup>H NMR (500 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 7.4−7.2 (m, 5H), 5.1 (m, 2H), 4.9−4.7 (m 1H), 4.4 (m, 1H), 4.15 (m, 1H), 3.1−2.9 (m, 2H), 2.6 (m, 1H), 2.4 (s, 3H), 1.8 (m, 1H), 1.6 (m, 1H) ppm. HRMS calcd for C<sub>26</sub>H<sub>30</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub> (M + H): 267.1504. Found: 267.1500. By a change of solvents, the cis-isomer can be obtained as the major product: To a solution of <b>18</b> (50.5 g, 201 mmol) in 700 mL of 1,2-dichloroethane was added a 2 M solution of methylamine in THF (201 mL, 402 mmol). After the mixture was stirred for 2 h, Na(OAc)<sub>3</sub>BH (64 g, 302 mmol) was added. After the mixture was stirred overnight, the reaction was quenched with saturated aqueous K<sub>2</sub>CO<sub>3</sub>, partitioned with CH<sub>2</sub>Cl<sub>2</sub>, separated, and the aqueous phase was extracted three times with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated by rotary evaporation. The residue was loaded onto a silica gel column and eluted with EtOAc, then 90:5:5 CHCl<sub>3</sub>/EtOAc/MeOH, and finally 80:10:10 CHCl<sub>3</sub>/EtOAc/MeOH. The column was repeated twice more on mixed fractions to provide 7 g (13%) of <b>19</b> and 38.7 g (72%) of <b>20</b> (100% pure).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Benzyl (3<i>S</i>,4<i>R</i>)-4-[(<i>tert</i>-Butoxycarbonyl)(methyl)amino]-3-fluoropiperidine-1-carboxylate (<b>23</b>) and Benzyl (3<i>R</i>,4<i>S</i>)-4-[(<i>tert</i>-Butoxycarbonyl)(methyl)amino]-3-fluoropiperidine-1-carboxylate (<b>24</b>)</h3><div class="NLM_p last">To a solution of <b>20</b> (2.9 g, 10.9 mmol) in 55 mL of CH<sub>2</sub>Cl<sub>2</sub> was added triethylamine (4.6 mL, 30.3 mmol) and di-<i>tert</i>-butyl dicarbonate (3.6 g, 16.4 mmol). After being stirred for 48 h, the mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and H<sub>2</sub>O, and the organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated by rotary evaporation. The residue was loaded onto a silica gel column in CHCl<sub>3</sub> and eluted with a gradient of 0−33% EtOAc in hexanes to provide a white solid. Resolution of the enantiomers was carried out chromatographically using a Chiralpak AD 10 cm × 50 cm column with 20% isopropanol in hexanes (with 0.1% diethylamine) at 150 mL/min to provide 1.78 g (45%) of the first eluting enatiomer <b>23</b> and 1.64 g (41%) of the second eluting enatiomer <b>24</b> (the absolute stereochemistry of <b>24</b> is assigned by small-molecule X-ray analysis of subsequent analogues (see US2005/0038074 or WO2005/102996). Analytical HPLC analysis of the eluent on a 4 mm × 250 mm Chiralpak AD column with 20% isopropanol in hexanes (with 0.1% diethylamine) at 1 mL/min indicated that <b>23</b> has <i>t</i><sub>R</sub> = 5.69 min and >98% ee and <b>24</b> has <i>t</i><sub>R</sub> = 6.52 min and ee = 98%. Data for <b>24</b>: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, extensive broadening at 25 °C) δ 7.4−7.3 (m, 5H), 5.13 (bs, 2H), 4.9−4.6 (m, 1H), 4.6−3.9 (m, 3H), 3.1−2.9 (m, 2H), 2.85 (bs, 3H), 2.15 (m, 1H), 1.5 (m, 1H), 1.47 (bs, 9H) ppm. HPLC purity: method A = 100%; method B = 100%. HRMS calcd for C<sub>19</sub>H<sub>27</sub>FN<sub>2</sub>O<sub>4</sub> (M + Na): 389.1847. Found: 389.1847. [α]<sub>D</sub> −72.9 (<i>c</i> 1.0, chloroform).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (3<i>R</i>,4<i>S</i>)-3-Fluoro-<i>N</i>,1-dimethylpiperidin-4-amine (<b>28</b>)</h3><div class="NLM_p last">To a solution of <b>24</b> (4.6 g, 12.5 mmol) in 150 mL of EtOH was added 1,4-cyclohexadiene (29.9 mL, 313 mmol) and 10% Pd on carbon (∼1 g). After being stirred overnight, the mixture was filtered through Celite and concentrated by rotary evaporation. The residue was dissolved in 75 mL of MeOH. Acetic acid (∼2 mL) and 37% aqueous formaldehyde (30.1 mL, 38 mmol) were added, and the mixture was stirred for 1 h. At that time, NaCNBH<sub>3</sub> (1.58 g, 25.1 mml) in 10 mL of MeOH was added and the mixture was aged for 2 h before being dumped into saturated aqueous NaHCO<sub>3</sub>. After extracting three times with CH<sub>2</sub>Cl<sub>2</sub>, the organic phase was washed with water, dried over MgSO<sub>4</sub>, filtered, and concentrated by rotary evaporation to provide 3.0 g of a colorless oil. LRMS = 247.2 (M + H). A portion of this material (1.43 g, 5.8 mmol) in 50 mL of EtOAc was treated with HCl gas until the solution was warm to the touch. The flask was capped and stirred for 2 h. The volatiles were removed by rotary evaporation, and the residue was triturated with Et<sub>2</sub>O and placed under high vacuum to provide a white solid. This material was partitioned between 5% aqueous Na<sub>2</sub>CO<sub>3</sub> and 2:1 CHCl<sub>3</sub>/EtOH. The layers were cut, and the aqueous phase was extracted twice more with 2:1 CHCl<sub>3</sub>/EtOH. The combined organic layers were washed with saturated brine and concentrated by rotary evaporation and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to provide 628 mg (50%) of <b>28</b> a colorless oil. <sup>1</sup>HNMR (500 MHz, CDCl<sub>3</sub>) δ 4.8 (d, <i>J</i> = 48.9 Hz, 1H), 3.15 (m, 1H), 2.85 (m, 1H), 2.5 (s, 3H), 2.45 (m, 1H), 2.3 (s, 3H), 2.2−2.0 (m, 2H), 1.9−1.7 (m, 2H) ppm. HRMS calcd for C<sub>7</sub>H<sub>15</sub>FN<sub>2</sub> (M + H): 147.1292. Found: 147.1300.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>S</i>)-2-({[<i>tert</i>-Butyl(dimethyl)silyl]oxy}methyl)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carbonyl Chloride (<b>29</b>)</h3><div class="NLM_p last">To a suspension of triphosgene (7.76 g, 26.2 mmol) in 600 mL of THF at 0 °C was added a solution of (<i>S</i>)-<b>8</b> (21 g, 52.3 mmol) and triethylamine (11 mL, 79 mmol) over ∼3 min. After being stirred for 1 h at 0 °C, the mixture was warmed to room temperature and stirred for an additional 3 h. The reaction was quenched with 300 mL of water, added to a separatory funnel containing EtOAc, and the layers were cut. The aqueous phase was extracted again with EtOAc, and the combined organic layers were washed with saturated brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, resuspended in CH<sub>2</sub>Cl<sub>2</sub>, and concentrated to provide <b>29</b> as a thick, colorless oil. This material is stable for months under nitrogen in a closed container at 0 °C. LC/MS (3.7 min run): <i>t</i><sub>R</sub> = 3.56 min (100% pure). LRMS = 464.1 (M + H).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (<b>30</b>)</h3><div class="NLM_p last">To a solution of <b>29</b> (1.6 g, 3.45 mmol) in 25 mL of THF was added <b>28</b> (630 mg, 4.3 mmol), triethylamine (1.44 mL, 10.3 mmol), and a catalytic amount of DMAP. After being stirred for 24 h at room temperature, the mixture was partitioned between EtOAc and saturated aqueous NaHCO<sub>3</sub>, and the organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated by rotary evaporation. The residue was purified by silica gel chromatography with 0−10% MeOH in CH<sub>2</sub>Cl<sub>2</sub> (containing ∼0.5% triethylamine) to provide ∼1.7 g of a pale-yellow taffy. This material was dissolved in 75 mL of CH<sub>3</sub>CN, 3 mL of triethylamine trihydrofluoride was added, and the mixture was stirred for 24 h at room temperature. An additional 3 mL of triethylamine trihydrofluoride was added, and the mixture was heated at 37 °C for 24 h. The mixture was cooled to room temperature, dumped into saturated aqueous NaHCO<sub>3</sub>, extracted three times with EtOAc, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated by rotary evaporation. The residue was purified by silica gel chromatography with a gradient of 0−50% 20:1:1 EtOH/NH<sub>4</sub>OH/H<sub>2</sub>O in EtOAc to provide 1.0 g (63%) of <b>30</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.35 (m, 4H), 7.25 (m, 1H), 7.05 (m, 1H), 6.95 (m, 2H), 6.28 (s, 1H), 5.22 (dd, <i>J</i> = 8.8, 3.7 Hz, 1H), 4.92 (d, <i>J</i> = 13.7 Hz, 1H), 4.80 (d, <i>J</i> = 50.3 Hz, 1H), 4.62 (d, <i>J</i> = 13.8 Hz, 1H), 4.44 (m, 1H), 4.1 − 4.0 (m, 2H), 3.15 (m, 1H), 3.11 (s, 3H), 3.0 (m, 1H), 2.4−2.1 (m, 3H), 2.31 (s, 3H), 1.70 (m, 1H) ppm. HPLC purity: method A = 100%; method B = 100%. HRMS calcd for C<sub>25</sub>H<sub>28</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub> (M + H): 460.2206. Found: 460.2213. [α]<sub>D</sub> −70.5 (<i>c</i> 1.0, chloroform).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Benzyl (3<i>S</i>,4<i>S</i>)-4-[(<i>tert</i>-Butoxycarbonyl)(methyl)amino]-3-fluoropiperidine-1-carboxylate (<b>21</b>) and Benzyl (3<i>R</i>,4<i>R</i>)-4-[(<i>tert</i>-Butoxycarbonyl)(methyl)amino]-3-fluoropiperidine-1-carboxylate (<b>22</b>)</h3><div class="NLM_p last">To a solution of <b>19</b> (3.7 g, 13.9 mmol) in 70 mL of CH<sub>2</sub>Cl<sub>2</sub> was added triethylamine (5.8 mL, 41.7 mmol) and di-<i>tert</i>-butyl dicarbonate (4.55 g, 20.9 mmol). After being stirred for 48 h, the mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and H<sub>2</sub>O, and the organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated by rotary evaporation. The residue was loaded onto a silica gel column in CHCl<sub>3</sub> and eluted with a gradient of 0−33% EtOAc in hexanes to provide a white solid. Resolution of the enantiomers was carried out chromatographically using a Chiralpak AD 10 cm × 50 cm column with 15% isopropanol in hexanes (with 0.1% diethylamine) at 150 mL/min to provide 2.3 g (45%) of the first eluting enatiomer <b>21</b> and 2.5 g (49%) of the second eluting enatiomer <b>22</b> (the absolute stereochemistry of <b>21</b> and <b>22</b> is not known but is tentatively assigned as shown to simplify visualization of the relative stereochemistry). Analytical HPLC analysis of the eluent on a 4 mm × 250 mm Chiralpak AD column with 15% isopropanol in hexanes (with 0.1% diethylamine) at 1 mL/min indicated that <b>21</b> has <i>t</i><sub>R</sub> = 7.41 min and 98% ee and <b>22</b> has <i>t</i><sub>R</sub> = 11.7 min and ee = 98%. Data for <b>21</b>: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, extensive broadening at 25 °C) δ 7.4−7.3 (m, 5H), 5.12 (bs, 2H), 4.7−4.35 (m, 2 H), 4.3−3.9 (m, 2H), 2.80 (bs, 5H), 1.8−1.6 (m, 2H), 1.46 (s, 9H) ppm. HPLC purity: method A = 100%; method B = 100%. HRMS calcd for C<sub>19</sub>H<sub>27</sub>FN<sub>2</sub>O<sub>4</sub> (M + Na): 389.1847. Found: 389.1850. [α]<sub>D</sub> −9.2 (<i>c</i> 1.0, chloroform).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>S</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (<b>31</b>)</h3><div class="NLM_p last">A procedure analogous to that used to prepare <b>30</b> was employed beginning with <b>21</b> to provide <b>31</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.35 (m, 4H), 7.25 (m, 1H), 7.05 (m, 1H), 6.95 (m, 2H), 6.29 (s, 1H), 4.91 (bs, 1H), 4.85 (dd, <i>J</i> = 14.2, 1.5 Hz, 1H), 4.8−4.7 (m, 1H), 4.71 (d, <i>J</i> = 12.8 Hz, 1H), 4.45 (m, 1H), 4.03 (d, <i>J</i> = 12.0 Hz, 1H), 3.82 (m, 1H), 3.26 (m, 1H), 2.90 (s, 3H), 2.83 (m, 1H), 2.33 (s, 3H), 2.15 (m, 1H), 2.05−1.9 (m, 2H), 1.70 (m, 1H) ppm. HPLC purity: method A = 100%; method B = 100%. HRMS calcd for C<sub>25</sub>H<sub>28</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub> (M + H): 460.2206. Found: 460.2196. [α]<sub>D</sub> −49.2 (<i>c</i> 0.5, chloroform).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/jm800386y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for compounds <b>12</b>−<b>16</b>, potency data for the epimers of <b>30</b> and <b>31</b>, and proton NMR spectra of all new compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800386y/suppl_file/jm800386y-file001.pdf">jm800386y-file001.pdf (605.87 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800386y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05724" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05724" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher D. Cox</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e6858e948f95b985899ea68b8394858dc885898b"><span class="__cf_email__" data-cfemail="36555e445f456955594e765b5344555d1855595b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul J. Coleman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Breslin</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David B. Whitman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert M. Garbaccio</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark E. Fraley</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolyn A. Buser</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eileen S. Walsh</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Hamilton</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Schaber</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert B. Lobell</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weikang Tao</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Davide</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald E. Diehl</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc T. Abrams</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vicki J. South</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans E. Huber</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maricel Torrent</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomayant Prueksaritanont</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunze Li</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald E. Slaughter</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Mahan</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Fernandez-Metzler</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youwei Yan</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence C. Kuo</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nancy E. Kohl</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George D. Hartman</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Cancer Research, Molecular Systems, Drug Metabolism, and Structural Biology, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Rick Woodward for the large-scale synthesis of intermediate <b>5</b>, Carl Homnick for determining chiral separation conditions for <b>8</b>, Dr. Chuck Ross and Joan Murphy for HRMS analysis, Dr. Steve Pitzenberger for 2D and NOE NMR analyses, Matt Zrada for p<i>K</i><sub>a</sub> determinations, Dr. David Dubost for stability and solubility measurements, and Dr. Tito Fojo of the National Institutes of Health for access to the PTX10 cell line.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Chabner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. G.,  Jr</span><span> </span><span class="NLM_article-title">Chemotherapy and the war on cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1038%2Fnrc1529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=15630416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVek" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=65-72&author=B.+A.+Chabnerauthor=T.+G.+Roberts&title=Chemotherapy+and+the+war+on+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy and the war on cancer</span></div><div class="casAuthors">Chabner, Bruce A.; Roberts, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-72</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The era of chemotherapy began in the 1940s with the first uses of nitrogen mustards and antifolate drugs.  Cancer drug development since then has transformed from a low-budget, government-supported research effort to a high-stakes, multi-billion dollar industry.  The targeted-therapy revolution has arrived, but the principles and limitations of chemotherapy discovered by the early researchers still apply.  This article chronicles the history of modern chemotherapy and identifies remaining challenges for the next generation of researchers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrszgbuDuTBobVg90H21EOLACvtfcHk0liNnhte0c3p4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVek&md5=d5c8b3dba59b9d6dcca473552525fa14</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1529%26sid%3Dliteratum%253Aachs%26aulast%3DChabner%26aufirst%3DB.%2BA.%26aulast%3DRoberts%26aufirst%3DT.%2BG.%26atitle%3DChemotherapy%2520and%2520the%2520war%2520on%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nadal, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olavarria, E.</span><span> </span><span class="NLM_article-title">Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies</span> <span class="citation_source-journal">J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1111%2Fj.1368-5031.2004.00173.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=15206509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslGksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2004&pages=511-516&author=E.+Nadalauthor=E.+Olavarria&title=Imatinib+mesylate+%28Gleevec%2FGlivec%29+a+molecular-targeted+therapy+for+chronic+myeloid+leukaemia+and+other+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies</span></div><div class="casAuthors">Nadal, E.; Olavarria, E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-516</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Imatinib mesylate (Gleevec/Glivec, Novartis, Basel, Switzerland), formerly called STI571, is a specific and potent inhibitor of the BCR-ABL tyrosine kinase, the mol. hallmark of chronic myeloid leukemia.  Several clin. trials have demonstrated the efficacy of imatinib in different phases of this disease.  On the other hand, imatinib is also active against other tyrosine kinases, such as ABL, the stem cell factor receptor (c-kit) and the platelet-derived growth factor receptor, whose inhibition might have potential implications for the treatment of several malignancies.  In this regard, imatinib has already shown a remarkable activity in patients with hypereosinophilic syndrome and gastrointestinal stromal tumors.  Imatinib is an example of how a better understanding of the pathogenetic mechanisms of a neoplastic disease can lead to the development of a mol.-targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlEoJuXQeoUbVg90H21EOLACvtfcHk0liNnhte0c3p4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslGksLo%253D&md5=6cbc6128a640d2835fa5640942e02d1d</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1111%2Fj.1368-5031.2004.00173.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1368-5031.2004.00173.x%26sid%3Dliteratum%253Aachs%26aulast%3DNadal%26aufirst%3DE.%26aulast%3DOlavarria%26aufirst%3DE.%26atitle%3DImatinib%2520mesylate%2520%2528Gleevec%252FGlivec%2529%2520a%2520molecular-targeted%2520therapy%2520for%2520chronic%2520myeloid%2520leukaemia%2520and%2520other%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Pract.%26date%3D2004%26volume%3D58%26spage%3D511%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hussain, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D. W.</span><span> </span><span class="NLM_article-title">Molecularly targeted therapeutics for breast cancer</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=215-224&author=S.+A.+Hussainauthor=D.+H.+Palmerauthor=D.+Spoonerauthor=D.+W.+Rea&title=Molecularly+targeted+therapeutics+for+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DS.%2BA.%26aulast%3DPalmer%26aufirst%3DD.%2BH.%26aulast%3DSpooner%26aufirst%3DD.%26aulast%3DRea%26aufirst%3DD.%2BW.%26atitle%3DMolecularly%2520targeted%2520therapeutics%2520for%2520breast%2520cancer%26jtitle%3DBioDrugs%26date%3D2007%26volume%3D21%26spage%3D215%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span> </span><span class="NLM_article-title">New molecularly targeted therapies for lung cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2740</span><span class="NLM_x">–</span> <span class="NLM_lpage">2750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=2740-2750&author=S.+Sunauthor=J.+H.+Schillerauthor=M.+Spinolaauthor=J.+D.+Minna&title=New+molecularly+targeted+therapies+for+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DSchiller%26aufirst%3DJ.%2BH.%26aulast%3DSpinola%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26atitle%3DNew%2520molecularly%2520targeted%2520therapies%2520for%2520lung%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D2740%26epage%3D2750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Grandinetti, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldspiel, B. R.</span><span> </span><span class="NLM_article-title">Sorafenib and sunitinib: novel targeted therapies for renal cell cancer</span> <span class="citation_source-journal">Pharmacotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1125-1144&author=C.+A.+Grandinettiauthor=B.+R.+Goldspiel&title=Sorafenib+and+sunitinib%3A+novel+targeted+therapies+for+renal+cell+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrandinetti%26aufirst%3DC.%2BA.%26aulast%3DGoldspiel%26aufirst%3DB.%2BR.%26atitle%3DSorafenib%2520and%2520sunitinib%253A%2520novel%2520targeted%2520therapies%2520for%2520renal%2520cell%2520cancer%26jtitle%3DPharmacotherapy%26date%3D2007%26volume%3D27%26spage%3D1125%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Conlin, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidman, A. D.</span><span> </span><span class="NLM_article-title">Taxanes in breast cancer: An update</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1007%2FBF02951422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=17164044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Grur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=22-30&author=A.+K.+Conlinauthor=A.+D.+Seidman&title=Taxanes+in+breast+cancer%3A+An+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Taxanes in breast cancer: an update</span></div><div class="casAuthors">Conlin, Alison K.; Seidman, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-30</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1523-3790</span>.
    
            (<span class="NLM_cas:orgname">Current Science Inc.</span>)
        </div><div class="casAbstract">A review.  Over the past decade the taxanes have proved to be fundamental in the treatment of breast cancer.  Initially found to have efficacy in metastatic breast cancer, the taxanes are now vital components in the treatment of early-stage disease, in which their addn. to adjuvant treatment of early breast cancer has been shown to improve overall survival.  In addn., the taxanes have demonstrated a role in first-line therapy for metastatic disease, with some of the highest efficacy of any class of chemotherapy.  Targeted therapies in combination with the taxanes have further improved survival for both early and metastatic disease.  New formulations of taxanes may both improve antitumor activity and reduce toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkK9pmS9I3abVg90H21EOLACvtfcHk0lgvo3e_oWU6VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Grur4%253D&md5=ded53533f64d08320ec1cb79c5ec2fbb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2FBF02951422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02951422%26sid%3Dliteratum%253Aachs%26aulast%3DConlin%26aufirst%3DA.%2BK.%26aulast%3DSeidman%26aufirst%3DA.%2BD.%26atitle%3DTaxanes%2520in%2520breast%2520cancer%253A%2520An%2520update%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2007%26volume%3D9%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Miglarese, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span> </span><span class="NLM_article-title">Development of new cancer therapeutic agents targeting mitosis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1517%2F13543784.15.11.1411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=17040200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyiurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=1411-1425&author=M.+R.+Miglareseauthor=R.+O.+Carlson&title=Development+of+new+cancer+therapeutic+agents+targeting+mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of new cancer therapeutic agents targeting mitosis</span></div><div class="casAuthors">Miglarese, Mark R.; Carlson, Robert O.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1411-1425</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Targeting cellular proliferation persists as a mainstay of cancer therapeutic strategy.  Although microtubule-targeting drugs (such as taxanes and vinca alkaloids) have been used successfully in the clinic to treat a variety of cancers, they carry substantial liabilities that have spurred drug companies to aggressively pursue new tubulin-targeting drug candidates with improved efficacy and toxicity profiles.  The recent discoveries of new mitotic targets for cancer therapy (such as kinesin spindle protein, Aurora kinases and Polo-like kinase-1) have also stimulated intense work focused on identifying novel antimitotic drugs directed at these new targets.  A no. of novel antimitotic drugs have demonstrated encouraging activity in preclin. models and have progressed into clin. development.  This review focuses on selected new antimitotic drugs under evaluation in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHZfWZQOMN27Vg90H21EOLACvtfcHk0lgvo3e_oWU6VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyiurvL&md5=3cfb8468b30b5206fe3f0413f9c8ec9f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1517%2F13543784.15.11.1411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.15.11.1411%26sid%3Dliteratum%253Aachs%26aulast%3DMiglarese%26aufirst%3DM.%2BR.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26atitle%3DDevelopment%2520of%2520new%2520cancer%2520therapeutic%2520agents%2520targeting%2520mitosis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D15%26spage%3D1411%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastians, H.</span><span> </span><span class="NLM_article-title">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1016%2Fj.drup.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=17669681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=162-181&author=M.+Schmidtauthor=H.+Bastians&title=Mitotic+drug+targets+and+the+development+of+novel+anti-mitotic+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span></div><div class="casAuthors">Schmidt, Mathias; Bastians, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">162-181</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that interfere with the normal progression of mitosis belong to the most successful chemotherapeutic compds. currently used for anti-cancer treatment.  Classically, these drugs are represented by microtubule binding drugs that inhibit the function of the mitotic spindle in order to halt the cell cycle in mitosis and to induce apoptosis in tumor cells.  However, these compds. act not only on proliferating tumor cells, but exhibit significant side effects on non-proliferating cells including neurons that are highly dependent on intracellular transport processes mediated by microtubules.  Therefore, there is a particular interest in developing novel anti-mitotic drugs that target non-microtubule structures.  In fact, recently several novel drugs that target mitotic kinesins or the Aurora and polo-like kinases have been developed and are currently tested in clin. trials.  In addn., approaches of cell cycle checkpoint abrogation during mitosis and at the G2/M transition inducing mitosis-assocd. tumor cell death are promising new strategies for anti-cancer therapy.  It is expected that this "next generation" of anti-mitotic drugs will be as successful as the classical anti-microtubule drugs, while avoiding some of the adverse side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOJi9lDecBLVg90H21EOLACvtfcHk0lgvo3e_oWU6VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N&md5=b7262b3578e6daaad41412780d022937</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DBastians%26aufirst%3DH.%26atitle%3DMitotic%2520drug%2520targets%2520and%2520the%2520development%2520of%2520novel%2520anti-mitotic%2520anticancer%2520drugs%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2007%26volume%3D10%26spage%3D162%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Wood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwell, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span> </span><span class="NLM_article-title">Past and future of the mitotic spindle as an oncology target</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1016%2FS1471-4892%2801%2900064-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=11710735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVelsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=370-377&author=K.+W.+Woodauthor=W.+D.+Cornwellauthor=J.+R.+Jackson&title=Past+and+future+of+the+mitotic+spindle+as+an+oncology+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Past and future of the mitotic spindle as an oncology target</span></div><div class="casAuthors">Wood, Kenneth W.; Cornwell, William D.; Jackson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Tubulin poisons were first discovered decades ago, but the recent clin. and com. success of Taxol has led to a renaissance in the search for novel mitotic spindle poisons to treat cancer.  Many tubulin poisons have been identified, but few have demonstrated clin. utility.  Recent studies have begun to identify the factors that differentiate the efficacy of these agents.  In addn., promising alternative approaches to targeting the mitotic spindle have been identified from detailed studies of mitotic regulation and mechanics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLTbni6UbogrVg90H21EOLACvtfcHk0lji8bYUNkrD_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVelsrk%253D&md5=1e7120d622f29b6d89d5127eaa72f61b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2801%2900064-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252801%252900064-9%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DK.%2BW.%26aulast%3DCornwell%26aufirst%3DW.%2BD.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26atitle%3DPast%2520and%2520future%2520of%2520the%2520mitotic%2520spindle%2520as%2520an%2520oncology%2520target%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2001%26volume%3D1%26spage%3D370%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0lji8bYUNkrD_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goldstein, L. S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philp, A. V.</span><span> </span><span class="NLM_article-title">The road less traveled: emerging principles of kinesin motor utilization</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1146%2Fannurev.cellbio.15.1.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=10611960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVSnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1999&pages=141-183&author=L.+S.+B.+Goldsteinauthor=A.+V.+Philp&title=The+road+less+traveled%3A+emerging+principles+of+kinesin+motor+utilization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">The road less traveled: emerging principles of kinesin motor utilization</span></div><div class="casAuthors">Goldstein, Lawrence S. B.; Philp, Alastair Valentine</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-183</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with approx. 220 refs.  Proteins of the kinesin superfamily utilize a conserved catalytic motor domain to generate movements in a wide variety of cellular processes.  In this review, we discuss the rapid expansion in our understanding of how eukaryotic cells take advantage of these proteins to generate force and movement in diverse functional contexts.  We summarize several recent examples revealing that the simplest view of a kinesin motor protein binding to and translocating a cargo along a microtubule track is inadequate.  In fact, this paradigm captures only a small subset of the many ways in which cells harness force prodn. to the generation of intracellular movements and functions.  We also highlight several situations where the catalytic kinesin motor domain may not be used to generate movement, but instead may be used in other biochem. and functional contexts.  Finally, we review some recent ideas about kinesin motor regulation, redundancy, and cargo attachment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoBQ1ujISDnrVg90H21EOLACvtfcHk0lji8bYUNkrD_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVSnur8%253D&md5=27625ad8c431a03f616e8f4c24f83c9e</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.15.1.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.15.1.141%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DL.%2BS.%2BB.%26aulast%3DPhilp%26aufirst%3DA.%2BV.%26atitle%3DThe%2520road%2520less%2520traveled%253A%2520emerging%2520principles%2520of%2520kinesin%2520motor%2520utilization%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D1999%26volume%3D15%26spage%3D141%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span> </span><span class="NLM_article-title">Kinesin motors and disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1016%2FS0962-8924%2802%2902400-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=12495847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsV2msbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=585-591&author=E.+Mandelkowauthor=E.-M.+Mandelkow&title=Kinesin+motors+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Kinesin motors and disease</span></div><div class="casAuthors">Mandelkow, Eckhard; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">585-591</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinesins are motor proteins that move cargoes such as vesicles, organelles and chromosomes along microtubules.  They are best known for their role in axonal transport and in mitosis.  There is a diverse family of kinesins, members of which differ in compn. and functions.  Roles of kinesins in diseases typically involve defective transport of cell components, transport of pathogens, or cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ptPoI2iRarVg90H21EOLACvtfcHk0lji8bYUNkrD_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsV2msbc%253D&md5=02ebe22982a81292c0a7ba93a7019712</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2802%2902400-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252802%252902400-5%26sid%3Dliteratum%253Aachs%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26atitle%3DKinesin%2520motors%2520and%2520disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2002%26volume%3D12%26spage%3D585%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sharp, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholey, J. M.</span><span> </span><span class="NLM_article-title">Microtubule motors in mitosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1038%2F35024000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=10993066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslSiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=41-47&author=D.+J.+Sharpauthor=G.+C.+Rogersauthor=J.+M.+Scholey&title=Microtubule+motors+in+mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule motors in mitosis</span></div><div class="casAuthors">Sharp, David J.; Rogers, Gregory C.; Scholey, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6800</span>),
    <span class="NLM_cas:pages">41-47</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 78 refs.  The mitotic spindle uses microtubule-based motor proteins to assemble itself and to segregate sister chromatids.  It is becoming clear that motors invoke several distinct mechanisms to generate the forces that drive mitosis.  Moreover, in carrying out its function, the spindle appears to pass through a series of transient steady-state structures, each established by a delicate balance of forces generated by multiple complementary and antagonistic motors.  Transitions from one steady state to the next can occur when a change in the activity of a subset of mitotic motors tips the balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSPtTwoWbhM7Vg90H21EOLACvtfcHk0lgsy64sZoxYcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslSiu7s%253D&md5=4cbeb9651ad5b8389ffd2fe8b8eb3b31</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2F35024000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35024000%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DD.%2BJ.%26aulast%3DRogers%26aufirst%3DG.%2BC.%26aulast%3DScholey%26aufirst%3DJ.%2BM.%26atitle%3DMicrotubule%2520motors%2520in%2520mitosis%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D41%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Heald, R.</span><span> </span><span class="NLM_article-title">Motor function in the mitotic spindle</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=399-402&author=R.+Heald&title=Motor+function+in+the+mitotic+spindle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeald%26aufirst%3DR.%26atitle%3DMotor%2520function%2520in%2520the%2520mitotic%2520spindle%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D399%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bergnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brejc, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belmont, L.</span><span> </span><span class="NLM_article-title">Mitotic kinesins: prospects for antimitotic drug discovery</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.2174%2F1568026053507697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=15853642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=127-145&author=G.+Bergnesauthor=K.+Brejcauthor=L.+Belmont&title=Mitotic+kinesins%3A+prospects+for+antimitotic+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic kinesins: prospects for antimitotic drug discovery</span></div><div class="casAuthors">Bergnes, Gustave; Brejc, Katjusa; Belmont, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-145</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinesins, mechanochem. enzymes that utilize the energy of ATP to translocate along or destabilize microtubules, are essential for accurate completion of cell division.  Recently, small mol. inhibitors of one kinesin, kinesin spindle protein (KSP/Eg5/kinesin 5), were shown to be efficacious in pre-clin. studies, with one quinazolinone-based inhibitor advancing to Phase II clin. trials as a potential anticancer chemotherapeutic agent.  This highlights the potential of KSP and other mitotic kinesins as targets for chemotherapeutic intervention.  Ten other kinesins were shown to play essential roles in cell division and thus may provide addnl. therapeutic opportunities.  In this review, the biol. roles of these proteins are described with emphasis on their importance to cell proliferation.  In addn., kinesin motor domain structure and mechanism are described with particular attention given to the conformational changes that offer opportunities for chem. inhibition.  Finally, a current list of KSP inhibitor classes is described in the context of their potential as clin. leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDH2W_-_N1cLVg90H21EOLACvtfcHk0lgsy64sZoxYcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLc%253D&md5=a9ce236f5aea736bfbbbe2638584b34c</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.2174%2F1568026053507697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507697%26sid%3Dliteratum%253Aachs%26aulast%3DBergnes%26aufirst%3DG.%26aulast%3DBrejc%26aufirst%3DK.%26aulast%3DBelmont%26aufirst%3DL.%26atitle%3DMitotic%2520kinesins%253A%2520prospects%2520for%2520antimitotic%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D127%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mayer, T. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, T. J.</span><span> </span><span class="NLM_article-title">Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1126%2Fscience.286.5441.971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=10542155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADyaK1MXntFaqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=971-974&author=T.+U.+Mayerauthor=T.+M.+Kapoorauthor=S.+J.+Haggartyauthor=R.+W.+Kingauthor=S.+L.+Schreiberauthor=T.+J.+Mitchison&title=Small+molecule+inhibitor+of+mitotic+spindle+bipolarity+identified+in+a+phenotype-based+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen</span></div><div class="casAuthors">Mayer, Thomas U.; Kapoor, Tarun M.; Haggarty, Stephen J.; King, Randall W.; Schreiber, Stuart L.; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5441</span>),
    <span class="NLM_cas:pages">971-974</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Small mols. that perturb specific protein functions are valuable tools for dissecting complex processes in mammalian cells.  A combination of two phenotype-based screens, one based on a specific posttranslational modification, the other visualizing microtubules and chromatin, was used to identify compds. that affect mitosis.  One compd., here named monastrol, arrested mammalian cells in mitosis with monopolar spindles.  In vitro, monastrol specifically inhibited the motility of the mitotic kinesin Eg5, a motor protein required for spindle bipolarity.  All previously known small mols. that specifically affect the mitotic machinery target tubulin.  Monastrol will therefore be a particularly useful tool for studying mitotic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogQtim1hvM_LVg90H21EOLACvtfcHk0lgsy64sZoxYcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFaqu7o%253D&md5=d1c47a3e2af49f229e5bf618ca2835f5</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5441.971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5441.971%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DT.%2BU.%26aulast%3DKapoor%26aufirst%3DT.%2BM.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibitor%2520of%2520mitotic%2520spindle%2520bipolarity%2520identified%2520in%2520a%2520phenotype-based%2520screen%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D971%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sakowicz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beraud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crompton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turincio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabala, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. W.</span><span> </span><span class="NLM_article-title">Antitumor activity of a kinesin inhibitor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3276</span><span class="NLM_x">–</span> <span class="NLM_lpage">3280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3276-3280&author=R.+Sakowiczauthor=J.+T.+Finerauthor=C.+Beraudauthor=A.+Cromptonauthor=E.+Lewisauthor=A.+Fritschauthor=Y.+Leeauthor=J.+Makauthor=R.+Moodyauthor=R.+Turincioauthor=J.+C.+Chabalaauthor=P.+Gonzalesauthor=S.+Rothauthor=S.+Weitmanauthor=K.+W.+Wood&title=Antitumor+activity+of+a+kinesin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakowicz%26aufirst%3DR.%26aulast%3DFiner%26aufirst%3DJ.%2BT.%26aulast%3DBeraud%26aufirst%3DC.%26aulast%3DCrompton%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DE.%26aulast%3DFritsch%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DMak%26aufirst%3DJ.%26aulast%3DMoody%26aufirst%3DR.%26aulast%3DTurincio%26aufirst%3DR.%26aulast%3DChabala%26aufirst%3DJ.%2BC.%26aulast%3DGonzales%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DS.%26aulast%3DWeitman%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DK.%2BW.%26atitle%3DAntitumor%2520activity%2520of%2520a%2520kinesin%2520inhibitor%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3276%26epage%3D3280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein inhibitors as anticancer agents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1517%2F13543776.16.11.1517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFems7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1517-1532&author=C.+Jiangauthor=Q.+Youauthor=Z.+Liauthor=Q.+Guo&title=Kinesin+spindle+protein+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Kinesin spindle protein inhibitors as anticancer agents</span></div><div class="casAuthors">Jiang, Cheng; You, Qidong; Li, Zhiyu; Guo, Qinglong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1517-1532</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Kinesin spindle protein (KSP), or Hs Eg5, is a member of the kinesin superfamily of mol. motor proteins that utilize the energy generated from the hydrolysis of ATP to transport vesicles, organelles and microtubules.  KSP plays essential roles in mitotic spindle function and its inhibition prevents normal bipolar spindle formation, leading to mitotic arrest and subsequently to apoptosis of cells.  Therefore, KSP inhibitors have potential as novel anticancer therapeutics.  Since the discovery of monastrol in 1999, many types of KSP inhibitors were reported.  This review describes the mechanism of action and development of different types of KSP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqah-wXCZWf6bVg90H21EOLACvtfcHk0liU71fQRM-1lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFems7jK&md5=dd6d0bb463788d201533de28696f5554</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.11.1517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.11.1517%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DQ.%26atitle%3DKinesin%2520spindle%2520protein%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D1517%26epage%3D1532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marcus, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelnak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannakakou, P.</span><span> </span><span class="NLM_article-title">Mitotic kinesin inhibitors induce mitotic arrest and cell death in paclitaxel-resistant and -sensitive cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">11569</span><span class="NLM_x">–</span> <span class="NLM_lpage">11577</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=11569-11577&author=A.+I.+Marcusauthor=U.+Petersauthor=S.+L.+Thomasauthor=S.+Garrettauthor=A.+Zelnakauthor=T.+M.+Kapoorauthor=P.+Giannakakou&title=Mitotic+kinesin+inhibitors+induce+mitotic+arrest+and+cell+death+in+paclitaxel-resistant+and+-sensitive+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarcus%26aufirst%3DA.%2BI.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DThomas%26aufirst%3DS.%2BL.%26aulast%3DGarrett%26aufirst%3DS.%26aulast%3DZelnak%26aufirst%3DA.%26aulast%3DKapoor%26aufirst%3DT.%2BM.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3DMitotic%2520kinesin%2520inhibitors%2520induce%2520mitotic%2520arrest%2520and%2520cell%2520death%2520in%2520paclitaxel-resistant%2520and%2520-sensitive%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D11569%26epage%3D11577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dutcher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novik, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcoullis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiernik, P. H.</span><span> </span><span class="NLM_article-title">20th-Century advances in drug therapy in oncology. Part II</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=11028247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Kmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2000&pages=1079-1092&author=J.+P.+Dutcherauthor=Y.+Novikauthor=K.+O%E2%80%99Boyleauthor=G.+Marcoullisauthor=C.+Seccoauthor=P.+H.+Wiernik&title=20th-Century+advances+in+drug+therapy+in+oncology.+Part+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">20th-century advances in drug therapy in oncology-part II</span></div><div class="casAuthors">Dutcher, Janice P.; Novik, Yelena; O'Boyle, Kevin; Marcoullis, George; Secco, Christiane; Wiernik, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1079-1092</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review with 180 refs.  Ongoing research in cancer therapy has led to the development of antineoplastic agents which target specific components of the cell cycle.  In Part II of this series, we discuss agents which target the mitotic mechanism by inhibiting microtubules.  Although many of these agents are being shown to have multiple effects, the Vinca alkaloids and the taxanes are known as antimitotic drugs.  They are among the most important anticancer agents currently available, and because of their unique mechanisms, can be combined with a wide variety of other antineoplastic agents in a spectrum of diseases.  In addn., in part II, we are discussing agents that target DNA and prevent replication and thus cell growth by inhibiting the enzymes which protect DNA during replication, the topoisomerases.  These drugs, too, have unique mechanisms of action and have become major components of combination regimens.  The topoisomerase I inhibitors are new drugs derived from an older parent drug, and their full possibilities are still being explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY9ROGkNmSNrVg90H21EOLACvtfcHk0liU71fQRM-1lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Kmt7Y%253D&md5=a919ccc80fd767d7da6e99173c5e8d85</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDutcher%26aufirst%3DJ.%2BP.%26aulast%3DNovik%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DK.%26aulast%3DMarcoullis%26aufirst%3DG.%26aulast%3DSecco%26aufirst%3DC.%26aulast%3DWiernik%26aufirst%3DP.%2BH.%26atitle%3D20th-Century%2520advances%2520in%2520drug%2520therapy%2520in%2520oncology.%2520Part%2520II%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D40%26spage%3D1079%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sorbera, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradell, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayés, M.</span><span> </span><span class="NLM_article-title">Ispinesib mesilate</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1358%2Fdof.2006.031.09.1034213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=778-787&author=L.+A.+Sorberaauthor=J.+Bolosauthor=N.+Serradellauthor=M.+Bay%C3%A9s&title=Ispinesib+mesilate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ispinesib mesilate</span></div><div class="casAuthors">Sorbera, L. A.; Bolos, J.; Serradell, N.; Bayes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">778-787</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  In the search for novel mitotic targets for the development of antineoplastic agents, Homo sapiens Eg5 kinesin spindle protein (KSP, HsEg5/KSP) was identified.  KSP is a member of a subfamily of kinesins that are involved in centrosome sepn. and bipolar spindle formation during mitosis.  It has been shown to function exclusively in mitosis and is preferentially over-expressed in malignant cells.  Inhibition of KSP interferes with the formation of the bipolar spindle required for proper sepn. and lining of chromosomes during mitosis, which ultimately leads to cell death.  KSP inhibitors may therefore effectively interfere with mitosis while showing an improved therapeutic index.  Ispinesib mesylate (715992, SB-715992, formerly CK-0238273) is one such KSP inhibitor that was found to be more selective for KSP over other members of the kinesin family.  It effectively induced tumor regression in several preclin. models.  Ispinesib was chosen for further development as an antimitotic agent and has shown efficacy in phase I and II trials in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeq9wPJpd0uLVg90H21EOLACvtfcHk0liU71fQRM-1lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKntw%253D%253D&md5=eee2df5eb9a47ce3c2882d2d150ae28a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.09.1034213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.09.1034213%26sid%3Dliteratum%253Aachs%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26aulast%3DBolos%26aufirst%3DJ.%26aulast%3DSerradell%26aufirst%3DN.%26aulast%3DBay%25C3%25A9s%26aufirst%3DM.%26atitle%3DIspinesib%2520mesilate%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D778%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><div class="note"><p class="first last">It is tempting to speculate that antimitotic agents designed to overcome known mechanisms of resistance, such as Pgp-overexpression and tubulin mutations, will lead to improved efficacy in the clinic against refractory tumors. Indeed, some recent studies have provided evidence in support of this hypothesis. See, for example, the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=It+is+tempting+to+speculate+that+antimitotic+agents+designed+to+overcome+known+mechanisms+of+resistance%2C+such+as+Pgp-overexpression+and+tubulin+mutations%2C+will+lead+to+improved+efficacy+in+the+clinic+against+refractory+tumors.+Indeed%2C+some+recent+studies+have+provided+evidence+in+support+of+this+hypothesis.+See%2C+for+example%2C+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Toppmeyer, D.; Seidman, A. D.; Pollak, M.; Russell, C.; Tkaczuk, K.; Verma, S.; Overmoyer, B.; Garg, V.; Ette, E.; Harding, M. W.; Demetri, G. D.</span><span> </span><span class="NLM_article-title">Safety and efficacy of the multidrug resistance inhibitor Incel (Biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel</span>.  <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span>− <span class="NLM_lpage">678</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=11895894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD38XislOqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=670-678&author=D.+Toppmeyer&author=A.+D.+Seidman&author=M.+Pollak&author=C.+Russell&author=K.+Tkaczuk&author=S.+Verma&author=B.+Overmoyer&author=V.+Garg&author=E.+Ette&author=M.+W.+Harding&author=G.+D.+Demetri&title=Safety+and+efficacy+of+the+multidrug+resistance+inhibitor+Incel+%28Biricodar%3B+VX-710%29+in+combination+with+paclitaxel+for+advanced+breast+cancer+refractory+to+paclitaxel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of the multidrug resistance inhibitor incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel</span></div><div class="casAuthors">Toppmeyer, Deborah; Seidman, Andrew D.; Pollak, Michael; Russell, Christy; Tkaczuk, Katherine; Verma, Shailendra; Overmoyer, Beth; Garg, Varun; Ette, Ene; Harding, Matthew W.; Demetri, George D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">670-678</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">VX-710 (biricodar, Incel) restores drug sensitivity to P-glycoprotein (MDR1) and multidrug resistance-assocd. protein (MRP1)-expressing cells.  This Phase II study evaluated the safety/tolerability, pharmacokinetics, and efficacy of VX-710 plus paclitaxel in women with locally advanced or metastatic breast cancer who were refractory to prior paclitaxel therapy.  Eligible patients had paclitaxel-refractory disease defined as progressive disease after a min. of two cycles of paclitaxel (weekly or 3-wk schedule) or relapsed/progressive disease within 6 mo of prior paclitaxel therapy.  Patients received 80 mg/m2 paclitaxel over 3 h starting 4 h after initiation of a 24-h continuous i.v. infusion of 120 mg/m2/h VX-710.  Cycles were repeated every 3 wk.  Thirty-seven patients received study treatment and 35 were evaluable for response.  VX-710 + paclitaxel therapy was generally well tolerated.  Myelosuppression was the principal toxicity, with a median nadir ANC cycle 1 of 0.76×109 cells/L and a 40% overall incidence of Grade 4 neutropenia.  Nonhematol. side effects (asthenia, paresthesia, headache, myalgia, nausea, and diarrhea) were generally mild to moderate and reversible.  Paclitaxel AUC (16.8±5.0 μg × h/mL) and clearance (5.1±1.3 L/h/m2) during the first treatment cycle were comparable with std. 175 mg/m2 paclitaxel administered in a 3-h schedule.  Four patients achieved partial responses (three of the four had progressive disease on prior paclitaxel) with a mean response duration of 5.5 mo.  The 11.4% (4 of 35) objective response rate obsd. in this study suggests that VX-710 can resensitize a subgroup of paclitaxel-refractory patients to paclitaxel.  The safety and pharmacokinetics of the VX-710/paclitaxel regimen support further evaluation in breast cancer patients with initial paclitaxel therapy to prevent emergence of the MDR phenotype in recurrent disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzLY_9EP6ep7Vg90H21EOLACvtfcHk0lgzQdr-6O5wLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislOqt7s%253D&md5=9fe5847597a8d38e98ba54b592def218</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToppmeyer%26aufirst%3DD.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520the%2520multidrug%2520resistance%2520inhibitor%2520Incel%2520%2528Biricodar%253B%2520VX-710%2529%2520in%2520combination%2520with%2520paclitaxel%2520for%2520advanced%2520breast%2520cancer%2520refractory%2520to%2520paclitaxel%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D670%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goodin, S.; Kane, M. P.; Rubin, E. H.</span><span> </span><span class="NLM_article-title">Epothilones: mechanism of action and biologic activity</span>.  <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span>− <span class="NLM_lpage">2025</span>.<div class="note"><p class="first last">However, results from these clinical trials, though positive, have been less than stellar, and the validity of this rationale is still often questioned. See the following:</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1200%2FJCO.2004.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=15143095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlCks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=2015-2025&author=S.+Goodin&author=M.+P.+Kane&author=E.+H.+Rubin&title=Epothilones%3A+mechanism+of+action+and+biologic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Epothilones: Mechanism of action and biologic activity</span></div><div class="casAuthors">Goodin, Susan; Kane, Michael P.; Rubin, Eric H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2015-2025</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Drugs that target microtubules are among the most commonly prescribed anticancer therapies.  Although the mechanisms by which perturbation of microtubule function leads to selective death of cancer cells remain unclear, several new microtubule-targeting compds. are undergoing clin. testing.  In part, these efforts focus on overcoming some of the problems assocd. with taxane-based therapies, including formulation and administration difficulties and susceptibility to resistance conferred by P-glycoprotein.  Epothilones have emerged from these efforts as a promising new class of anticancer drugs.  Preclin. studies indicate that epothilones bind to and stabilize microtubules in a manner similar but not identical to that of paclitaxel and that epothilones are effective in paclitaxel-resistant tumor models.  Clin. phase I and early phase II data are available for BMS-247550, BMS-310705, EPO906, and KOS-862.  The results suggest that these compds. have a broad range of antitumor activity at doses and schedules assocd. with tolerable side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9nGTh_uHrDrVg90H21EOLACvtfcHk0lgzQdr-6O5wLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlCks7w%253D&md5=97203c9109a4719c8395e46ffdd8683c</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DGoodin%26aufirst%3DS.%26atitle%3DEpothilones%253A%2520mechanism%2520of%2520action%2520and%2520biologic%2520activity%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D2015%26epage%3D2025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Greenberger, L. M.; Sampath, D.</span><span> </span><span class="NLM_article-title">Resistance to Taxanes</span>. In  <span class="citation_source-book">Cancer Drug Discovery and Development: Cancer Drug Resistance</span>; <span class="NLM_contrib-group">Teicher, B.</span>, Ed.; <span class="NLM_publisher-name">Humana Press Inc.</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">329</span>− <span class="NLM_lpage">357</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=329-357&author=L.+M.+Greenberger&author=D.+Sampathauthor=B.+Teicher&title=Cancer+Drug+Discovery+and+Development%3A+Cancer+Drug+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26atitle%3DResistance%2520to%2520Taxanes%26btitle%3DCancer%2520Drug%2520Discovery%2520and%2520Development%253A%2520Cancer%2520Drug%2520Resistance%26aulast%3DTeicher%26aufirst%3DB.%26pub%3DHumana%2520Press%2520Inc%26date%3D2006%26spage%3D329%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ferlini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raspaglio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicchillitti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozzetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prislei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartollino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, G.</span><span> </span><span class="NLM_article-title">Looking at drug resistance mechanisms for microtubule interacting drugs: Does TUBB3 work?</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.2174%2F156800907783220453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=18220531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFOnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=704-712&author=C.+Ferliniauthor=G.+Raspaglioauthor=L.+Cicchillittiauthor=S.+Mozzettiauthor=S.+Prisleiauthor=S.+Bartollinoauthor=G.+Scambia&title=Looking+at+drug+resistance+mechanisms+for+microtubule+interacting+drugs%3A+Does+TUBB3+work%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12dR"><div class="casContent"><span class="casTitleNuber">12d</span><div class="casTitle"><span class="NLM_cas:atitle">Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?</span></div><div class="casAuthors">Ferlini, Cristiano; Raspaglio, Giuseppina; Cicchillitti, Lucia; Mozzetti, Simona; Prislei, Silvia; Bartollino, Silvia; Scambia, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">704-712</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Vinca alkaloids and taxanes represent the mainstay of medical treatment of hematol. and solid tumors.  Unfortunately, a major clin. problem with these agents is drug resistance.  Although a plethora of mechanisms of drug resistance have been described, only a few of them have been validated in clin. trials.  Among these, the one involving the protein TUBB3 seems to represent a promising target for studying drug resistance.  In fact, it seems that this protein is a factor promoting cell survival and represents an endogenous element of an inherent drug-resistance program built into cells to counteract the activity of microtubule-interacting drugs.  Its pivotal role has been ascertained in clin. trials in lung, breast, and ovarian cancer, three diseases that can be successfully treated with microtubule-interacting drugs.  Although TUBB3 is probably not a unique factor in drug resistance, the hope is that direct targeting of this protein will increase the response to microtubule-interacting drugs, thereby overcoming an important element in the growth of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrWfd2bj6X67Vg90H21EOLACvtfcHk0lgzQdr-6O5wLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFOnsbo%253D&md5=42f53ae398eeeca0726f36dc32aaa37d</span></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.2174%2F156800907783220453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800907783220453%26sid%3Dliteratum%253Aachs%26aulast%3DFerlini%26aufirst%3DC.%26aulast%3DRaspaglio%26aufirst%3DG.%26aulast%3DCicchillitti%26aufirst%3DL.%26aulast%3DMozzetti%26aufirst%3DS.%26aulast%3DPrislei%26aufirst%3DS.%26aulast%3DBartollino%26aufirst%3DS.%26aulast%3DScambia%26aufirst%3DG.%26atitle%3DLooking%2520at%2520drug%2520resistance%2520mechanisms%2520for%2520microtubule%2520interacting%2520drugs%253A%2520Does%2520TUBB3%2520work%253F%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2007%26volume%3D7%26spage%3D704%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2041</span><span class="NLM_x">–</span> <span class="NLM_lpage">2045</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2041-2045&author=C.+D.+Coxauthor=M.+J.+Breslinauthor=B.+J.+Marianoauthor=P.+J.+Colemanauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=H.+E.+Huberauthor=N.+E.+Kohlauthor=M.+Torrentauthor=Y.+Yanauthor=L.+C.+Kuoauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+1%3A+The+discovery+of+3%2C5-dihydropyrazoles+as+potent+and+selective+inhibitors+of+the+mitotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DMariano%26aufirst%3DB.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25201%253A%2520The%2520discovery%2520of%25203%252C5-dihydropyrazoles%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520mitotic%2520kinesin%2520KSP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2041%26epage%3D2045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasber, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1775-1779&author=M.+E.+Fraleyauthor=R.+M.+Garbaccioauthor=K.+L.+Arringtonauthor=W.+F.+Hoffmanauthor=E.+S.+Tasberauthor=P.+J.+Colemanauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+Fernandezauthor=M.+D.+Schaberauthor=R.+B.+Lobellauthor=W.+Taoauthor=V.+J.+Southauthor=Y.+Yanauthor=L.+C.+Kuoauthor=T.+Prueksaritanontauthor=C.+Shuauthor=M.+Torrentauthor=D.+C.+Heimbrookauthor=N.+E.+Kohlauthor=H.+E.+Huberauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+2%3A+The+design%2C+synthesis%2C+and+characterization+of+2%2C4-diaryl-2%2C5-dihydropyrrole+inhibitors+of+the+mitotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DTasber%26aufirst%3DE.%2BS.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DSchaber%26aufirst%3DM.%2BD.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DShu%26aufirst%3DC.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25202%253A%2520The%2520design%252C%2520synthesis%252C%2520and%2520characterization%2520of%25202%252C4-diaryl-2%252C5-dihydropyrrole%2520inhibitors%2520of%2520the%2520mitotic%2520kinesin%2520KSP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1775%26epage%3D1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the miotic kinesin KSP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3175&author=C.+D.+Coxauthor=M.+Torrentauthor=M.+J.+Breslinauthor=B.+J.+Marianoauthor=D.+B.+Whitmanauthor=P.+J.+Colemanauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=M.+D.+Schaberauthor=R.+B.+Lobellauthor=W.+Taoauthor=V.+J.+Southauthor=N.+E.+Kohlauthor=Y.+Yanauthor=L.+C.+Kuoauthor=T.+Prueksaritanontauthor=D.+E.+Slaughterauthor=C.+Liauthor=E.+Mahanauthor=B.+Luauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+4%3A+Structure-based+design+of+5-alkylamino-3%2C5-diaryl-4%2C5-dihydropyrazoles+as+potent%2C+water-soluble+inhibitors+of+the+miotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DMariano%26aufirst%3DB.%2BJ.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DSchaber%26aufirst%3DM.%2BD.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DSlaughter%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMahan%26aufirst%3DE.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25204%253A%2520Structure-based%2520design%2520of%25205-alkylamino-3%252C5-diaryl-4%252C5-dihydropyrazoles%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520the%2520miotic%2520kinesin%2520KSP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zrada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 5: Discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by β-fluorination to overcome cellular efflux by P-glycoprotein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2697</span><span class="NLM_x">–</span> <span class="NLM_lpage">2702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2697-2702&author=C.+D.+Coxauthor=M.+J.+Breslinauthor=D.+B.+Whitmanauthor=P.+J.+Colemanauthor=R.+M.+Garbaccioauthor=M.+E.+Fraleyauthor=M.+M.+Zradaauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=R.+B.+Lobellauthor=W.+Taoauthor=M.+T.+Abramsauthor=V.+J.+Southauthor=H.+E.+Huberauthor=N.+E.+Kohlauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+5%3A+Discovery+of+2-propylamino-2%2C4-diaryl-2%2C5-dihydropyrroles+as+potent%2C+water-soluble+KSP+inhibitors%2C+and+modulation+of+their+basicity+by+%CE%B2-fluorination+to+overcome+cellular+efflux+by+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DZrada%26aufirst%3DM.%2BM.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DAbrams%26aufirst%3DM.%2BT.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25205%253A%2520Discovery%2520of%25202-propylamino-2%252C4-diaryl-2%252C5-dihydropyrroles%2520as%2520potent%252C%2520water-soluble%2520KSP%2520inhibitors%252C%2520and%2520modulation%2520of%2520their%2520basicity%2520by%2520%25CE%25B2-fluorination%2520to%2520overcome%2520cellular%2520efflux%2520by%2520P-glycoprotein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2697%26epage%3D2702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davide, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahan, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Metzler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salata, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5390</span><span class="NLM_x">–</span> <span class="NLM_lpage">5395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5390-5395&author=P.+J.+Colemanauthor=J.+D.+Schreierauthor=C.+D.+Coxauthor=M.+E.+Fraleyauthor=R.+M.+Garbaccioauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=R.+B.+Lobellauthor=K.+Rickertauthor=W.+Taoauthor=R.+E.+Diehlauthor=V.+J.+Southauthor=J.+P.+Davideauthor=N.+E.+Kohlauthor=Y.+Yanauthor=L.+Kuoauthor=T.+Prueksaritanontauthor=C.+Liauthor=E.+A.+Mahanauthor=C.+Fernandez-Metzlerauthor=J.+J.+Salataauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+6%3A+Design+and+synthesis+of+3%2C5-diaryl-4%2C5-dihydropyrazole+amides+as+potent+inhibitors+of+the+mitotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DDiehl%26aufirst%3DR.%2BE.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DDavide%26aufirst%3DJ.%2BP.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMahan%26aufirst%3DE.%2BA.%26aulast%3DFernandez-Metzler%26aufirst%3DC.%26aulast%3DSalata%26aufirst%3DJ.%2BJ.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25206%253A%2520Design%2520and%2520synthesis%2520of%25203%252C5-diaryl-4%252C5-dihydropyrazole%2520amides%2520as%2520potent%2520inhibitors%2520of%2520the%2520mitotic%2520kinesin%2520KSP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5390%26epage%3D5395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Roden, D. M.</span><span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0lidx3aBGRJMpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasber, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 3: Synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1780</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1780-1783&author=R.+M.+Garbaccioauthor=M.+E.+Fraleyauthor=E.+S.+Tasberauthor=C.+M.+Olsonauthor=W.+F.+Hoffmanauthor=K.+L.+Arringtonauthor=M.+Torrentauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=M.+D.+Schaberauthor=C.+Fernandezauthor=R.+B.+Lobellauthor=W.+Taoauthor=V.+J.+Southauthor=Y.+Yanauthor=L.+C.+Kuoauthor=T.+Prueksaritanontauthor=D.+E.+Slaughterauthor=C.+Shuauthor=D.+C.+Heimbrookauthor=N+E.+Kohlauthor=H.+E.+Huberauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+3%3A+Synthesis+and+evaluation+of+phenolic+2%2C4-diaryl-2%2C5-dihydropyrroles+with+reduced+hERG+binding+and+employment+of+a+phosphate+prodrug+strategy+for+aqueous+solubility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DTasber%26aufirst%3DE.%2BS.%26aulast%3DOlson%26aufirst%3DC.%2BM.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DSchaber%26aufirst%3DM.%2BD.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DSlaughter%26aufirst%3DD.%2BE.%26aulast%3DShu%26aufirst%3DC.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DKohl%26aufirst%3DN%2BE.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25203%253A%2520Synthesis%2520and%2520evaluation%2520of%2520phenolic%25202%252C4-diaryl-2%252C5-dihydropyrroles%2520with%2520reduced%2520hERG%2520binding%2520and%2520employment%2520of%2520a%2520phosphate%2520prodrug%2520strategy%2520for%2520aqueous%2520solubility%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1780%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lhR-tiAU0wdRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><div class="note"><p class="first last">By comparison, <b>2</b> had an MDR ratio of 4.6 with an EC<sub>50</sub> of 26.4 nM in the overexpressing cell line.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=By+comparison%2C+2+had+an+MDR+ratio+of+4.6+with+an+EC50+of+26.4+nM+in+the+overexpressing+cell+line."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">For a review of the relevance of Pgp to drug discovery, see the following:</p></div><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, M.</span><span> </span><span class="NLM_article-title">Clinical relevance of P-glycoprotein in drug therapy</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1081%2FDMR-120026871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=14705869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1ygsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=417-454&author=J.+H.+Linauthor=M.+Yamazaki&title=Clinical+relevance+of+P-glycoprotein+in+drug+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Relevance of P-Glycoprotein in Drug Therapy</span></div><div class="casAuthors">Lin, Jiunn H.; Yamazaki, Masayo</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">417-454</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  The drug efflux transporter P-glycoprotein (P-gp) is known to confer multidrug resistance in cancer chemotherapy.  The P-gp is highly expressed in many types of tumor cells, as well as many normal tissues, including the apical surface of intestinal epithelial cells, and the luminal surface of capillary endothelial cells in the brain.  Because of its expression and localization, it has been suggested that P-gp plays an important role in cancer chemotherapy, intestinal absorption, and brain uptake.  This review addresses the significance of the role of P-gp in cancer chemotherapy, drug absorption, and brain uptake.  Based on the clin. and animal studies with P-gp modulators, it has become apparent that the role of P-gp in multidrug resistance is far less important compared to other biol. factors.  Although P-gp is highly expressed in both intestinal epithelial cells and endothelial cells of brain capillaries and functions as an efflux transporter in both organs, the magnitude of P-gp's impact on intestinal absorption and brain uptake of drugs is quant. very different.  From animal and clin. studies, it is evident that P-gp plays a very important role in CNS penetration of drugs, whereas the effect of P-gp on drug absorption is not as important as generally believed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyF-MM7RjqZLVg90H21EOLACvtfcHk0lhR-tiAU0wdRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1ygsLw%253D&md5=22c8b47bccd0f577ca0f8589d442402f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1081%2FDMR-120026871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120026871%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DYamazaki%26aufirst%3DM.%26atitle%3DClinical%2520relevance%2520of%2520P-glycoprotein%2520in%2520drug%2520therapy%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2003%26volume%3D35%26spage%3D417%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">How does P-glycoprotein recognize its substrates?</span> <span class="citation_source-journal">Int. J. Clin. Pharmacol Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=9476149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1KntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1998&pages=50-54&author=A.+Seelig&title=How+does+P-glycoprotein+recognize+its+substrates%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">How does P-glycoprotein recognize its substrates?</span></div><div class="casAuthors">Seelig, A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-54</span>CODEN:
                <span class="NLM_cas:coden">ICTHEK</span>;
        ISSN:<span class="NLM_cas:issn">0946-1965</span>.
    
            (<span class="NLM_cas:orgname">Dustri-Verlag Dr. Karl Feistle</span>)
        </div><div class="casAbstract">The structures of 100 compds. previously tested as P-glycoprotein (Pgp) substrates were screened to find potential elements responsible for substrate-Pgp interaction and for Pgp overexpression.  It is suggested that a set of well-defined structural elements is required for an interaction with Pgp.  The recognition elements are formed by 2 (type I unit) or 3 electron donor groups (type II unit) with a fixed spatial sepn.  Type I units consist of 2 electron donor groups with a spatial sepn. of 2.5 ←.  Type II units contain either 2 electron donor groups with a spatial sepn. of 4.6 ← or 3 electron donor groups with a spatial sepn. of the outer 2 groups of 4.6 ←.  All mols. which contain at least 1 type I or 1 type II unit are predicted to be Pgp substrates.  The binding to Pgp increases with the strength and the no. of electron donor or H-bonding acceptor groups forming the type I and type II units.  Correspondingly a high percentage of amino acids with H-bonding donor side chains is found in the transmembrane sequences of Pgp relevant for substrate interaction.  Mols. which minimally contain 1 type II unit are predicted to be inducers of Pgp overexpression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAcqpuaufbjbVg90H21EOLACvtfcHk0lhR-tiAU0wdRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1KntA%253D%253D&md5=bf372aacf6a4015c2d60be921438daed</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DHow%2520does%2520P-glycoprotein%2520recognize%2520its%2520substrates%253F%26jtitle%3DInt.%2520J.%2520Clin.%2520Pharmacol%2520Ther.%26date%3D1998%26volume%3D36%26spage%3D50%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stouch, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, O.</span><span> </span><span class="NLM_article-title">Progress in understanding the structure−activity relationships of P-glycoproetin</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=315-328&author=T.+R.+Stouchauthor=O.+Gudmundsson&title=Progress+in+understanding+the+structure%E2%88%92activity+relationships+of+P-glycoproetin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStouch%26aufirst%3DT.%2BR.%26aulast%3DGudmundsson%26aufirst%3DO.%26atitle%3DProgress%2520in%2520understanding%2520the%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520P-glycoproetin%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D315%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Raub, T. J.</span><span> </span><span class="NLM_article-title">P-Glycoprotein recognition of substrates and circumvention through rational drug design</span> <span class="citation_source-journal">Mol. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp0500871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=3-25&author=T.+J.+Raub&title=P-Glycoprotein+recognition+of+substrates+and+circumvention+through+rational+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design</span></div><div class="casAuthors">Raub, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is now well recognized that membrane efflux transporters, esp. P-glycoprotein (P-gp; ABCB1), play a role in detg. the absorption, distribution, metab., excretion, and toxicol. behaviors of some drugs and mols. in development.  An investment in screening structure-activity relation (SAR) is warranted in early discovery when exposure and/or target activity in an in vivo efficacy model is not achieved and P-gp efflux is identified as a rate-limiting factor.  However, the amt. of investment in SAR must be placed into perspective by assessing the risks assocd. with the intended therapeutic target, the potency and margin of safety of the compd., the intended patient population(s), and the market competition.  The task of rationally designing a chem. strategy for circumventing a limiting P-gp interaction can be daunting.  The necessity of retaining biol. potency and metabolic stability places restrictions on what can be done, and the factors for P-gp recognition of substrates are complicated and poorly understood.  The parameters within the assays that affect overall pump efficiency or net efflux, such as passive diffusion, membrane partitioning, and mol. interaction between pump and substrate, should be understood when interpreting data sets assocd. with chem. around a scaffold.  No single, functional group alone is often the cause, but one group can accentuate the recognition points existing within a scaffold.  This can be likened to a rheostat, rather than an on/off switch, where addn. or removal of a key group can increase or decrease the pumping efficiency.  The most practical approach to de-emphasize the limiting effects of P-gp on a particular scaffold is to increase passive diffusion.  Efflux pumping efficiency may be overcome when passive diffusion is fast enough.  Eliminating, or substituting with fewer, groups that solvate in water, or decreasing their hydrogen bonding capacity, and adding halogen groups can increase passive diffusion.  Reducing mol. size, replacing electroneg. atoms, blocking or masking H-bond donors with N-alkylation or bulky flanking groups, introducing constrained conformation, or by promoting intramol. hydrogen bonds are all examples of steps to take.  This review discusses our understanding of how P-gp recognizes and pumps compds. as substrates and describes cases where structural changes were made in a chem. scaffold to circumvent the effects of P-gp interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRbEgPosNnxrVg90H21EOLACvtfcHk0lhR-tiAU0wdRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP&md5=cc89be920dfa0e32edb994be94626aa5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fmp0500871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp0500871%26sid%3Dliteratum%253Aachs%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DP-Glycoprotein%2520recognition%2520of%2520substrates%2520and%2520circumvention%2520through%2520rational%2520drug%2520design%26jtitle%3DMol.%2520Pharm.%26date%3D2006%26volume%3D3%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Yates, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearbey, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuetz, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaan, P. W.</span><span> </span><span class="NLM_article-title">Structural determinants of P-glycoprotein-mediated transport of glucocorticoids</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1794</span><span class="NLM_x">–</span> <span class="NLM_lpage">1803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=1794-1803&author=C.+R.+Yatesauthor=C.+Changauthor=J.+D.+Kearbeyauthor=K.+Yasudaauthor=E.+G.+Schuetzauthor=D.+D.+Millerauthor=J.+T.+Daltonauthor=P.+W.+Swaan&title=Structural+determinants+of+P-glycoprotein-mediated+transport+of+glucocorticoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DC.%2BR.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DKearbey%26aufirst%3DJ.%2BD.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DSchuetz%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26atitle%3DStructural%2520determinants%2520of%2520P-glycoprotein-mediated%2520transport%2520of%2520glucocorticoids%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26spage%3D1794%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cerny, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzlik, R. P.</span><span> </span><span class="NLM_article-title">Cyclopropylamine inactivation of cytochromes P450: role of metabolic intermediate complexes</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2005&pages=265-275&author=M.+A.+Cernyauthor=R.+P.+Hanzlik&title=Cyclopropylamine+inactivation+of+cytochromes+P450%3A+role+of+metabolic+intermediate+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCerny%26aufirst%3DM.%2BA.%26aulast%3DHanzlik%26aufirst%3DR.%2BP.%26atitle%3DCyclopropylamine%2520inactivation%2520of%2520cytochromes%2520P450%253A%2520role%2520of%2520metabolic%2520intermediate%2520complexes%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2005%26volume%3D426%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Goncharov, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radilov, A. S.</span><span> </span><span class="NLM_article-title">Toxicology of fluoroacetate: a review, with possible directions for therapy research</span> <span class="citation_source-journal">J. Appl. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1002%2Fjat.1118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=16252258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFerurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=148-161&author=N.+V.+Goncharovauthor=R.+O.+Jenkinsauthor=A.+S.+Radilov&title=Toxicology+of+fluoroacetate%3A+a+review%2C+with+possible+directions+for+therapy+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicology of fluoroacetate: a review, with possible directions for therapy research</span></div><div class="casAuthors">Goncharov, Nikolay V.; Jenkins, Richard O.; Radilov, Andrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-161</span>CODEN:
                <span class="NLM_cas:coden">JJATDK</span>;
        ISSN:<span class="NLM_cas:issn">0260-437X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Fluoroacetate (FA; CH2FCOOR) is highly toxic towards humans and other mammals through inhibition of the enzyme aconitase in the tricarboxylic acid cycle, caused by 'lethal synthesis' of an isomer of fluorocitrate (FC).  FA is found in a range of plant species and their ingestion can cause the death of ruminant animals.  Some fluorinated compds. used as anticancer agents, narcotic analgesics, pesticides or industrial chems. metabolize to FA as intermediate products.  The chem. characteristics of FA and the clin. signs of intoxication warrant the re-evaluation of the toxic danger of FA and renewed efforts in the search for effective therapeutic means.  Antidotal therapy for FA intoxication was aimed at preventing fluorocitrate synthesis and aconitase blockade in mitochondria, and at providing citrate outflow from this organelle.  Despite a greatly improved understanding of the biochem. mechanism of FA toxicity, ethanol, if taken immediately after the poisoning, was the most acceptable antidote for the past 6 decades.  This review deals with the clin. signs and physiol. and biochem. mechanisms of FA intoxication to provide an explanation of why, even after decades of investigation, has no effective therapy to FA intoxication been elaborated.  An apparent lack of integrated toxicol. studies is viewed as a limiter of progress in this regard.  Two principal ways of developing effective therapies for FA intoxication are considered.  Firstly, competitive inhibition of FA interaction with CoA and of FC interaction with aconitase.  Secondly, channeling the alternative metabolic pathways by orienting the fate of citrate via cytosolic aconitase, and by maintaining the flux of reducing equiv. into the TCA cycle via glutamate dehydrogenase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmt9jcqnW8rVg90H21EOLACvtfcHk0ljxejXCKHIAcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFerurs%253D&md5=d2e2b695c218a75c93b6a0c779e0bebb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fjat.1118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjat.1118%26sid%3Dliteratum%253Aachs%26aulast%3DGoncharov%26aufirst%3DN.%2BV.%26aulast%3DJenkins%26aufirst%3DR.%2BO.%26aulast%3DRadilov%26aufirst%3DA.%2BS.%26atitle%3DToxicology%2520of%2520fluoroacetate%253A%2520a%2520review%252C%2520with%2520possible%2520directions%2520for%2520therapy%2520research%26jtitle%3DJ.%2520Appl.%2520Toxicol.%26date%3D2006%26volume%3D26%26spage%3D148%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">van Niel, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broughton, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locker, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyes, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. L.</span><span> </span><span class="NLM_article-title">Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT<sub>1D</sub> receptor ligands with improved pharmacokinetic profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2087</span><span class="NLM_x">–</span> <span class="NLM_lpage">2104</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981133m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2087-2104&author=M.+B.+van+Nielauthor=I.+Collinsauthor=M.+S.+Beerauthor=H.+B.+Broughtonauthor=S.+K.+F.+Chengauthor=S.+C.+Goodacreauthor=A.+Healdauthor=K.+L.+Lockerauthor=A.+M.+MacLeodauthor=D.+Morrisonauthor=C.+R.+Moyesauthor=D.+O.+O%E2%80%99Connorauthor=A.+Pikeauthor=M.+Rowleyauthor=M.+G.+N.+Russellauthor=B.+Sohalauthor=J.+A.+Stantonauthor=S.+Thomasauthor=H.+Verrierauthor=A.+P.+Wattauthor=J.+L.+Castro&title=Fluorination+of+3-%283-%28piperidin-1-yl%29propyl%29indoles+and+3-%283-%28piperazin-1-yl%29propyl%29indoles+gives+selective+human+5-HT1D+receptor+ligands+with+improved+pharmacokinetic+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm981133m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981133m%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNiel%26aufirst%3DM.%2BB.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DBeer%26aufirst%3DM.%2BS.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DCheng%26aufirst%3DS.%2BK.%2BF.%26aulast%3DGoodacre%26aufirst%3DS.%2BC.%26aulast%3DHeald%26aufirst%3DA.%26aulast%3DLocker%26aufirst%3DK.%2BL.%26aulast%3DMacLeod%26aufirst%3DA.%2BM.%26aulast%3DMorrison%26aufirst%3DD.%26aulast%3DMoyes%26aufirst%3DC.%2BR.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%2BO.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DRussell%26aufirst%3DM.%2BG.%2BN.%26aulast%3DSohal%26aufirst%3DB.%26aulast%3DStanton%26aufirst%3DJ.%2BA.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DVerrier%26aufirst%3DH.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26atitle%3DFluorination%2520of%25203-%25283-%2528piperidin-1-yl%2529propyl%2529indoles%2520and%25203-%25283-%2528piperazin-1-yl%2529propyl%2529indoles%2520gives%2520selective%2520human%25205-HT1D%2520receptor%2520ligands%2520with%2520improved%2520pharmacokinetic%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2087%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><div class="note"><p class="first last">The absolute stereochemistry of <b>30</b> was proven by X-ray analysis, whereas the absolute stereochemistry at C3 and C4 of the piperidine ring in <b>31</b> is not known but is drawn as such to simplify visualization of the relative stereochemistry. See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a> for full details and characterization of all four isomers.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+absolute+stereochemistry+of+30+was+proven+by+X-ray+analysis%2C+whereas+the+absolute+stereochemistry+at+C3+and+C4+of+the+piperidine+ring+in+31+is+not+known+but+is+drawn+as+such+to+simplify+visualization+of+the+relative+stereochemistry.+See+Experimental+Section+and+Supporting+Information+for+full+details+and+characterization+of+all+four+isomers."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Crosio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fimia, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loury, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassone-Corsi, P.</span><span> </span><span class="NLM_article-title">Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian aurora kinases</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">874</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1128%2FMCB.22.3.874-885.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=11784863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt12nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=874-885&author=C.+Crosioauthor=G.+M.+Fimiaauthor=R.+Louryauthor=M.+Kimuraauthor=Y.+Okanoauthor=H.+Zhouauthor=S.+Senauthor=C.+D.+Allisauthor=P.+Sassone-Corsi&title=Mitotic+phosphorylation+of+histone+H3%3A+spatio-temporal+regulation+by+mammalian+aurora+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian aurora kinases</span></div><div class="casAuthors">Crosio, Claudia; Fimia, Gian Maria; Loury, Romain; Kimura, Masashi; Okano, Yukio; Zhou, Hongyi; Sen, Subrata; Allis, C. David; Sassone-Corsi, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-885</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Phosphorylation at a highly conserved serine residue (Ser-10) in the histone H3 tail is considered to be a crucial event for the onset of mitosis.  This modification appears early in the G2 phase within pericentromeric heterochromatin and spreads in an ordered fashion coincident with mitotic chromosome condensation.  Mutation of Ser-10 is essential in Tetrahymena, since it results in abnormal chromosome segregation and extensive chromosome loss during mitosis and meiosis, establishing a strong link between signaling and chromosome dynamics.  Although mitotic H3 phosphorylation has been long recognized, the transduction routes and the identity of the protein kinases involved have been elusive.  Here we show that the expression of Aurora-A and Aurora-B, two kinases of the Aurora/AIK family, is tightly coordinated with H3 phosphorylation during the G2/M transition.  During the G2 phase, the Aurora-A kinase is coexpressed while the Aurora-B kinase colocalizes with phosphorylated histone H3.  At prophase and metaphase, Aurora-A is highly localized in the centrosomic region and in the spindle poles while Aurora-B is present in the centromeric region concurrent with H3 phosphorylation, to then translocate by cytokinesis to the midbody region.  Both Aurora-A and Aurora-B proteins phys. interact with the H3 tail and efficiently phosphorylate Ser10 both in vitro and in vivo, even if Aurora-A appears to be a better H3 kinase than Aurora-B.  Since Aurora-A and Aurora-B are known to be overexpressed in a variety of human cancers, our findings provide an attractive link between cell transformation, chromatin modifications and a specific kinase system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOtyPtqNysDbVg90H21EOLACvtfcHk0ljbNey7Gv13kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt12nsA%253D%253D&md5=8e455152fc5b3244d07110ebcbfa0d0a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.3.874-885.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.3.874-885.2002%26sid%3Dliteratum%253Aachs%26aulast%3DCrosio%26aufirst%3DC.%26aulast%3DFimia%26aufirst%3DG.%2BM.%26aulast%3DLoury%26aufirst%3DR.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSen%26aufirst%3DS.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26aulast%3DSassone-Corsi%26aufirst%3DP.%26atitle%3DMitotic%2520phosphorylation%2520of%2520histone%2520H3%253A%2520spatio-temporal%2520regulation%2520by%2520mammalian%2520aurora%2520kinases%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D874%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davide, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span> </span><span class="NLM_article-title">Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=49-59&author=W.+Taoauthor=V.+J.+Southauthor=Y.+Zhangauthor=J.+P.+Davideauthor=L.+Farrellauthor=N.+E.+Kohlauthor=L.+Sepp-Lorenzinoauthor=R.+B.+Lobell&title=Induction+of+apoptosis+by+an+inhibitor+of+the+mitotic+kinesin+KSP+requires+both+activation+of+the+spindle+assembly+checkpoint+and+mitotic+slippage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DW.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDavide%26aufirst%3DJ.%2BP.%26aulast%3DFarrell%26aufirst%3DL.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26atitle%3DInduction%2520of%2520apoptosis%2520by%2520an%2520inhibitor%2520of%2520the%2520mitotic%2520kinesin%2520KSP%2520requires%2520both%2520activation%2520of%2520the%2520spindle%2520assembly%2520checkpoint%2520and%2520mitotic%2520slippage%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26spage%3D49%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><div class="note"><p class="first last">In mouse models, MTD is typically defined as ≤10% deaths due to mechanism-based toxicity. In studies with <b>30</b> infused at 12 (mg/kg)/day, there was 1 death out of 34 mice dosed, providing a 3% rate of death for this cohort</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+mouse+models%2C+MTD+is+typically+defined+as+%E2%89%A410%25+deaths+due+to+mechanism-based+toxicity.+In+studies+with+30+infused+at+12+%28mg%2Fkg%29%2Fday%2C+there+was+1+death+out+of+34+mice+dosed%2C+providing+a+3%25+rate+of+death+for+this+cohort."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">The sequence of KSP is highly conserved across species, and the IC<sub>50</sub> of <b>30</b> was found to be 2.2 ± 1.2 nM and 4.8 ± 1.0 nM against human and mouse KSP, respectively. Therefore, we expect little difference in therapeutic index across species due to differences in KSP potency</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+sequence+of+KSP+is+highly+conserved+across+species%2C+and+the+IC50+of+30+was+found+to+be+2.2+%C2%B1+1.2+nM+and+4.8+%C2%B1+1.0+nM+against+human+and+mouse+KSP%2C+respectively.+Therefore%2C+we+expect+little+difference+in+therapeutic+index+across+species+due+to+differences+in+KSP+potency."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><div class="note"><p class="first last">For instance, compound <b>24</b> in ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a> has cell potency and serum shift numbers of 3.4 and 6.6 nM, respectively, and its in vivo EC<sub>90</sub> is 38 nM</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+instance%2C+compound+24+in+ref+14+has+cell+potency+and+serum+shift+numbers+of+3.4+and+6.6+nM%2C+respectively%2C+and+its+in+vivo+EC90+is+38+nM."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><div class="note"><p class="first last">Because mice become neutropenic and recover more quickly than humans, a once per week for 3 weeks schedule in humans (q7d × 3) is mimicked by a once every 4 days for 12 days cycle in mouse (q4d × 3). Minipumps were not used in this protocol to allow for dosing on multiple days</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Because+mice+become+neutropenic+and+recover+more+quickly+than+humans%2C+a+once+per+week+for+3+weeks+schedule+in+humans+%28q7d+%C3%97+3%29+is+mimicked+by+a+once+every+4+days+for+12+days+cycle+in+mouse+%28q4d+%C3%97+3%29.+Minipumps+were+not+used+in+this+protocol+to+allow+for+dosing+on+multiple+days."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Giannakakou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sackett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buters, J. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poruchynsky, M. S.</span><span> </span><span class="NLM_article-title">Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">17118</span><span class="NLM_x">–</span> <span class="NLM_lpage">17125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=17118-17125&author=P.+Giannakakouauthor=D.+L.+Sackettauthor=Y.-K.+Kangauthor=Z.+Zhanauthor=J.+T.+M.+Butersauthor=T.+Fojoauthor=M.+S.+Poruchynsky&title=Paclitaxel-resistant+human+ovarian+cancer+cells+have+mutant+%CE%B2-tubulins+that+exhibit+impaired+paclitaxel-driven+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiannakakou%26aufirst%3DP.%26aulast%3DSackett%26aufirst%3DD.%2BL.%26aulast%3DKang%26aufirst%3DY.-K.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DButers%26aufirst%3DJ.%2BT.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DPoruchynsky%26aufirst%3DM.%2BS.%26atitle%3DPaclitaxel-resistant%2520human%2520ovarian%2520cancer%2520cells%2520have%2520mutant%2520%25CE%25B2-tubulins%2520that%2520exhibit%2520impaired%2520paclitaxel-driven%2520polymerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D17118%26epage%3D17125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><div class="note"><p class="first last">The data shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> for efficacy in the KB-v cell line were generated by dosing <b>30</b> on a qd × 1 schedule at 40 mpk as a suspension in methylcellulose. This represents the MTD for this schedule, and this dosing paradigm has shown good efficacy in a number of experiments. The data from the q4d × 3 schedule in the KB-v cell line are not shown because in this experiment (run only once), the vehicle control group displayed much less tumor progression than expected, similar to that of the group treated with <b>30</b>. However, as expected, the mice treated with paclitaxel in this study experienced significant tumor growth. The reason for the low rate of tumor progression in the vehicle group from this experiment is not known</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+data+shown+in+Figure+4+for+efficacy+in+the+KB-v+cell+line+were+generated+by+dosing+30+on+a+qd+%C3%97+1+schedule+at+40+mpk+as+a+suspension+in+methylcellulose.+This+represents+the+MTD+for+this+schedule%2C+and+this+dosing+paradigm+has+shown+good+efficacy+in+a+number+of+experiments.+The+data+from+the+q4d+%C3%97+3+schedule+in+the+KB-v+cell+line+are+not+shown+because+in+this+experiment+%28run+only+once%29%2C+the+vehicle+control+group+displayed+much+less+tumor+progression+than+expected%2C+similar+to+that+of+the+group+treated+with+30.+However%2C+as+expected%2C+the+mice+treated+with+paclitaxel+in+this+study+experienced+significant+tumor+growth.+The+reason+for+the+low+rate+of+tumor+progression+in+the+vehicle+group+from+this+experiment+is+not+known."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halczenko, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span> </span><span class="NLM_article-title">Inhibition of a mitotic motor protein: where, how, and conformational consequences</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2004&pages=547-554&author=Y.+Yanauthor=V.+Sardanaauthor=B.+Xuauthor=C.+Homnickauthor=W.+Halczenkoauthor=C.+A.+Buserauthor=M.+Schaberauthor=G.+D.+Hartmanauthor=H.+E.+Huberauthor=L.+C.+Kuo&title=Inhibition+of+a+mitotic+motor+protein%3A+where%2C+how%2C+and+conformational+consequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DHomnick%26aufirst%3DC.%26aulast%3DHalczenko%26aufirst%3DW.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DSchaber%26aufirst%3DM.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26atitle%3DInhibition%2520of%2520a%2520mitotic%2520motor%2520protein%253A%2520where%252C%2520how%252C%2520and%2520conformational%2520consequences%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D335%26spage%3D547%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Parish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucete, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugger, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakowicz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.-M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Novel ATP-competitive kinesin spindle protein inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4939</span><span class="NLM_x">–</span> <span class="NLM_lpage">4952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4939-4952&author=C.+A.+Parishauthor=N.+D.+Adamsauthor=K.+R.+Augerauthor=J.+L.+Burgessauthor=J.+D.+Carsonauthor=A.+M.+Chaudhariauthor=R.+A.+Copelandauthor=M.+A.+Diamondauthor=C.+A.+Donatelliauthor=K.+J.+Duffyauthor=L.+F.+Fauceteauthor=J.+T.+Finerauthor=W.+F.+Huffmanauthor=E.+D.+Huggerauthor=J.+R.+Jacksonauthor=S.+D.+Knightauthor=L.+Luoauthor=M.+L.+Mooreauthor=K.+A.+Newlanderauthor=L.+H.+Ridgersauthor=R.+Sakowiczauthor=A.+N.+Shawauthor=C.-M.+M.+Sungauthor=D.+Suttonauthor=K.+W.+Woodauthor=S.-Y.+Zhangauthor=M.+N.+Zimmermanauthor=D.+Dhanak&title=Novel+ATP-competitive+kinesin+spindle+protein+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParish%26aufirst%3DC.%2BA.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26aulast%3DFaucete%26aufirst%3DL.%2BF.%26aulast%3DFiner%26aufirst%3DJ.%2BT.%26aulast%3DHuffman%26aufirst%3DW.%2BF.%26aulast%3DHugger%26aufirst%3DE.%2BD.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%2BH.%26aulast%3DSakowicz%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DA.%2BN.%26aulast%3DSung%26aufirst%3DC.-M.%2BM.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DWood%26aufirst%3DK.%2BW.%26aulast%3DZhang%26aufirst%3DS.-Y.%26aulast%3DZimmerman%26aufirst%3DM.%2BN.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DNovel%2520ATP-competitive%2520kinesin%2520spindle%2520protein%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4939%26epage%3D4952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rickert, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasber, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span> </span><span class="NLM_article-title">Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2008&pages=220-231&author=K.+W.+Rickertauthor=M.+Schaberauthor=M.+Torrentauthor=L.+A.+Neilsonauthor=E.+S.+Tasberauthor=R.+M.+Garbaccioauthor=P.+J.+Colemanauthor=D.+Harveyauthor=Y.+Zhangauthor=Y.+Yangauthor=G.+Marshallauthor=L.+Leeauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buser&title=Discovery+and+biochemical+characterization+of+selective+ATP+competitive+inhibitors+of+the+human+mitotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRickert%26aufirst%3DK.%2BW.%26aulast%3DSchaber%26aufirst%3DM.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DNeilson%26aufirst%3DL.%2BA.%26aulast%3DTasber%26aufirst%3DE.%2BS.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHarvey%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMarshall%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26atitle%3DDiscovery%2520and%2520biochemical%2520characterization%2520of%2520selective%2520ATP%2520competitive%2520inhibitors%2520of%2520the%2520human%2520mitotic%2520kinesin%2520KSP%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2008%26volume%3D469%26spage%3D220%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><div class="note"><p class="first last">The coordinates have been deposited with the RCSB Protein Data Bank under the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CJO">3CJO</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+coordinates+have+been+deposited+with+the+RCSB+Protein+Data+Bank+under+the+accession+code+3CJO."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Stein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, N. G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandrendreis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooley, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, G.</span><span> </span><span class="NLM_article-title">Phase I clinical and pharmacokinetic (PK) trial of the kinesin spindle protein (KSP) inhibitor MK-0731 in patients with solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">18S</span><span class="NLM_x">) </span> <span class="NLM_fpage">2548</span><div class="note"><p class="first last">(ASCO Annual Meeting Proceedings Part I)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=2548&issue=18S&author=M.+N.+Steinauthor=E.+H.+Rubinauthor=K.+Taberauthor=R.+C.+Fernandezauthor=N.+G.+B.+Agrawalauthor=E.+Vandrendreisauthor=K.+Hsuauthor=A.+Walkerauthor=K.+Holenauthor=L.+Xueauthor=P.+C.+Cooleyauthor=G.+Wilding&title=Phase+I+clinical+and+pharmacokinetic+%28PK%29+trial+of+the+kinesin+spindle+protein+%28KSP%29+inhibitor+MK-0731+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DM.%2BN.%26aulast%3DRubin%26aufirst%3DE.%2BH.%26aulast%3DTaber%26aufirst%3DK.%26aulast%3DFernandez%26aufirst%3DR.%2BC.%26aulast%3DAgrawal%26aufirst%3DN.%2BG.%2BB.%26aulast%3DVandrendreis%26aufirst%3DE.%26aulast%3DHsu%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DA.%26aulast%3DHolen%26aufirst%3DK.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DCooley%26aufirst%3DP.%2BC.%26aulast%3DWilding%26aufirst%3DG.%26atitle%3DPhase%2520I%2520clinical%2520and%2520pharmacokinetic%2520%2528PK%2529%2520trial%2520of%2520the%2520kinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitor%2520MK-0731%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26issue%3D18S%26spage%3D2548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Shen, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardarelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">261</span><span class="NLM_x">, </span> <span class="NLM_fpage">7762</span><span class="NLM_x">–</span> <span class="NLM_lpage">7770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=3711108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADyaL28XksFChs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=7762-7770&author=D.+W.+Shenauthor=C.+Cardarelliauthor=J.+Hwangauthor=M.+Cornwellauthor=N.+Richertauthor=S.+Ishiiauthor=I.+Pastanauthor=M.+M.+Gottesman&title=Multiple+drug-resistant+human+KB+carcinoma+cells+independently+selected+for+high-level+resistance+to+colchicine%2C+adriamycin%2C+or+vinblastine+show+changes+in+expression+of+specific+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins</span></div><div class="casAuthors">Shen, Ding Wu; Cardarelli, Carol; Hwang, Jaulang; Cornwell, Marilyn; Richert, Nancy; Ishii, Shunsuke; Pastan, Ira; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7762-70</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Four cell lines derived from the human KB carcinoma cell line which express high-level multiple drug resistance were established.  One of these lines was selected for resistance to colchicine  [64-86-8], one was selected for resistance to colchicine in the presence of the tumor promoter, mezerein  [34807-41-5], one for resistance to vinblastine  [865-21-4], and one for resistance to adriamycin  [25316-40-9].  All of these cell lines were cross-resistant to the other selective agents.  The development of multidrug resistance in these cultured human carcinoma cells was assocd. with a limited no. of specific protein alterations revealed by high-resoln., 2-dimensional gel electrophoresis and Western blot anal.  These protein alterations in multidrug-resistant lines included the decreased prevalence of members of a family of proteins of mol. mass 70,000 to 80,000 daltons, pI 4.8-5.0, the increased synthesis of a protein of mol. mass 21,000 daltons, pI 5.0, in the colchicine-resistant cell lines only, and the increased expression of a 170,000-dalton protein in membrane prepns. from all of the resistant cells.  The loss of the 70,000- to 80,000-dalton proteins in the multidrug-resistant lines, which was also be demonstrated by immunopptn. of these proteins with specific antisera, was assocd. with a loss of translatable mRNA for these proteins.  Apparently, only a limited no. of protein changes occur in multidrug-resistant cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24ZiGUZbjD7Vg90H21EOLACvtfcHk0li8j2RuQKpvog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFChs7w%253D&md5=b8fc5057559ea644506e76b643733a90</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DD.%2BW.%26aulast%3DCardarelli%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DJ.%26aulast%3DCornwell%26aufirst%3DM.%26aulast%3DRichert%26aufirst%3DN.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DMultiple%2520drug-resistant%2520human%2520KB%2520carcinoma%2520cells%2520independently%2520selected%2520for%2520high-level%2520resistance%2520to%2520colchicine%252C%2520adriamycin%252C%2520or%2520vinblastine%2520show%2520changes%2520in%2520expression%2520of%2520specific%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D7762%26epage%3D7770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12','cit12a','cit12b','cit12c','cit12d'],'ref13':['cit13a','cit13b','cit13c','cit13d'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 124 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jin Zhu, Wenbo Su, Cheng Xiong, Ruifang Bai, Qingfa Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Ming Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free [3+2] Cycloaddition of Electron-Deficient Alkynes and o-Hydroxyaryl Azomethine Ylides in Water. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (29)
                                     , 18244-18253. <a href="https://doi.org/10.1021/acsomega.0c01856" title="DOI URL">https://doi.org/10.1021/acsomega.0c01856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c01856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c01856%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DCatalyst-Free%252B%25255B3%25252B2%25255D%252BCycloaddition%252Bof%252BElectron-Deficient%252BAlkynes%252Band%252Bo-Hydroxyaryl%252BAzomethine%252BYlides%252Bin%252BWater%26aulast%3DZhu%26aufirst%3DJin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22042020%26date%3D02062020%26date%3D14072020%26volume%3D5%26issue%3D29%26spage%3D18244%26epage%3D18253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qi Zhang, Munira Taj Muhammad, Mong-Feng Chiou, Yihang Jiao, Hongli Bao, <span class="NLM_string-name hlFld-ContribAuthor">Yajun Li</span>. </span><span class="cited-content_cbyCitation_article-title">1,4-Fluoroamination of 1,3-Enynes en Route to Fluorinated Allenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (13)
                                     , 5261-5265. <a href="https://doi.org/10.1021/acs.orglett.0c01953" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01953%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3D1%25252C4-Fluoroamination%252Bof%252B1%25252C3-Enynes%252Ben%252BRoute%252Bto%252BFluorinated%252BAllenes%26aulast%3DZhang%26aufirst%3DQi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10062020%26date%3D17062020%26volume%3D22%26issue%3D13%26spage%3D5261%26epage%3D5265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benjamin M. Johnson, Yue-Zhong Shu, Xiaoliang Zhuo, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic and Pharmaceutical Aspects of Fluorinated Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6315-6386. <a href="https://doi.org/10.1021/acs.jmedchem.9b01877" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01877%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetabolic%252Band%252BPharmaceutical%252BAspects%252Bof%252BFluorinated%252BCompounds%26aulast%3DJohnson%26aufirst%3DBenjamin%2BM.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D12112019%26date%3D17032020%26volume%3D63%26issue%3D12%26spage%3D6315%26epage%3D6386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huaizhi Li, Bhoomireddy Rajendra Prasad Reddy, <span class="NLM_string-name hlFld-ContribAuthor">Xihe Bi</span>. </span><span class="cited-content_cbyCitation_article-title">Transformation of Alkynes into α- or β-Difluorinated Alkyl Azides by an Efficient One-Pot Two-Step Procedure. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 9358-9362. <a href="https://doi.org/10.1021/acs.orglett.9b03593" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03593%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTransformation%252Bof%252BAlkynes%252Binto%252B%2525CE%2525B1-%252Bor%252B%2525CE%2525B2-Difluorinated%252BAlkyl%252BAzides%252Bby%252Ban%252BEfficient%252BOne-Pot%252BTwo-Step%252BProcedure%26aulast%3DLi%26aufirst%3DHuaizhi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11102019%26date%3D25112019%26volume%3D21%26issue%3D23%26spage%3D9358%26epage%3D9362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">César de Oliveira, Haoyu S. Yu, Wei Chen, Robert Abel, <span class="NLM_string-name hlFld-ContribAuthor">Lingle Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Correction to “Rigorous Free Energy Perturbation Approach to Estimating Relative Binding Affinities between Ligands with Multiple Protonation and Tautomeric States”. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2019,</strong> <em>15 </em>
                                    (10)
                                     , 5758-5758. <a href="https://doi.org/10.1021/acs.jctc.9b00841" title="DOI URL">https://doi.org/10.1021/acs.jctc.9b00841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.9b00841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.9b00841%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DCorrection%252Bto%252B%2525E2%252580%25259CRigorous%252BFree%252BEnergy%252BPerturbation%252BApproach%252Bto%252BEstimating%252BRelative%252BBinding%252BAffinities%252Bbetween%252BLigands%252Bwith%252BMultiple%252BProtonation%252Band%252BTautomeric%252BStates%2525E2%252580%25259D%26aulast%3Dde%2BOliveira%26aufirst%3DC%25C3%25A9sar%26date%3D2019%26date%3D2019%26date%3D24092019%26volume%3D15%26issue%3D10%26spage%3D5758%26epage%3D5758%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DRigorous%252BFree%252BEnergy%252BPerturbation%252BApproach%252Bto%252BEstimating%252BRelative%252BBinding%252BAffinities%252Bbetween%252BLigands%252Bwith%252BMultiple%252BProtonation%252Band%252BTautomeric%252BStates%26aulast%3Dde%2BOliveira%26aufirst%3DC%25C3%25A9sar%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D07082018%26date%3D26122018%26date%3D11122018%26volume%3D15%26issue%3D1%26spage%3D424%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fumie Sakurai, Takafumi Yukawa, <span class="NLM_string-name hlFld-ContribAuthor">Takahiko Taniguchi</span>. </span><span class="cited-content_cbyCitation_article-title">Direct and Regioselective Monofluorination of N-Protected Pyridone Derivatives using N-Fluorobenzenesulfonimide (NFSI). </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (18)
                                     , 7254-7257. <a href="https://doi.org/10.1021/acs.orglett.9b02482" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02482%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDirect%252Band%252BRegioselective%252BMonofluorination%252Bof%252BN-Protected%252BPyridone%252BDerivatives%252Busing%252BN-Fluorobenzenesulfonimide%252B%252528NFSI%252529%26aulast%3DSakurai%26aufirst%3DFumie%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17072019%26date%3D06092019%26volume%3D21%26issue%3D18%26spage%3D7254%26epage%3D7257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Yue Pan</span>. </span><span class="cited-content_cbyCitation_article-title">The Dark Side of Fluorine. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (7)
                                     , 1016-1019. <a href="https://doi.org/10.1021/acsmedchemlett.9b00235" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00235%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252BDark%252BSide%252Bof%252BFluorine%26aulast%3DPan%26aufirst%3DYue%26date%3D2019%26date%3D2019%26date%3D20062019%26volume%3D10%26issue%3D7%26spage%3D1016%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anton
V. Chernykh, Kostiantyn P. Melnykov, Nataliya A. Tolmacheva, Ivan S. Kondratov, Dmytro S. Radchenko, Constantin G. Daniliuc, Dmitriy M. Volochnyuk, Sergey V. Ryabukhin, Yuliya O. Kuchkovska, <span class="NLM_string-name hlFld-ContribAuthor">Oleksandr O. Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Last of the gem-Difluorocycloalkanes: Synthesis and Characterization of 2,2-Difluorocyclobutyl-Substituted Building Blocks. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (13)
                                     , 8487-8496. <a href="https://doi.org/10.1021/acs.joc.9b00719" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00719%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLast%252Bof%252Bthe%252Bgem-Difluorocycloalkanes%25253A%252BSynthesis%252Band%252BCharacterization%252Bof%252B2%25252C2-Difluorocyclobutyl-Substituted%252BBuilding%252BBlocks%26aulast%3DChernykh%26aufirst%3DAnton%2BV.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13032019%26date%3D24042019%26date%3D16042019%26volume%3D84%26issue%3D13%26spage%3D8487%26epage%3D8496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">César de Oliveira, Haoyu S. Yu, Wei Chen, Robert Abel, <span class="NLM_string-name hlFld-ContribAuthor">Lingle Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Rigorous Free Energy Perturbation Approach to Estimating Relative Binding Affinities between Ligands with Multiple Protonation and Tautomeric States. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2019,</strong> <em>15 </em>
                                    (1)
                                     , 424-435. <a href="https://doi.org/10.1021/acs.jctc.8b00826" title="DOI URL">https://doi.org/10.1021/acs.jctc.8b00826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.8b00826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.8b00826%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DRigorous%252BFree%252BEnergy%252BPerturbation%252BApproach%252Bto%252BEstimating%252BRelative%252BBinding%252BAffinities%252Bbetween%252BLigands%252Bwith%252BMultiple%252BProtonation%252Band%252BTautomeric%252BStates%26aulast%3Dde%2BOliveira%26aufirst%3DC%25C3%25A9sar%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D07082018%26date%3D26122018%26date%3D11122018%26volume%3D15%26issue%3D1%26spage%3D424%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jia-Nan Mo, Wan-Lei Yu, Jian-Qiang Chen, Xiu-Qin Hu, <span class="NLM_string-name hlFld-ContribAuthor">Peng-Fei Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Regiospecific Three-Component Aminofluorination of Olefins via Photoredox Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (15)
                                     , 4471-4474. <a href="https://doi.org/10.1021/acs.orglett.8b01760" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01760%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRegiospecific%252BThree-Component%252BAminofluorination%252Bof%252BOlefins%252Bvia%252BPhotoredox%252BCatalysis%26aulast%3DMo%26aufirst%3DJia-Nan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05062018%26date%3D18072018%26volume%3D20%26issue%3D15%26spage%3D4471%26epage%3D4474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 5822-5880. <a href="https://doi.org/10.1021/acs.jmedchem.7b01788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorine%252Band%252BFluorinated%252BMotifs%252Bin%252Bthe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bfor%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D05122017%26date%3D05022018%26volume%3D61%26issue%3D14%26spage%3D5822%26epage%3D5880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Katrina
M. Mennie, Steven M. Banik, Elaine C. Reichert, <span class="NLM_string-name hlFld-ContribAuthor">Eric N. Jacobsen</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Diastereo- and Enantioselective Fluoroamination of Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (14)
                                     , 4797-4802. <a href="https://doi.org/10.1021/jacs.8b02143" title="DOI URL">https://doi.org/10.1021/jacs.8b02143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b02143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b02143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCatalytic%252BDiastereo-%252Band%252BEnantioselective%252BFluoroamination%252Bof%252BAlkenes%26aulast%3DMennie%26aufirst%3DKatrina%2BM.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22022018%26date%3D29032018%26date%3D27032018%26volume%3D140%26issue%3D14%26spage%3D4797%26epage%3D4802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Ajmal  Khan</span>, <span class="hlFld-ContribAuthor ">Renfeng  Zheng</span>, <span class="hlFld-ContribAuthor ">Long Yi  Jin</span>, and <span class="hlFld-ContribAuthor ">Yong Jian  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed Asymmetric Decarboxylative Cycloaddition of Vinylethylene Carbonates with Imines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (24)
                                     , 6230-6233. <a href="https://doi.org/10.1021/acs.orglett.5b03218" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b03218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b03218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b03218%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPd-Catalyzed%252BAsymmetric%252BDecarboxylative%252BCycloaddition%252Bof%252BVinylethylene%252BCarbonates%252Bwith%252BImines%26aulast%3DYang%26aufirst%3DLei%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D07112015%26date%3D09122015%26date%3D18122015%26volume%3D17%26issue%3D24%26spage%3D6230%26epage%3D6233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric P.  Gillis</span>, <span class="hlFld-ContribAuthor ">Kyle J.  Eastman</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hill</span>, <span class="hlFld-ContribAuthor ">David J.  Donnelly</span>, and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Fluorine in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8315-8359. <a href="https://doi.org/10.1021/acs.jmedchem.5b00258" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplications%252Bof%252BFluorine%252Bin%252BMedicinal%252BChemistry%26aulast%3DGillis%26aufirst%3DEric%2BP.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D22072015%26date%3D12112015%26volume%3D58%26issue%3D21%26spage%3D8315%26epage%3D8359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pier Alexandre  Champagne</span>, <span class="hlFld-ContribAuthor ">Justine  Desroches</span>, <span class="hlFld-ContribAuthor ">Jean-Denys  Hamel</span>, <span class="hlFld-ContribAuthor ">Mathilde  Vandamme</span>, and <span class="hlFld-ContribAuthor ">Jean-François  Paquin</span>  . </span><span class="cited-content_cbyCitation_article-title">Monofluorination of Organic Compounds: 10 Years of Innovation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (17)
                                     , 9073-9174. <a href="https://doi.org/10.1021/cr500706a" title="DOI URL">https://doi.org/10.1021/cr500706a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500706a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500706a%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DMonofluorination%252Bof%252BOrganic%252BCompounds%25253A%252B10%252BYears%252Bof%252BInnovation%26aulast%3DChampagne%26aufirst%3DPier%2BAlexandre%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D17122014%26date%3D09042015%26date%3D09092015%26volume%3D115%26issue%3D17%26spage%3D9073%26epage%3D9174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Zheng</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, and <span class="hlFld-ContribAuthor ">Renhua  Fan</span>  . </span><span class="cited-content_cbyCitation_article-title">Iodine(III)-Mediated Oxidative Cross-Coupling of Enamines and Propargylamines under Metal-Free Conditions: An Alternative Way to Prepare Highly Substituted 3-Pyrrolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (4)
                                     , 916-919. <a href="https://doi.org/10.1021/acs.orglett.5b00026" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b00026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b00026%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIodine%252528III%252529-Mediated%252BOxidative%252BCross-Coupling%252Bof%252BEnamines%252Band%252BPropargylamines%252Bunder%252BMetal-Free%252BConditions%25253A%252BAn%252BAlternative%252BWay%252Bto%252BPrepare%252BHighly%252BSubstituted%252B3-Pyrrolines%26aulast%3DZheng%26aufirst%3DChen%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D05012015%26date%3D06022015%26date%3D20022015%26volume%3D17%26issue%3D4%26spage%3D916%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yang</span>, <span class="hlFld-ContribAuthor ">Michelle L.  Lamb</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Edward J.  Hennessy</span>, <span class="hlFld-ContribAuthor ">Gurmit  Grewal</span>, <span class="hlFld-ContribAuthor ">Li  Sha</span>, <span class="hlFld-ContribAuthor ">Mark  Zambrowski</span>, <span class="hlFld-ContribAuthor ">Michael H.  Block</span>, <span class="hlFld-ContribAuthor ">James E.  Dowling</span>, <span class="hlFld-ContribAuthor ">Nancy  Su</span>, <span class="hlFld-ContribAuthor ">Jiaquan  Wu</span>, <span class="hlFld-ContribAuthor ">Tracy  Deegan</span>, <span class="hlFld-ContribAuthor ">Keith  Mikule</span>, <span class="hlFld-ContribAuthor ">Wenxian  Wang</span>, <span class="hlFld-ContribAuthor ">Rüdiger  Kaspera</span>, <span class="hlFld-ContribAuthor ">Claudio  Chuaqui</span>, and <span class="hlFld-ContribAuthor ">Huawei  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent KIFC1 Inhibitors Using a Method of Integrated High-Throughput Synthesis and Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9958-9970. <a href="https://doi.org/10.1021/jm501179r" title="DOI URL">https://doi.org/10.1021/jm501179r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501179r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501179r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BKIFC1%252BInhibitors%252BUsing%252Ba%252BMethod%252Bof%252BIntegrated%252BHigh-Throughput%252BSynthesis%252Band%252BScreening%26aulast%3DYang%26aufirst%3DBin%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01082014%26date%3D02122014%26date%3D11122014%26date%3D19112014%26volume%3D57%26issue%3D23%26spage%3D9958%26epage%3D9970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon J.  Shaw</span>, <span class="hlFld-ContribAuthor ">Dane A.  Goff</span>, <span class="hlFld-ContribAuthor ">Luke A.  Boralsky</span>, <span class="hlFld-ContribAuthor ">Mark  Irving</span>, and <span class="hlFld-ContribAuthor ">Rajinder  Singh</span>  . </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of cis-3-Fluoropiperidin-4-ol, a Building Block for Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (17)
                                     , 8892-8897. <a href="https://doi.org/10.1021/jo401352z" title="DOI URL">https://doi.org/10.1021/jo401352z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo401352z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo401352z%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEnantioselective%252BSynthesis%252Bof%252Bcis-3-Fluoropiperidin-4-ol%25252C%252Ba%252BBuilding%252BBlock%252Bfor%252BMedicinal%252BChemistry%26aulast%3DShaw%26aufirst%3DSimon%2BJ.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D24062013%26date%3D19082013%26date%3D06092013%26volume%3D78%26issue%3D17%26spage%3D8892%26epage%3D8897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanthi  Nagarajan</span>, <span class="hlFld-ContribAuthor ">Dimitrios A.  Skoufias</span>, <span class="hlFld-ContribAuthor ">Frank  Kozielski</span>, and <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>  . </span><span class="cited-content_cbyCitation_article-title">Receptor–Ligand Interaction-Based Virtual Screening for Novel Eg5/Kinesin Spindle Protein Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2561-2573. <a href="https://doi.org/10.1021/jm201290v" title="DOI URL">https://doi.org/10.1021/jm201290v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201290v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201290v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DReceptor%2525E2%252580%252593Ligand%252BInteraction-Based%252BVirtual%252BScreening%252Bfor%252BNovel%252BEg5%25252FKinesin%252BSpindle%252BProtein%252BInhibitors%26aulast%3DNagarajan%26aufirst%3DShanthi%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D22072011%26date%3D01032012%26date%3D22032012%26date%3D06022012%26volume%3D55%26issue%3D6%26spage%3D2561%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Li</span> and <span class="hlFld-ContribAuthor ">Junliang  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Lewis Acid-catalyzed [3 + 2]Cyclo-addition of Alkynes with N-Tosyl-aziridines via Carbon–Carbon Bond Cleavage: Synthesis of Highly Substituted 3-Pyrrolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2011,</strong> <em>13 </em>
                                    (22)
                                     , 5940-5943. <a href="https://doi.org/10.1021/ol202603e" title="DOI URL">https://doi.org/10.1021/ol202603e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol202603e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol202603e%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DLewis%252BAcid-catalyzed%252B%25255B3%252B%25252B%252B2%25255DCyclo-addition%252Bof%252BAlkynes%252Bwith%252BN-Tosyl-aziridines%252Bvia%252BCarbon%2525E2%252580%252593Carbon%252BBond%252BCleavage%25253A%252BSynthesis%252Bof%252BHighly%252BSubstituted%252B3-Pyrrolines%26aulast%3DLi%26aufirst%3DLei%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D20072011%26date%3D26102011%26date%3D18112011%26volume%3D13%26issue%3D22%26spage%3D5940%26epage%3D5943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria-Elena  Theoclitou</span>, <span class="hlFld-ContribAuthor ">Brian  Aquila</span>, <span class="hlFld-ContribAuthor ">Michael H.  Block</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Brassil</span>, <span class="hlFld-ContribAuthor ">Lillian  Castriotta</span>, <span class="hlFld-ContribAuthor ">Erin  Code</span>, <span class="hlFld-ContribAuthor ">Michael P.  Collins</span>, <span class="hlFld-ContribAuthor ">Audrey M.  Davies</span>, <span class="hlFld-ContribAuthor ">Tracy  Deegan</span>, <span class="hlFld-ContribAuthor ">Jayachandran  Ezhuthachan</span>, <span class="hlFld-ContribAuthor ">Sandra  Filla</span>, <span class="hlFld-ContribAuthor ">Ellen  Freed</span>, <span class="hlFld-ContribAuthor ">Haiqing  Hu</span>, <span class="hlFld-ContribAuthor ">Dennis  Huszar</span>, <span class="hlFld-ContribAuthor ">Muthusamy  Jayaraman</span>, <span class="hlFld-ContribAuthor ">Deborah  Lawson</span>, <span class="hlFld-ContribAuthor ">Paula M  Lewis</span>, <span class="hlFld-ContribAuthor ">Murali V. P.  Nadella</span>, <span class="hlFld-ContribAuthor ">Vibha  Oza</span>, <span class="hlFld-ContribAuthor ">Maniyan  Padmanilayam</span>, <span class="hlFld-ContribAuthor ">Timothy  Pontz</span>, <span class="hlFld-ContribAuthor ">Lucienne  Ronco</span>, <span class="hlFld-ContribAuthor ">Daniel  Russell</span>, <span class="hlFld-ContribAuthor ">David  Whitston</span>, and <span class="hlFld-ContribAuthor ">Xiaolan  Zheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (+)-N-(3-Aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (19)
                                     , 6734-6750. <a href="https://doi.org/10.1021/jm200629m" title="DOI URL">https://doi.org/10.1021/jm200629m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200629m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200629m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528%25252B%252529-N-%2525283-Aminopropyl%252529-N-%25255B1-%2525285-benzyl-3-methyl-4-oxo-%25255B1%25252C2%25255Dthiazolo%25255B5%25252C4-d%25255Dpyrimidin-6-yl%252529-2-methylpropyl%25255D-4-methylbenzamide%252B%252528AZD4877%252529%25252C%252Ba%252BKinesin%252BSpindle%252BProtein%252BInhibitor%252Band%252BPotential%252BAnticancer%252BAgent%26aulast%3DTheoclitou%26aufirst%3DMaria-Elena%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D18052011%26date%3D07092011%26date%3D13102011%26volume%3D54%26issue%3D19%26spage%3D6734%26epage%3D6750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (8)
                                     , 2529-2591. <a href="https://doi.org/10.1021/jm1013693" title="DOI URL">https://doi.org/10.1021/jm1013693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1013693%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynopsis%252Bof%252BSome%252BRecent%252BTactical%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D20102010%26date%3D17032011%26date%3D28042011%26volume%3D54%26issue%3D8%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hung Yi Kristal  Kaan</span>, <span class="hlFld-ContribAuthor ">Johanna  Weiss</span>, <span class="hlFld-ContribAuthor ">Dominik  Menger</span>, <span class="hlFld-ContribAuthor ">Venkatasubramanian  Ulaganathan</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Tkocz</span>, <span class="hlFld-ContribAuthor ">Christian  Laggner</span>, <span class="hlFld-ContribAuthor ">Florence  Popowycz</span>, <span class="hlFld-ContribAuthor ">Benoît  Joseph</span>, and <span class="hlFld-ContribAuthor ">Frank  Kozielski</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure−Activity Relationship and Multidrug Resistance Study of New S-trityl-l-Cysteine Derivatives As Inhibitors of Eg5. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (6)
                                     , 1576-1586. <a href="https://doi.org/10.1021/jm100991m" title="DOI URL">https://doi.org/10.1021/jm100991m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100991m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100991m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252588%252592Activity%252BRelationship%252Band%252BMultidrug%252BResistance%252BStudy%252Bof%252BNew%252BS-trityl-l-Cysteine%252BDerivatives%252BAs%252BInhibitors%252Bof%252BEg5%26aulast%3DKaan%26aufirst%3DHung%2BYi%2BKristal%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D02082010%26date%3D23022011%26date%3D24032011%26volume%3D54%26issue%3D6%26spage%3D1576%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Savade  Solanki</span>, <span class="hlFld-ContribAuthor ">Paolo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Corine  Mas-Droux</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Caterina  Barillari</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Richard  Bayliss</span>, and <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzimidazole Inhibitors Induce a DFG-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure−Activity Relationship. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (6)
                                     , 1626-1639. <a href="https://doi.org/10.1021/jm1011726" title="DOI URL">https://doi.org/10.1021/jm1011726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1011726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1011726%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole%252BInhibitors%252BInduce%252Ba%252BDFG-Out%252BConformation%252Bof%252BNever%252Bin%252BMitosis%252BGene%252BA-Related%252BKinase%252B2%252B%252528Nek2%252529%252Bwithout%252BBinding%252Bto%252Bthe%252BBack%252BPocket%252Band%252BReveal%252Ba%252BNonlinear%252BStructure%2525E2%252588%252592Activity%252BRelationship%26aulast%3DSolanki%26aufirst%3DSavade%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D09092010%26date%3D02032011%26date%3D24032011%26volume%3D54%26issue%3D6%26spage%3D1626%26epage%3D1639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring the Intermediate States of ADP−ATP Exchange: A Simulation Study on Eg5. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2011,</strong> <em>115 </em>
                                    (5)
                                     , 784-795. <a href="https://doi.org/10.1021/jp107255t" title="DOI URL">https://doi.org/10.1021/jp107255t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jp107255t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjp107255t%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DExploring%252Bthe%252BIntermediate%252BStates%252Bof%252BADP%2525E2%252588%252592ATP%252BExchange%25253A%252BA%252BSimulation%252BStudy%252Bon%252BEg5%26aulast%3DZhang%26aufirst%3DWei%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D02082010%26date%3D04112010%26date%3D30122010%26date%3D10022011%26volume%3D115%26issue%3D5%26spage%3D784%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Payal R.  Sheth</span>, <span class="hlFld-ContribAuthor ">Gerald W.  Shipps, Jr.</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Seghezzi</span>, <span class="hlFld-ContribAuthor ">Catherine K.  Smith</span>, <span class="hlFld-ContribAuthor ">Cheng-Chi  Chuang</span>, <span class="hlFld-ContribAuthor ">David  Sanden</span>, <span class="hlFld-ContribAuthor ">Andrea D.  Basso</span>, <span class="hlFld-ContribAuthor ">Lev  Vilenchik</span>, <span class="hlFld-ContribAuthor ">Kimberly  Gray</span>, <span class="hlFld-ContribAuthor ">D. Allen  Annis</span>, <span class="hlFld-ContribAuthor ">Elliott  Nickbarg</span>, <span class="hlFld-ContribAuthor ">Yao  Ma</span>, <span class="hlFld-ContribAuthor ">Brian  Lahue</span>, <span class="hlFld-ContribAuthor ">Ronald  Herbst</span>, and <span class="hlFld-ContribAuthor ">Hung V.  Le</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Benzimidazole Inhibitors Bind to a Unique Site in the Kinesin Spindle Protein Motor Domain. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2010,</strong> <em>49 </em>
                                    (38)
                                     , 8350-8358. <a href="https://doi.org/10.1021/bi1005283" title="DOI URL">https://doi.org/10.1021/bi1005283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi1005283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi1005283%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DNovel%252BBenzimidazole%252BInhibitors%252BBind%252Bto%252Ba%252BUnique%252BSite%252Bin%252Bthe%252BKinesin%252BSpindle%252BProtein%252BMotor%252BDomain%26aulast%3DSheth%26aufirst%3DPayal%2BR.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D08042010%26date%3D16082010%26date%3D03092010%26date%3D28092010%26date%3D18082010%26volume%3D49%26issue%3D38%26spage%3D8350%26epage%3D8358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hung Yi Kristal  Kaan</span>, <span class="hlFld-ContribAuthor ">Venkatasubramanian  Ulaganathan</span>, <span class="hlFld-ContribAuthor ">Oliver  Rath</span>, <span class="hlFld-ContribAuthor ">Hana  Prokopcová</span>, <span class="hlFld-ContribAuthor ">Doris  Dallinger</span>, <span class="hlFld-ContribAuthor ">C. Oliver  Kappe</span> and <span class="hlFld-ContribAuthor ">Frank  Kozielski</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Basis for Inhibition of Eg5 by Dihydropyrimidines: Stereoselectivity of Antimitotic Inhibitors Enastron, Dimethylenastron and Fluorastrol. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (15)
                                     , 5676-5683. <a href="https://doi.org/10.1021/jm100421n" title="DOI URL">https://doi.org/10.1021/jm100421n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100421n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100421n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BBasis%252Bfor%252BInhibition%252Bof%252BEg5%252Bby%252BDihydropyrimidines%25253A%252BStereoselectivity%252Bof%252BAntimitotic%252BInhibitors%252BEnastron%25252C%252BDimethylenastron%252Band%252BFluorastrol%26aulast%3DKaan%26aufirst%3DHung%2BYi%2BKristal%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D06042010%26date%3D02072010%26date%3D12082010%26volume%3D53%26issue%3D15%26spage%3D5676%26epage%3D5683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrakumar  Appayee</span> and <span class="hlFld-ContribAuthor ">Stacey E.  Brenner-Moyer</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic Enantioselective Olefin Aminofluorination. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2010,</strong> <em>12 </em>
                                    (15)
                                     , 3356-3359. <a href="https://doi.org/10.1021/ol101167z" title="DOI URL">https://doi.org/10.1021/ol101167z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol101167z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol101167z%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOrganocatalytic%252BEnantioselective%252BOlefin%252BAminofluorination%26aulast%3DAppayee%26aufirst%3DChandrakumar%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D20%252005%25202010%26date%3D24062010%26date%3D06082010%26volume%3D12%26issue%3D15%26spage%3D3356%26epage%3D3359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiangping Qian, Andrew McDonald, Han-Jie Zhou, Nicholas D. Adams, Cynthia A. Parrish, Kevin J. Duffy, Duke M. Fitch, Rosanna Tedesco, Luke W. Ashcraft, Bing Yao, Hong Jiang, Jennifer K. Huang, Melchor V. Marin, Carrie E. Aroyan, Jianchao Wang, Seyed Ahmed, Joelle L. Burgess, Amita M. Chaudhari, Carla A. Donatelli, Michael G. Darcy, Lance H. Ridgers, Ken A. Newlander, Stanley J. Schmidt, Deping Chai, Mariela Colón, Michael N. Zimmerman, Latesh Lad, Roman Sakowicz, Stephen Schauer, Lisa Belmont, Ramesh Baliga, Daniel W. Pierce, Jeffrey T. Finer, Zhengping Wang, Bradley P. Morgan, David J. Morgans, Jr., Kurt R. Auger, Chiu-Mei Sung, Jeff D. Carson, Lusong Luo, Erin D. Hugger, Robert A. Copeland, David Sutton, John D. Elliott, Jeffrey R. Jackson, Kenneth W. Wood, Dashyant Dhanak, Gustave Bergnes, <span class="NLM_string-name hlFld-ContribAuthor">Steven D. Knight</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>1 </em>
                                    (1)
                                     , 30-34. <a href="https://doi.org/10.1021/ml900018m" title="DOI URL">https://doi.org/10.1021/ml900018m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml900018m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml900018m%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bthe%252BFirst%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BCentromere-Associated%252BProtein%252BE%25253A%252BGSK923295%26aulast%3DQian%26aufirst%3DXiangping%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D17122009%26date%3D04012010%26date%3D19012010%26date%3D08042010%26volume%3D1%26issue%3D1%26spage%3D30%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Payal R.  Sheth</span>, <span class="hlFld-ContribAuthor ">Andrea  Basso</span>, <span class="hlFld-ContribAuthor ">José S.  Duca</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Polina  Ogas</span>, <span class="hlFld-ContribAuthor ">Kimberly  Gray</span>, <span class="hlFld-ContribAuthor ">Lissette  Nale</span>, <span class="hlFld-ContribAuthor ">Anthony F.  Mannarino</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Prongay</span> and <span class="hlFld-ContribAuthor ">Hung V.  Le</span>  . </span><span class="cited-content_cbyCitation_article-title">Thermodynamics of Nucleotide and Inhibitor Binding to Wild-Type and Ispinesib-Resistant Forms of Human Kinesin Spindle Protein. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2009,</strong> <em>48 </em>
                                    (46)
                                     , 11045-11055. <a href="https://doi.org/10.1021/bi900946r" title="DOI URL">https://doi.org/10.1021/bi900946r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi900946r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi900946r%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DThermodynamics%252Bof%252BNucleotide%252Band%252BInhibitor%252BBinding%252Bto%252BWild-Type%252Band%252BIspinesib-Resistant%252BForms%252Bof%252BHuman%252BKinesin%252BSpindle%252BProtein%26aulast%3DSheth%26aufirst%3DPayal%2BR.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D04062009%26date%3D13102009%26date%3D29102009%26date%3D24112009%26date%3D13102009%26volume%3D48%26issue%3D46%26spage%3D11045%26epage%3D11055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Wender</span> and <span class="hlFld-ContribAuthor ">Daniel  Strand</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclocarboamination of Alkynes with Aziridines: Synthesis of 2,3-Dihydropyrroles by a Catalyzed Formal [3 + 2] Cycloaddition. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2009,</strong> <em>131 </em>
                                    (22)
                                     , 7528-7529. <a href="https://doi.org/10.1021/ja901799s" title="DOI URL">https://doi.org/10.1021/ja901799s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja901799s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja901799s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCyclocarboamination%252Bof%252BAlkynes%252Bwith%252BAziridines%25253A%252BSynthesis%252Bof%252B2%25252C3-Dihydropyrroles%252Bby%252Ba%252BCatalyzed%252BFormal%252B%25255B3%252B%25252B%252B2%25255D%252BCycloaddition%26aulast%3DWender%26aufirst%3DPaul%2BA.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D08%252003%25202009%26date%3D12052009%26date%3D10062009%26volume%3D131%26issue%3D22%26spage%3D7528%26epage%3D7529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajarshi  Mondal</span>, <span class="hlFld-ContribAuthor ">Mohamed  Agbaria</span>, <span class="hlFld-ContribAuthor ">Zackaria  Nairoukh</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated Rings: Conformation and Application. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.1002/chem.202005425" title="DOI URL">https://doi.org/10.1002/chem.202005425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202005425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202005425%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DFluorinated%252BRings%25253A%252BConformation%252Band%252BApplication%26aulast%3DMondal%26aufirst%3DRajarshi%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacques  LePaih</span>, <span class="hlFld-ContribAuthor ">Dane A.  Goff</span>, <span class="hlFld-ContribAuthor ">Rajinder  Singh</span>, <span class="hlFld-ContribAuthor ">Simon J.  Shaw</span>. </span><span class="cited-content_cbyCitation_article-title">Efforts towards a Noyori reduction of a 3-fluorpiperidin-4-one with dynamic kinetic resolution. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>66 </em>, 152764. <a href="https://doi.org/10.1016/j.tetlet.2020.152764" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152764%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DEfforts%252Btowards%252Ba%252BNoyori%252Breduction%252Bof%252Ba%252B3-fluorpiperidin-4-one%252Bwith%252Bdynamic%252Bkinetic%252Bresolution%26aulast%3DLePaih%26aufirst%3DJacques%26date%3D2021%26volume%3D66%26spage%3D152764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Xi</span>, <span class="hlFld-ContribAuthor ">Chenchen  Wang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingping  Qu</span>, <span class="hlFld-ContribAuthor ">Yifeng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Regio‐, Diastereo‐, and Enantioselective 1,2‐Arylfluorination of Internal Enamides. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (5)
                                     , 2731-2735. <a href="https://doi.org/10.1002/ange.202012882" title="DOI URL">https://doi.org/10.1002/ange.202012882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202012882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202012882%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BRegio%2525E2%252580%252590%25252C%252BDiastereo%2525E2%252580%252590%25252C%252Band%252BEnantioselective%252B1%25252C2%2525E2%252580%252590Arylfluorination%252Bof%252BInternal%252BEnamides%26aulast%3DXi%26aufirst%3DYang%26date%3D2021%26date%3D2020%26volume%3D133%26issue%3D5%26spage%3D2731%26epage%3D2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Xi</span>, <span class="hlFld-ContribAuthor ">Chenchen  Wang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingping  Qu</span>, <span class="hlFld-ContribAuthor ">Yifeng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Regio‐, Diastereo‐, and Enantioselective 1,2‐Arylfluorination of Internal Enamides. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (5)
                                     , 2699-2703. <a href="https://doi.org/10.1002/anie.202012882" title="DOI URL">https://doi.org/10.1002/anie.202012882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202012882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202012882%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BRegio%2525E2%252580%252590%25252C%252BDiastereo%2525E2%252580%252590%25252C%252Band%252BEnantioselective%252B1%25252C2%2525E2%252580%252590Arylfluorination%252Bof%252BInternal%252BEnamides%26aulast%3DXi%26aufirst%3DYang%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D5%26spage%3D2699%26epage%3D2703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabel  Garcia-Saez</span>, <span class="hlFld-ContribAuthor ">Dimitrios A.  Skoufias</span>. </span><span class="cited-content_cbyCitation_article-title">Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>184 </em>, 114364. <a href="https://doi.org/10.1016/j.bcp.2020.114364" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114364%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DEg5%252Btargeting%252Bagents%25253A%252BFrom%252Bnew%252Banti-mitotic%252Bbased%252Binhibitor%252Bdiscovery%252Bto%252Bcancer%252Btherapy%252Band%252Bresistance%26aulast%3DGarcia-Saez%26aufirst%3DIsabel%26date%3D2021%26volume%3D184%26spage%3D114364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Tsung  Hsu</span>, <span class="hlFld-ContribAuthor ">Yi-Hung  Liu</span>, <span class="hlFld-ContribAuthor ">Shiuh-Tzung  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Benzylidene-3-Pyrrolines and Their Synthetic Transformation. </span><span class="cited-content_cbyCitation_journal-name">Reactions</span><span> <strong>2020,</strong> <em>1 </em>
                                    (2)
                                     , 47-53. <a href="https://doi.org/10.3390/reactions1020005" title="DOI URL">https://doi.org/10.3390/reactions1020005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/reactions1020005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Freactions1020005%26sid%3Dliteratum%253Aachs%26jtitle%3DReactions%26atitle%3DSynthesis%252Bof%252B2-Benzylidene-3-Pyrrolines%252Band%252BTheir%252BSynthetic%252BTransformation%26aulast%3DHsu%26aufirst%3DMing-Tsung%26date%3D2020%26date%3D2020%26volume%3D1%26issue%3D2%26spage%3D47%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barry M.  Trost</span>, <span class="hlFld-ContribAuthor ">Jacob S.  Tracy</span>, <span class="hlFld-ContribAuthor ">Tas  Yusoontorn</span>, <span class="hlFld-ContribAuthor ">Chao‐I Joey  Hung</span>. </span><span class="cited-content_cbyCitation_article-title">Acyclic Branched α‐Fluoro Ketones for the Direct Asymmetric Mannich Reaction Leading to the Synthesis of β‐Tetrasubstituted β‐Fluoro Amines. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (6)
                                     , 2390-2394. <a href="https://doi.org/10.1002/ange.201913927" title="DOI URL">https://doi.org/10.1002/ange.201913927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201913927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201913927%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DAcyclic%252BBranched%252B%2525CE%2525B1%2525E2%252580%252590Fluoro%252BKetones%252Bfor%252Bthe%252BDirect%252BAsymmetric%252BMannich%252BReaction%252BLeading%252Bto%252Bthe%252BSynthesis%252Bof%252B%2525CE%2525B2%2525E2%252580%252590Tetrasubstituted%252B%2525CE%2525B2%2525E2%252580%252590Fluoro%252BAmines%26aulast%3DTrost%26aufirst%3DBarry%2BM.%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D6%26spage%3D2390%26epage%3D2394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barry M.  Trost</span>, <span class="hlFld-ContribAuthor ">Jacob S.  Tracy</span>, <span class="hlFld-ContribAuthor ">Tas  Yusoontorn</span>, <span class="hlFld-ContribAuthor ">Chao‐I Joey  Hung</span>. </span><span class="cited-content_cbyCitation_article-title">Acyclic Branched α‐Fluoro Ketones for the Direct Asymmetric Mannich Reaction Leading to the Synthesis of β‐Tetrasubstituted β‐Fluoro Amines. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (6)
                                     , 2370-2374. <a href="https://doi.org/10.1002/anie.201913927" title="DOI URL">https://doi.org/10.1002/anie.201913927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201913927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201913927%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DAcyclic%252BBranched%252B%2525CE%2525B1%2525E2%252580%252590Fluoro%252BKetones%252Bfor%252Bthe%252BDirect%252BAsymmetric%252BMannich%252BReaction%252BLeading%252Bto%252Bthe%252BSynthesis%252Bof%252B%2525CE%2525B2%2525E2%252580%252590Tetrasubstituted%252B%2525CE%2525B2%2525E2%252580%252590Fluoro%252BAmines%26aulast%3DTrost%26aufirst%3DBarry%2BM.%26date%3D2020%26volume%3D59%26issue%3D6%26spage%3D2370%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongquan  Ning</span>, <span class="hlFld-ContribAuthor ">Paramasivam  Sivaguru</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Zanoni</span>, <span class="hlFld-ContribAuthor ">Edward A.  Anderson</span>, <span class="hlFld-ContribAuthor ">Xihe  Bi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of β-Difluoroalkyl Azides via Elusive 1,2-Azide Migration. </span><span class="cited-content_cbyCitation_journal-name">Chem</span><span> <strong>2020,</strong> <em>6 </em>
                                    (2)
                                     , 486-496. <a href="https://doi.org/10.1016/j.chempr.2019.12.004" title="DOI URL">https://doi.org/10.1016/j.chempr.2019.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chempr.2019.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chempr.2019.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DChem%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B2-Difluoroalkyl%252BAzides%252Bvia%252BElusive%252B1%25252C2-Azide%252BMigration%26aulast%3DNing%26aufirst%3DYongquan%26date%3D2020%26volume%3D6%26issue%3D2%26spage%3D486%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esperanza Macarena  Algarín</span>, <span class="hlFld-ContribAuthor ">Susana  Hernández-García</span>, <span class="hlFld-ContribAuthor ">Mercedes  Garayoa</span>, <span class="hlFld-ContribAuthor ">Enrique M.  Ocio</span>. </span><span class="cited-content_cbyCitation_article-title">Filanesib for the treatment of multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2020,</strong> <em>29 </em>
                                    (1)
                                     , 5-14. <a href="https://doi.org/10.1080/13543784.2020.1703179" title="DOI URL">https://doi.org/10.1080/13543784.2020.1703179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2020.1703179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2020.1703179%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DFilanesib%252Bfor%252Bthe%252Btreatment%252Bof%252Bmultiple%252Bmyeloma%26aulast%3DAlgar%25C3%25ADn%26aufirst%3DEsperanza%2BMacarena%26date%3D2020%26date%3D2019%26volume%3D29%26issue%3D1%26spage%3D5%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederick A.  Luzzio</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and reactivity of fluorinated heterocycles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-84. <a href="https://doi.org/10.1016/bs.aihch.2020.02.001" title="DOI URL">https://doi.org/10.1016/bs.aihch.2020.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2020.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2020.02.001%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Band%252Breactivity%252Bof%252Bfluorinated%252Bheterocycles%26aulast%3DLuzzio%26aufirst%3DFrederick%2BA.%26date%3D2020%26spage%3D1%26epage%3D84%26pub%3DElsevier%26date%3D2020%26volume%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mayank</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Singh</span>, <span class="hlFld-ContribAuthor ">Navneet  Kaur</span>, <span class="hlFld-ContribAuthor ">Neha  Garg</span>, <span class="hlFld-ContribAuthor ">Narinder  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer SAR establishment and novel accruing signal transduction model of drug action using biscoumarin scaffold. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2019,</strong> <em>83 </em>, 107104. <a href="https://doi.org/10.1016/j.compbiolchem.2019.107104" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2019.107104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2019.107104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2019.107104%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DAnticancer%252BSAR%252Bestablishment%252Band%252Bnovel%252Baccruing%252Bsignal%252Btransduction%252Bmodel%252Bof%252Bdrug%252Baction%252Busing%252Bbiscoumarin%252Bscaffold%26aulast%3DMayank%26date%3D2019%26volume%3D83%26spage%3D107104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamran  Amiri</span>, <span class="hlFld-ContribAuthor ">Hormoz  Khosravi</span>, <span class="hlFld-ContribAuthor ">Saeed  Balalaie</span>, <span class="hlFld-ContribAuthor ">Farhad  Golmohammadi</span>, <span class="hlFld-ContribAuthor ">Muhammad U.  Anwar</span>, <span class="hlFld-ContribAuthor ">Ahmed  Al-Harrasi</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and chemo-selective cyclization of allenic-Ugi products for the synthesis of 3-pyrroline skeletons. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (39)
                                     , 8858-8870. <a href="https://doi.org/10.1039/C9OB01963D" title="DOI URL">https://doi.org/10.1039/C9OB01963D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01963D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01963D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRegio-%252Band%252Bchemo-selective%252Bcyclization%252Bof%252Ballenic-Ugi%252Bproducts%252Bfor%252Bthe%252Bsynthesis%252Bof%252B3-pyrroline%252Bskeletons%26aulast%3DAmiri%26aufirst%3DKamran%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D39%26spage%3D8858%26epage%3D8870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Qing-Fei  Huang</span>, <span class="hlFld-ContribAuthor ">Wen-Lin  Zou</span>, <span class="hlFld-ContribAuthor ">Qing-Zhu  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Feng</span>, <span class="hlFld-ContribAuthor ">Zhi-Qiang  Jia</span>, <span class="hlFld-ContribAuthor ">Yue  Liu</span>, <span class="hlFld-ContribAuthor ">Jun-Long  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approach to skeletally diverse nitrogen heterocycles from dicyano-2-methylenebut-3-enoates. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (19)
                                     , 3321-3326. <a href="https://doi.org/10.1039/C9QO00509A" title="DOI URL">https://doi.org/10.1039/C9QO00509A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO00509A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO00509A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSynthetic%252Bapproach%252Bto%252Bskeletally%252Bdiverse%252Bnitrogen%252Bheterocycles%252Bfrom%252Bdicyano-2-methylenebut-3-enoates%26aulast%3DZhang%26aufirst%3DXiang%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D19%26spage%3D3321%26epage%3D3326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanthi  Nagarajan</span>, <span class="hlFld-ContribAuthor ">Sugunadevi  Sakkiah</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring a potential allosteric inhibition mechanism in the motor domain of human Eg-5. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (9)
                                     , 2394-2403. <a href="https://doi.org/10.1080/07391102.2018.1486229" title="DOI URL">https://doi.org/10.1080/07391102.2018.1486229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1486229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1486229%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DExploring%252Ba%252Bpotential%252Ballosteric%252Binhibition%252Bmechanism%252Bin%252Bthe%252Bmotor%252Bdomain%252Bof%252Bhuman%252BEg-5%26aulast%3DNagarajan%26aufirst%3DShanthi%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D9%26spage%3D2394%26epage%3D2403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiadi  Zhou</span>, <span class="hlFld-ContribAuthor ">Ye  Fang</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Jianjun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-free regioselective hydroxyfluorination and aminofluorination of α,β-unsaturated ketones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (18)
                                     , 4470-4474. <a href="https://doi.org/10.1039/C9OB00467J" title="DOI URL">https://doi.org/10.1039/C9OB00467J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00467J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00467J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCatalyst-free%252Bregioselective%252Bhydroxyfluorination%252Band%252Baminofluorination%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-unsaturated%252Bketones%26aulast%3DZhou%26aufirst%3DJiadi%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D18%26spage%3D4470%26epage%3D4474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liping  Zhu</span>, <span class="hlFld-ContribAuthor ">Jiale  Xiong</span>, <span class="hlFld-ContribAuthor ">Junkai  An</span>, <span class="hlFld-ContribAuthor ">Nannan  Chen</span>, <span class="hlFld-ContribAuthor ">Jijun  Xue</span>, <span class="hlFld-ContribAuthor ">Xianxing  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Highly efficient regio-selective ring-opening nucleophilic fluorination of aziridines and azetidines: access to β- or γ-fluorinated amino acid derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (15)
                                     , 3797-3804. <a href="https://doi.org/10.1039/C9OB00172G" title="DOI URL">https://doi.org/10.1039/C9OB00172G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00172G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00172G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DHighly%252Befficient%252Bregio-selective%252Bring-opening%252Bnucleophilic%252Bfluorination%252Bof%252Baziridines%252Band%252Bazetidines%25253A%252Baccess%252Bto%252B%2525CE%2525B2-%252Bor%252B%2525CE%2525B3-fluorinated%252Bamino%252Bacid%252Bderivatives%26aulast%3DZhu%26aufirst%3DLiping%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D15%26spage%3D3797%26epage%3D3804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Muthuraja</span>, <span class="hlFld-ContribAuthor ">V.  Veeramani</span>, <span class="hlFld-ContribAuthor ">S.  Prakash</span>, <span class="hlFld-ContribAuthor ">M.  Himesh</span>, <span class="hlFld-ContribAuthor ">U.  Venkatasubramanian</span>, <span class="hlFld-ContribAuthor ">P.  Manisankar</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship of pyrazolo pyrimidine derivatives as inhibitors of mitotic kinesin Eg5 and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 493-504. <a href="https://doi.org/10.1016/j.bioorg.2018.12.014" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.12.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.12.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Bof%252Bpyrazolo%252Bpyrimidine%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bmitotic%252Bkinesin%252BEg5%252Band%252Banticancer%252Bagents%26aulast%3DMuthuraja%26aufirst%3DP.%26date%3D2019%26volume%3D84%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noelia S.  Medran</span>, <span class="hlFld-ContribAuthor ">Agustina  La-Venia</span>, <span class="hlFld-ContribAuthor ">Sebastian A.  Testero</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-mediated synthesis of pyrrolines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (12)
                                     , 6804-6844. <a href="https://doi.org/10.1039/C8RA10247C" title="DOI URL">https://doi.org/10.1039/C8RA10247C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA10247C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA10247C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMetal-mediated%252Bsynthesis%252Bof%252Bpyrrolines%26aulast%3DMedran%26aufirst%3DNoelia%2BS.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D12%26spage%3D6804%26epage%3D6844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrasekaran  Balakumar</span>, <span class="hlFld-ContribAuthor ">Muthusamy  Ramesh</span>, <span class="hlFld-ContribAuthor ">Chuin Lean  Tham</span>, <span class="hlFld-ContribAuthor ">Samukelisiwe Pretty  Khathi</span>, <span class="hlFld-ContribAuthor ">Frank  Kozielski</span>, <span class="hlFld-ContribAuthor ">Cherukupalli  Srinivasulu</span>, <span class="hlFld-ContribAuthor ">Girish A.  Hampannavar</span>, <span class="hlFld-ContribAuthor ">Nisar  Sayyad</span>, <span class="hlFld-ContribAuthor ">Mahmoud E.  Soliman</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand- and structure-based
              in silico
              studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (14)
                                     , 3687-3704. <a href="https://doi.org/10.1080/07391102.2017.1396255" title="DOI URL">https://doi.org/10.1080/07391102.2017.1396255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1396255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1396255%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DLigand-%252Band%252Bstructure-based%252Bin%252Bsilico%252Bstudies%252Bto%252Bidentify%252Bkinesin%252Bspindle%252Bprotein%252B%252528KSP%252529%252Binhibitors%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DBalakumar%26aufirst%3DChandrasekaran%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D14%26spage%3D3687%26epage%3D3704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep K.  Talapatra</span>, <span class="hlFld-ContribAuthor ">Chuin Lean  Tham</span>, <span class="hlFld-ContribAuthor ">Paolo  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Roberto  Cirilli</span>, <span class="hlFld-ContribAuthor ">Balakumar  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Frank  Kozielski</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 641-651. <a href="https://doi.org/10.1016/j.ejmech.2018.07.006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCrystal%252Bstructure%252Bof%252Bthe%252BEg5%252B-%252BK858%252Bcomplex%252Band%252Bimplications%252Bfor%252Bstructure-based%252Bdesign%252Bof%252Bthiadiazole-containing%252Binhibitors%26aulast%3DTalapatra%26aufirst%3DSandeep%2BK.%26date%3D2018%26volume%3D156%26spage%3D641%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Giantulli</span>, <span class="hlFld-ContribAuthor ">Francesca  De Iuliis</span>, <span class="hlFld-ContribAuthor ">Ludovica  Taglieri</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Giusi  Menichelli</span>, <span class="hlFld-ContribAuthor ">Stefania  Morrone</span>, <span class="hlFld-ContribAuthor ">Susanna  Scarpa</span>, <span class="hlFld-ContribAuthor ">Ida  Silvestri</span>. </span><span class="cited-content_cbyCitation_article-title">Growth arrest and apoptosis induced by kinesin Eg5 inhibitor K858 and by its 1,3,4-thiadiazoline analogue in tumor cells. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Drugs</span><span> <strong>2018,</strong> <em>29 </em>
                                    (7)
                                     , 674-681. <a href="https://doi.org/10.1097/CAD.0000000000000641" title="DOI URL">https://doi.org/10.1097/CAD.0000000000000641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CAD.0000000000000641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCAD.0000000000000641%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Drugs%26atitle%3DGrowth%252Barrest%252Band%252Bapoptosis%252Binduced%252Bby%252Bkinesin%252BEg5%252Binhibitor%252BK858%252Band%252Bby%252Bits%252B1%25252C3%25252C4-thiadiazoline%252Banalogue%252Bin%252Btumor%252Bcells%26aulast%3DGiantulli%26aufirst%3DSabrina%26date%3D2018%26volume%3D29%26issue%3D7%26spage%3D674%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Muthuraja</span>, <span class="hlFld-ContribAuthor ">M.  Himesh</span>, <span class="hlFld-ContribAuthor ">S.  Prakash</span>, <span class="hlFld-ContribAuthor ">U.  Venkatasubramanian</span>, <span class="hlFld-ContribAuthor ">P.  Manisankar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-(1-(6-acetamido-5-phenylpyrimidin-4-yl) piperidin-3-yl) amide derivatives as potential inhibitors for mitotic kinesin spindle protein. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>148 </em>, 106-115. <a href="https://doi.org/10.1016/j.ejmech.2018.02.010" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252BN-%2525281-%2525286-acetamido-5-phenylpyrimidin-4-yl%252529%252Bpiperidin-3-yl%252529%252Bamide%252Bderivatives%252Bas%252Bpotential%252Binhibitors%252Bfor%252Bmitotic%252Bkinesin%252Bspindle%252Bprotein%26aulast%3DMuthuraja%26aufirst%3DP.%26date%3D2018%26volume%3D148%26spage%3D106%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhusheng  Huang</span>, <span class="hlFld-ContribAuthor ">Zonghao  Dai</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Fulai  Yang</span>, <span class="hlFld-ContribAuthor ">Qingfa  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of functionalized 2,5-dihydropyrrole derivatives
              via
              a convenient [3 + 2] annulation of azomethine ylides with allenoates. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (36)
                                     , 6638-6646. <a href="https://doi.org/10.1039/C8OB01946K" title="DOI URL">https://doi.org/10.1039/C8OB01946K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01946K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01946K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bfunctionalized%252B2%25252C5-dihydropyrrole%252Bderivatives%252Bvia%252Ba%252Bconvenient%252B%25255B3%252B%25252B%252B2%25255D%252Bannulation%252Bof%252Bazomethine%252Bylides%252Bwith%252Ballenoates%26aulast%3DHuang%26aufirst%3DZhusheng%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D36%26spage%3D6638%26epage%3D6646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony J.  Roecker</span>, <span class="hlFld-ContribAuthor ">Melissa  Egbertson</span>, <span class="hlFld-ContribAuthor ">Kristen L.G.  Jones</span>, <span class="hlFld-ContribAuthor ">Robert  Gomez</span>, <span class="hlFld-ContribAuthor ">Richard L.  Kraus</span>, <span class="hlFld-ContribAuthor ">Yuxing  Li</span>, <span class="hlFld-ContribAuthor ">Amy Jo  Koser</span>, <span class="hlFld-ContribAuthor ">Mark O.  Urban</span>, <span class="hlFld-ContribAuthor ">Rebecca  Klein</span>, <span class="hlFld-ContribAuthor ">Michelle  Clements</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Panigel</span>, <span class="hlFld-ContribAuthor ">Christopher  Daley</span>, <span class="hlFld-ContribAuthor ">Jixin  Wang</span>, <span class="hlFld-ContribAuthor ">Eleftheria N.  Finger</span>, <span class="hlFld-ContribAuthor ">John  Majercak</span>, <span class="hlFld-ContribAuthor ">Vincent  Santarelli</span>, <span class="hlFld-ContribAuthor ">Irene  Gregan</span>, <span class="hlFld-ContribAuthor ">Matthew  Cato</span>, <span class="hlFld-ContribAuthor ">Tracey  Filzen</span>, <span class="hlFld-ContribAuthor ">Aneta  Jovanovska</span>, <span class="hlFld-ContribAuthor ">Ying-Hong  Wang</span>, <span class="hlFld-ContribAuthor ">Deping  Wang</span>, <span class="hlFld-ContribAuthor ">Leo A.  Joyce</span>, <span class="hlFld-ContribAuthor ">Edward C.  Sherer</span>, <span class="hlFld-ContribAuthor ">Xuanjia  Peng</span>, <span class="hlFld-ContribAuthor ">Xiu  Wang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Sun</span>, <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>, <span class="hlFld-ContribAuthor ">Andrea K.  Houghton</span>, <span class="hlFld-ContribAuthor ">Mark E.  Layton</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of selective, orally bioavailable, N -linked arylsulfonamide Na v 1.7 inhibitors with pain efficacy in mice. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (10)
                                     , 2087-2093. <a href="https://doi.org/10.1016/j.bmcl.2017.03.085" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bselective%25252C%252Borally%252Bbioavailable%25252C%252BN%252B-linked%252Barylsulfonamide%252BNa%252Bv%252B1.7%252Binhibitors%252Bwith%252Bpain%252Befficacy%252Bin%252Bmice%26aulast%3DRoecker%26aufirst%3DAnthony%2BJ.%26date%3D2017%26volume%3D27%26issue%3D10%26spage%3D2087%26epage%3D2093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You Hwa  Son</span>, <span class="hlFld-ContribAuthor ">Chi Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Sang Un  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Mitotic Blockers by Phenotypic Screening of a Clinical Compound Library. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2016,</strong> <em>37 </em>
                                    (12)
                                     , 1942-1946. <a href="https://doi.org/10.1002/bkcs.10999" title="DOI URL">https://doi.org/10.1002/bkcs.10999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.10999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.10999%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DIdentification%252Bof%252BMitotic%252BBlockers%252Bby%252BPhenotypic%252BScreening%252Bof%252Ba%252BClinical%252BCompound%252BLibrary%26aulast%3DSon%26aufirst%3DYou%2BHwa%26date%3D2016%26date%3D2016%26volume%3D37%26issue%3D12%26spage%3D1942%26epage%3D1946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yutaka  Nakajima</span>, <span class="hlFld-ContribAuthor ">Naohiro  Aoyama</span>, <span class="hlFld-ContribAuthor ">Fumie  Takahashi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sasaki</span>, <span class="hlFld-ContribAuthor ">Keiko  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Ayako  Moritomo</span>, <span class="hlFld-ContribAuthor ">Masamichi  Inami</span>, <span class="hlFld-ContribAuthor ">Misato  Ito</span>, <span class="hlFld-ContribAuthor ">Koji  Nakamura</span>, <span class="hlFld-ContribAuthor ">Fumihiro  Nakamori</span>, <span class="hlFld-ContribAuthor ">Takayuki  Inoue</span>, <span class="hlFld-ContribAuthor ">Shohei  Shirakami</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of 4,6-diaminonicotinamide derivatives as novel and potent immunomodulators targeting JAK3. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (19)
                                     , 4711-4722. <a href="https://doi.org/10.1016/j.bmc.2016.08.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252B4%25252C6-diaminonicotinamide%252Bderivatives%252Bas%252Bnovel%252Band%252Bpotent%252Bimmunomodulators%252Btargeting%252BJAK3%26aulast%3DNakajima%26aufirst%3DYutaka%26date%3D2016%26volume%3D24%26issue%3D19%26spage%3D4711%26epage%3D4722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoya  Yukawa</span>, <span class="hlFld-ContribAuthor ">Yoshihisa  Nakada</span>, <span class="hlFld-ContribAuthor ">Nobuki  Sakauchi</span>, <span class="hlFld-ContribAuthor ">Taku  Kamei</span>, <span class="hlFld-ContribAuthor ">Masami  Yamada</span>, <span class="hlFld-ContribAuthor ">Yusuke  Ohba</span>, <span class="hlFld-ContribAuthor ">Ikuo  Fujimori</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Ueno</span>, <span class="hlFld-ContribAuthor ">Maiko  Takiguchi</span>, <span class="hlFld-ContribAuthor ">Masako  Kuno</span>, <span class="hlFld-ContribAuthor ">Izumi  Kamo</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Yasushi  Fujioka</span>, <span class="hlFld-ContribAuthor ">Tomoko  Igari</span>, <span class="hlFld-ContribAuthor ">Yuji  Ishichi</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Tsukamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors – Part 3. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (16)
                                     , 3716-3726. <a href="https://doi.org/10.1016/j.bmc.2016.06.014" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.06.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.06.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bperipheral-selective%252Bnoradrenaline%252Breuptake%252Binhibitors%252B%2525E2%252580%252593%252BPart%252B3%26aulast%3DYukawa%26aufirst%3DTomoya%26date%3D2016%26volume%3D24%26issue%3D16%26spage%3D3716%26epage%3D3726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ling  Zhai</span>, <span class="hlFld-ContribAuthor ">Wenyan  Lu</span>, <span class="hlFld-ContribAuthor ">Rebecca J.  Boohaker</span>, <span class="hlFld-ContribAuthor ">Indira  Padmalayam</span>, <span class="hlFld-ContribAuthor ">Yonghe  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>88 </em>
                                    (2)
                                     , 178-187. <a href="https://doi.org/10.1111/cbdd.12744" title="DOI URL">https://doi.org/10.1111/cbdd.12744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12744%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDiscovery%252Bof%252BNovel%252BAllosteric%252BEg5%252BInhibitors%252BThrough%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DZhang%26aufirst%3DWei%26date%3D2016%26date%3D2016%26volume%3D88%26issue%3D2%26spage%3D178%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsuya  Kato</span>, <span class="hlFld-ContribAuthor ">Daiyoon  Lee</span>, <span class="hlFld-ContribAuthor ">Licun  Wu</span>, <span class="hlFld-ContribAuthor ">Priya  Patel</span>, <span class="hlFld-ContribAuthor ">Ahn Jin  Young</span>, <span class="hlFld-ContribAuthor ">Hironobu  Wada</span>, <span class="hlFld-ContribAuthor ">Hsin-Pei  Hu</span>, <span class="hlFld-ContribAuthor ">Hideki  Ujiie</span>, <span class="hlFld-ContribAuthor ">Mitsuhito  Kaji</span>, <span class="hlFld-ContribAuthor ">Satoshi  Kano</span>, <span class="hlFld-ContribAuthor ">Shinichi  Matsuge</span>, <span class="hlFld-ContribAuthor ">Hiromitsu  Domen</span>, <span class="hlFld-ContribAuthor ">Kichizo  Kaga</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Matsui</span>, <span class="hlFld-ContribAuthor ">Hiromi  Kanno</span>, <span class="hlFld-ContribAuthor ">Yutaka  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Kanako C.  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Matsuno</span>, <span class="hlFld-ContribAuthor ">Marc  De Perrot</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Yasufuku</span>. </span><span class="cited-content_cbyCitation_article-title">Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Oncology</span><span> <strong>2016,</strong> <em>49 </em>
                                    (2)
                                     , 448-456. <a href="https://doi.org/10.3892/ijo.2016.3566" title="DOI URL">https://doi.org/10.3892/ijo.2016.3566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijo.2016.3566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijo.2016.3566%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Oncology%26atitle%3DKinesin%252Bfamily%252Bmembers%252BKIF11%252Band%252BKIF23%252Bas%252Bpotential%252Btherapeutic%252Btargets%252Bin%252Bmalignant%252Bpleural%252Bmesothelioma%26aulast%3DKato%26aufirst%3DTatsuya%26date%3D2016%26date%3D2016%26volume%3D49%26issue%3D2%26spage%3D448%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoya  Yukawa</span>, <span class="hlFld-ContribAuthor ">Ikuo  Fujimori</span>, <span class="hlFld-ContribAuthor ">Taku  Kamei</span>, <span class="hlFld-ContribAuthor ">Yoshihisa  Nakada</span>, <span class="hlFld-ContribAuthor ">Nobuki  Sakauchi</span>, <span class="hlFld-ContribAuthor ">Masami  Yamada</span>, <span class="hlFld-ContribAuthor ">Yusuke  Ohba</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Ueno</span>, <span class="hlFld-ContribAuthor ">Maiko  Takiguchi</span>, <span class="hlFld-ContribAuthor ">Masako  Kuno</span>, <span class="hlFld-ContribAuthor ">Izumi  Kamo</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Yasushi  Fujioka</span>, <span class="hlFld-ContribAuthor ">Tomoko  Igari</span>, <span class="hlFld-ContribAuthor ">Yuji  Ishichi</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Tsukamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors—Part 2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (14)
                                     , 3207-3217. <a href="https://doi.org/10.1016/j.bmc.2016.05.038" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.05.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.05.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bperipheral-selective%252Bnoradrenaline%252Breuptake%252Binhibitors%2525E2%252580%252594Part%252B2%26aulast%3DYukawa%26aufirst%3DTomoya%26date%3D2016%26volume%3D24%26issue%3D14%26spage%3D3207%26epage%3D3217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Coffinet</span>, <span class="hlFld-ContribAuthor ">Florian  Jaroschik</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Vasse</span>. </span><span class="cited-content_cbyCitation_article-title">Zirconocenes vs. Alanes: a Crucial Choice of the Allyl Source for Highly Diastereoselective Allylzincation of Nonracemic Chiral Imines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (13)
                                     , 2319-2327. <a href="https://doi.org/10.1002/ejoc.201600214" title="DOI URL">https://doi.org/10.1002/ejoc.201600214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600214%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DZirconocenes%252Bvs.%252BAlanes%25253A%252Ba%252BCrucial%252BChoice%252Bof%252Bthe%252BAllyl%252BSource%252Bfor%252BHighly%252BDiastereoselective%252BAllylzincation%252Bof%252BNonracemic%252BChiral%252BImines%26aulast%3DCoffinet%26aufirst%3DMichael%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D13%26spage%3D2319%26epage%3D2327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie M  Myers</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (4)
                                     , 463-489. <a href="https://doi.org/10.4155/fmc.16.5" title="DOI URL">https://doi.org/10.4155/fmc.16.5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.16.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.16.5%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bfindings%252Band%252Bfuture%252Bdirections%252Bfor%252Binterpolar%252Bmitotic%252Bkinesin%252Binhibitors%252Bin%252Bcancer%252Btherapy%26aulast%3DMyers%26aufirst%3DStephanie%2BM%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D463%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Yan</span>, <span class="hlFld-ContribAuthor ">Zheng  Fang</span>, <span class="hlFld-ContribAuthor ">Qing-Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-Hong  Guo</span>, <span class="hlFld-ContribAuthor ">Xiang-Guo  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Conformation-induced regioselective and divergent opening of epoxides by fluoride: facile access to hydroxylated fluoro-piperidines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (13)
                                     , 3469-3475. <a href="https://doi.org/10.1039/C6OB00063K" title="DOI URL">https://doi.org/10.1039/C6OB00063K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00063K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00063K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DConformation-induced%252Bregioselective%252Band%252Bdivergent%252Bopening%252Bof%252Bepoxides%252Bby%252Bfluoride%25253A%252Bfacile%252Baccess%252Bto%252Bhydroxylated%252Bfluoro-piperidines%26aulast%3DYan%26aufirst%3DNan%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D13%26spage%3D3469%26epage%3D3475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Bin  Han</span>, <span class="hlFld-ContribAuthor ">Cheng-Pan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">A solvent-free facile synthesis of (E)-bis(phosphonium)ethylenes from organo-phosphines and TfOCH2CF2H reagent. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (45)
                                     , 6219-6222. <a href="https://doi.org/10.1016/j.tetlet.2015.09.092" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.09.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.09.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.09.092%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bsolvent-free%252Bfacile%252Bsynthesis%252Bof%252B%252528E%252529-bis%252528phosphonium%252529ethylenes%252Bfrom%252Borgano-phosphines%252Band%252BTfOCH2CF2H%252Breagent%26aulast%3DWang%26aufirst%3DShi-Meng%26date%3D2015%26volume%3D56%26issue%3D45%26spage%3D6219%26epage%3D6222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey T.  Bagdanoff</span>, <span class="hlFld-ContribAuthor ">Rama  Jain</span>, <span class="hlFld-ContribAuthor ">Wooseok  Han</span>, <span class="hlFld-ContribAuthor ">Shejin  Zhu</span>, <span class="hlFld-ContribAuthor ">Ann-Marie  Madiera</span>, <span class="hlFld-ContribAuthor ">Patrick S.  Lee</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Ma</span>, <span class="hlFld-ContribAuthor ">Daniel  Poon</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (18)
                                     , 3788-3792. <a href="https://doi.org/10.1016/j.bmcl.2015.07.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.07.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.07.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.07.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTetrahydropyrrolo-diazepenones%252Bas%252Binhibitors%252Bof%252BERK2%252Bkinase%26aulast%3DBagdanoff%26aufirst%3DJeffrey%2BT.%26date%3D2015%26volume%3D25%26issue%3D18%26spage%3D3788%26epage%3D3792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yutaka  Nakajima</span>, <span class="hlFld-ContribAuthor ">Takayuki  Inoue</span>, <span class="hlFld-ContribAuthor ">Kazuo  Nakai</span>, <span class="hlFld-ContribAuthor ">Koichiro  Mukoyoshi</span>, <span class="hlFld-ContribAuthor ">Hisao  Hamaguchi</span>, <span class="hlFld-ContribAuthor ">Keiko  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sasaki</span>, <span class="hlFld-ContribAuthor ">Akira  Tanaka</span>, <span class="hlFld-ContribAuthor ">Fumie  Takahashi</span>, <span class="hlFld-ContribAuthor ">Shigeki  Kunikawa</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Usuda</span>, <span class="hlFld-ContribAuthor ">Ayako  Moritomo</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Higashi</span>, <span class="hlFld-ContribAuthor ">Masamichi  Inami</span>, <span class="hlFld-ContribAuthor ">Shohei  Shirakami</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4871-4883. <a href="https://doi.org/10.1016/j.bmc.2015.05.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B1H-pyrrolo%25255B2%25252C3-b%25255Dpyridine-5-carboxamide%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Befficacious%252Bimmunomodulators%252Btargeting%252BJAK3%26aulast%3DNakajima%26aufirst%3DYutaka%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4871%26epage%3D4883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pinhong  Chen</span>, <span class="hlFld-ContribAuthor ">Guosheng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Advancements in Aminofluorination of Alkenes and Alkynes: Convenient Access to β-Fluoroamines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (20)
                                     , 4295-4309. <a href="https://doi.org/10.1002/ejoc.201500231" title="DOI URL">https://doi.org/10.1002/ejoc.201500231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201500231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201500231%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAdvancements%252Bin%252BAminofluorination%252Bof%252BAlkenes%252Band%252BAlkynes%25253A%252BConvenient%252BAccess%252Bto%252B%2525CE%2525B2-Fluoroamines%26aulast%3DChen%26aufirst%3DPinhong%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D20%26spage%3D4295%26epage%3D4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mitsuko  Takenaga</span>, <span class="hlFld-ContribAuthor ">Yuki  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Tomoki  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Yuki  Ohta</span>, <span class="hlFld-ContribAuthor ">Yukie  Tokura</span>, <span class="hlFld-ContribAuthor ">Akemi  Hamaguchi</span>, <span class="hlFld-ContribAuthor ">Daisuke  Asai</span>, <span class="hlFld-ContribAuthor ">Hideki  Nakashima</span>, <span class="hlFld-ContribAuthor ">Shinya  Oishi</span>, <span class="hlFld-ContribAuthor ">Nobutaka  Fujii</span>. </span><span class="cited-content_cbyCitation_article-title">Potential new chemotherapy strategy for human ovarian carcinoma with a novel KSP inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2015,</strong> <em>463 </em>
                                    (3)
                                     , 222-228. <a href="https://doi.org/10.1016/j.bbrc.2015.05.029" title="DOI URL">https://doi.org/10.1016/j.bbrc.2015.05.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2015.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2015.05.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DPotential%252Bnew%252Bchemotherapy%252Bstrategy%252Bfor%252Bhuman%252Bovarian%252Bcarcinoma%252Bwith%252Ba%252Bnovel%252BKSP%252Binhibitor%26aulast%3DTakenaga%26aufirst%3DMitsuko%26date%3D2015%26volume%3D463%26issue%3D3%26spage%3D222%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Umar Faruk  Mansoor</span>, <span class="hlFld-ContribAuthor ">Angie R.  Angeles</span>, <span class="hlFld-ContribAuthor ">Chaoyang  Dai</span>, <span class="hlFld-ContribAuthor ">Liping  Yang</span>, <span class="hlFld-ContribAuthor ">Dilrukshi  Vitharana</span>, <span class="hlFld-ContribAuthor ">Andrea D.  Basso</span>, <span class="hlFld-ContribAuthor ">Kimberly  Gray</span>, <span class="hlFld-ContribAuthor ">Huadong  Tang</span>, <span class="hlFld-ContribAuthor ">Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Lianzhu  Liang</span>, <span class="hlFld-ContribAuthor ">Omaira  Allbritton</span>, <span class="hlFld-ContribAuthor ">M. Arshad  Siddiqui</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (10)
                                     , 2424-2434. <a href="https://doi.org/10.1016/j.bmc.2015.03.052" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.03.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.03.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.03.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bspiro%252B1%25252C3%25252C4-thiadiazolines%252Bas%252Bpotent%25252C%252Borally%252Bbioavailable%252Band%252Bbrain%252Bpenetrant%252BKSP%252Binhibitors%26aulast%3DMansoor%26aufirst%3DUmar%2BFaruk%26date%3D2015%26volume%3D23%26issue%3D10%26spage%3D2424%26epage%3D2434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajmal  Khan</span>, <span class="hlFld-ContribAuthor ">Juxiang  Xing</span>, <span class="hlFld-ContribAuthor ">Jingming  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuhe  Kan</span>, <span class="hlFld-ContribAuthor ">Wanbin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Enantioselective Decarboxylative Cycloaddition of Vinylethylene Carbonates with Isocyanates. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (1)
                                     , 120-124. <a href="https://doi.org/10.1002/chem.201405830" title="DOI URL">https://doi.org/10.1002/chem.201405830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201405830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201405830%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DPalladium-Catalyzed%252BEnantioselective%252BDecarboxylative%252BCycloaddition%252Bof%252BVinylethylene%252BCarbonates%252Bwith%252BIsocyanates%26aulast%3DKhan%26aufirst%3DAjmal%26date%3D2015%26date%3D2014%26volume%3D21%26issue%3D1%26spage%3D120%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Devenderan  Ramanathan</span>, <span class="hlFld-ContribAuthor ">Kasi  Pitchumani</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(I)-Catalyzed One-Pot Synthesis of Highly Functionalized Pyrrolidines from Sulfonyl Azides, Alkynes, and Dimethyl 2-(Phenylamino)maleate. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (3)
                                     , 463-467. <a href="https://doi.org/10.1002/ejoc.201403285" title="DOI URL">https://doi.org/10.1002/ejoc.201403285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201403285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201403285%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper%252528I%252529-Catalyzed%252BOne-Pot%252BSynthesis%252Bof%252BHighly%252BFunctionalized%252BPyrrolidines%252Bfrom%252BSulfonyl%252BAzides%25252C%252BAlkynes%25252C%252Band%252BDimethyl%252B2-%252528Phenylamino%252529maleate%26aulast%3DRamanathan%26aufirst%3DDevenderan%26date%3D2015%26date%3D2014%26volume%3D2015%26issue%3D3%26spage%3D463%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A. D.  Good</span>, <span class="hlFld-ContribAuthor ">Giacomo  Berretta</span>, <span class="hlFld-ContribAuthor ">Nahoum G.  Anthony</span>, <span class="hlFld-ContribAuthor ">Simon P.  Mackay</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Development of Eg5 Inhibitors for the Clinic. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 27-52. <a href="https://doi.org/10.1007/978-94-017-9732-0_2" title="DOI URL">https://doi.org/10.1007/978-94-017-9732-0_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-017-9732-0_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-017-9732-0_2%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BDevelopment%252Bof%252BEg5%252BInhibitors%252Bfor%252Bthe%252BClinic%26aulast%3DGood%26aufirst%3DJames%2BA.%2BD.%26date%3D2015%26date%3D2015%26spage%3D27%26epage%3D52%26pub%3DSpringer%2520Netherlands%26atitle%3DKinesins%252Band%252BCancer%26aulast%3DKozielski%252C%2BFSB%26aufirst%3DFrank%26date%3D2015%26volume%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerhard  Gross</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for Enhancing Oral Bioavailability and Brain Penetration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 631-655. <a href="https://doi.org/10.1016/B978-0-12-417205-0.00027-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-417205-0.00027-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417205-0.00027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417205-0.00027-4%26sid%3Dliteratum%253Aachs%26atitle%3DStrategies%252Bfor%252BEnhancing%252BOral%252BBioavailability%252Band%252BBrain%252BPenetration%26aulast%3DGross%26aufirst%3DGerhard%26date%3D2015%26spage%3D631%26epage%3D655%26pub%3DElsevier%26atitle%3DThe%252BPractice%252Bof%252BMedicinal%252BChemistry%26date%3D2015%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven  Swallow</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 65-133. <a href="https://doi.org/10.1016/bs.pmch.2014.11.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2014.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2014.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2014.11.001%26sid%3Dliteratum%253Aachs%26atitle%3DFluorine%252Bin%252BMedicinal%252BChemistry%26aulast%3DSwallow%26aufirst%3DSteven%26date%3D2015%26spage%3D65%26epage%3D133%26pub%3DElsevier%26date%3D2015%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei-Fei  Tang</span>, <span class="hlFld-ContribAuthor ">Wu-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Xingxin  Yu</span>, <span class="hlFld-ContribAuthor ">Wei-Ping  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(OAc)
              2
              /FOXAP complex catalyzed construction of 2,5-dihydropyrrole derivatives via asymmetric 1,3-dipolar cycloaddition of azomethine ylides to ethynyl ketones. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Science & Technology</span><span> <strong>2015,</strong> <em>5 </em>
                                    (7)
                                     , 3568-3575. <a href="https://doi.org/10.1039/C5CY00422E" title="DOI URL">https://doi.org/10.1039/C5CY00422E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CY00422E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CY00422E%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Science%2520%2526%2520Technology%26atitle%3DCu%252528OAc%252529%252B2%252B%25252FFOXAP%252Bcomplex%252Bcatalyzed%252Bconstruction%252Bof%252B2%25252C5-dihydropyrrole%252Bderivatives%252Bvia%252Basymmetric%252B1%25252C3-dipolar%252Bcycloaddition%252Bof%252Bazomethine%252Bylides%252Bto%252Bethynyl%252Bketones%26aulast%3DTang%26aufirst%3DFei-Fei%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D7%26spage%3D3568%26epage%3D3575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Ugarte</span>, <span class="hlFld-ContribAuthor ">Katherine  Porth</span>, <span class="hlFld-ContribAuthor ">Svetlana  Sadekova</span>. </span><span class="cited-content_cbyCitation_article-title">Histone H3 Phosphorylation in Human Skin Histoculture as a Tool to Evaluate Patient's Response to Antiproliferative Drugs. </span><span class="cited-content_cbyCitation_journal-name">Biomarker Insights</span><span> <strong>2015,</strong> <em>10s4 </em>, BMI.S29515. <a href="https://doi.org/10.4137/BMI.S29515" title="DOI URL">https://doi.org/10.4137/BMI.S29515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4137/BMI.S29515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4137%2FBMI.S29515%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomarker%2520Insights%26atitle%3DHistone%252BH3%252BPhosphorylation%252Bin%252BHuman%252BSkin%252BHistoculture%252Bas%252Ba%252BTool%252Bto%252BEvaluate%252BPatient%252527s%252BResponse%252Bto%252BAntiproliferative%252BDrugs%26aulast%3DUgarte%26aufirst%3DFernando%26date%3D2015%26date%3D2016%26volume%3D10s4%26spage%3DBMI.S29515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  Carbajales</span>, <span class="hlFld-ContribAuthor ">Miguel Ángel  Prado</span>, <span class="hlFld-ContribAuthor ">Hugo  Gutiérrez-de-Terán</span>, <span class="hlFld-ContribAuthor ">Ángel  Cores</span>, <span class="hlFld-ContribAuthor ">Jhonny  Azuaje</span>, <span class="hlFld-ContribAuthor ">Silvia  Novio</span>, <span class="hlFld-ContribAuthor ">María Jesús  Nuñez</span>, <span class="hlFld-ContribAuthor ">Belén  Fernández-García</span>, <span class="hlFld-ContribAuthor ">Eddy  Sotelo</span>, <span class="hlFld-ContribAuthor ">Xerardo  García-Mera</span>, <span class="hlFld-ContribAuthor ">Pedro  Sánchez-Lazo</span>, <span class="hlFld-ContribAuthor ">Manuel  Freire-Garabal</span>, <span class="hlFld-ContribAuthor ">Alberto  Coelho</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of New KSP-Eg5 Inhibitors Assisted by a Targeted Multicomponent Reaction. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2014,</strong> <em>15 </em>
                                    (10)
                                     , 1471-1480. <a href="https://doi.org/10.1002/cbic.201402089" title="DOI URL">https://doi.org/10.1002/cbic.201402089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201402089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201402089%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DStructure-Based%252BDesign%252Bof%252BNew%252BKSP-Eg5%252BInhibitors%252BAssisted%252Bby%252Ba%252BTargeted%252BMulticomponent%252BReaction%26aulast%3DCarbajales%26aufirst%3DCarlos%26date%3D2014%26date%3D2014%26volume%3D15%26issue%3D10%26spage%3D1471%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaodong  Li</span>, <span class="hlFld-ContribAuthor ">Chengwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Chao  Liu</span>, <span class="hlFld-ContribAuthor ">Chaozhong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal-free, room-temperature radical azidofluorination of unactivated alkenes in aqueous solution. </span><span class="cited-content_cbyCitation_journal-name">Org. Chem. Front.</span><span> <strong>2014,</strong> <em>1 </em>
                                    (1)
                                     , 100-104. <a href="https://doi.org/10.1039/C3QO00037K" title="DOI URL">https://doi.org/10.1039/C3QO00037K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3QO00037K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3QO00037K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Chem.%2520Front.%26atitle%3DTransition-metal-free%25252C%252Broom-temperature%252Bradical%252Bazidofluorination%252Bof%252Bunactivated%252Balkenes%252Bin%252Baqueous%252Bsolution%26aulast%3DLi%26aufirst%3DZhaodong%26date%3D2014%26date%3D2014%26volume%3D1%26issue%3D1%26spage%3D100%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bayalagmaa  Nyamaa</span>, <span class="hlFld-ContribAuthor ">Hyoung Kyu  Kim</span>, <span class="hlFld-ContribAuthor ">Yu Jeong  Jeong</span>, <span class="hlFld-ContribAuthor ">In-Sung  Song</span>, <span class="hlFld-ContribAuthor ">Jin  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Kinesin Spindle Protein Inhibition in Translational Research. </span><span class="cited-content_cbyCitation_journal-name">Journal of Lipid and Atherosclerosis</span><span> <strong>2014,</strong> <em>3 </em>
                                    (2)
                                     , 63. <a href="https://doi.org/10.12997/jla.2014.3.2.63" title="DOI URL">https://doi.org/10.12997/jla.2014.3.2.63</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12997/jla.2014.3.2.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12997%2Fjla.2014.3.2.63%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Lipid%2520and%2520Atherosclerosis%26atitle%3DKinesin%252BSpindle%252BProtein%252BInhibition%252Bin%252BTranslational%252BResearch%26aulast%3DNyamaa%26aufirst%3DBayalagmaa%26date%3D2014%26volume%3D3%26issue%3D2%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siva Senthil Kumar  Boominathan</span>, <span class="hlFld-ContribAuthor ">Wan‐Ping  Hu</span>, <span class="hlFld-ContribAuthor ">Gopal Chandru  Senadi</span>, <span class="hlFld-ContribAuthor ">Jeh‐Jeng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Silver(I)‐Catalyzed Conia‐Ene Reaction: Synthesis of 3‐Pyrrolines
              via
              a 5‐
              endo
              ‐
              dig
              Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2013,</strong> <em>355 </em>
                                    (18)
                                     , 3570-3574. <a href="https://doi.org/10.1002/adsc.201300844" title="DOI URL">https://doi.org/10.1002/adsc.201300844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201300844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201300844%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSilver%252528I%252529%2525E2%252580%252590Catalyzed%252BConia%2525E2%252580%252590Ene%252BReaction%25253A%252BSynthesis%252Bof%252B3%2525E2%252580%252590Pyrrolines%252Bvia%252Ba%252B5%2525E2%252580%252590%252Bendo%252B%2525E2%252580%252590%252Bdig%252BCyclization%26aulast%3DBoominathan%26aufirst%3DSiva%2BSenthil%2BKumar%26date%3D2013%26date%3D2013%26volume%3D355%26issue%3D18%26spage%3D3570%26epage%3D3574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing-Jun  Dong</span>, <span class="hlFld-ContribAuthor ">Qing-Shan  Li</span>, <span class="hlFld-ContribAuthor ">Zhi-Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Shu-Fu  Wang</span>, <span class="hlFld-ContribAuthor ">Meng-Yue  Zhao</span>, <span class="hlFld-ContribAuthor ">Yong-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>70 </em>, 427-433. <a href="https://doi.org/10.1016/j.ejmech.2013.09.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.09.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.09.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.09.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bflavone%252Band%252Bisoflavone%252Bderivatives%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252BKSP%252B%252528kinesin%252Bspindle%252Bprotein%252529%252Binhibitors%26aulast%3DDong%26aufirst%3DJing-Jun%26date%3D2013%26volume%3D70%26spage%3D427%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward J.  Wojcik</span>, <span class="hlFld-ContribAuthor ">Rebecca S.  Buckley</span>, <span class="hlFld-ContribAuthor ">Jessica  Richard</span>, <span class="hlFld-ContribAuthor ">Liqiong  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Huckaba</span>, <span class="hlFld-ContribAuthor ">Sunyoung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Kinesin-5: Cross-bridging mechanism to targeted clinical therapy. </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2013,</strong> <em>531 </em>
                                    (2)
                                     , 133-149. <a href="https://doi.org/10.1016/j.gene.2013.08.004" title="DOI URL">https://doi.org/10.1016/j.gene.2013.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2013.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2013.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DKinesin-5%25253A%252BCross-bridging%252Bmechanism%252Bto%252Btargeted%252Bclinical%252Btherapy%26aulast%3DWojcik%26aufirst%3DEdward%2BJ.%26date%3D2013%26volume%3D531%26issue%3D2%26spage%3D133%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tong  Chen</span>, <span class="hlFld-ContribAuthor ">Nana  Shao</span>, <span class="hlFld-ContribAuthor ">Huajian  Zhu</span>, <span class="hlFld-ContribAuthor ">Boya  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongbin  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade reaction for 3-pyrrolines and pyrroles from nitroallylic acetates and N-mesyl 2-aminoethanones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (49)
                                     , 10558-10564. <a href="https://doi.org/10.1016/j.tet.2013.10.045" title="DOI URL">https://doi.org/10.1016/j.tet.2013.10.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.10.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.10.045%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCascade%252Breaction%252Bfor%252B3-pyrrolines%252Band%252Bpyrroles%252Bfrom%252Bnitroallylic%252Bacetates%252Band%252BN-mesyl%252B2-aminoethanones%26aulast%3DChen%26aufirst%3DTong%26date%3D2013%26volume%3D69%26issue%3D49%26spage%3D10558%26epage%3D10564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Jiang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Kinesin spindle protein inhibitors in cancer: a patent review (2008 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (12)
                                     , 1547-1560. <a href="https://doi.org/10.1517/13543776.2013.833606" title="DOI URL">https://doi.org/10.1517/13543776.2013.833606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.833606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.833606%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DKinesin%252Bspindle%252Bprotein%252Binhibitors%252Bin%252Bcancer%25253A%252Ba%252Bpatent%252Breview%252B%2525282008%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DJiang%26aufirst%3DCheng%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D12%26spage%3D1547%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hualong  Song</span>, <span class="hlFld-ContribAuthor ">Shanshan  Zhou</span>, <span class="hlFld-ContribAuthor ">Rubing  Wang</span>, <span class="hlFld-ContribAuthor ">Shaoshun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Kinesin Spindle Protein (KSP) Inhibitors in Combination with Chemotherapeutic Agents for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (11)
                                     , 1736-1749. <a href="https://doi.org/10.1002/cmdc.201300228" title="DOI URL">https://doi.org/10.1002/cmdc.201300228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300228%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DKinesin%252BSpindle%252BProtein%252B%252528KSP%252529%252BInhibitors%252Bin%252BCombination%252Bwith%252BChemotherapeutic%252BAgents%252Bfor%252BCancer%252BTherapy%26aulast%3DSong%26aufirst%3DHualong%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D11%26spage%3D1736%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Jones</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Vuky</span>, <span class="hlFld-ContribAuthor ">Tony  Elliott</span>, <span class="hlFld-ContribAuthor ">Graham  Mead</span>, <span class="hlFld-ContribAuthor ">José Angel  Arranz</span>, <span class="hlFld-ContribAuthor ">John  Chester</span>, <span class="hlFld-ContribAuthor ">Simon  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Arkadiusz Z.  Dudek</span>, <span class="hlFld-ContribAuthor ">Volker  Müller-Mattheis</span>, <span class="hlFld-ContribAuthor ">Marc-Oliver  Grimm</span>, <span class="hlFld-ContribAuthor ">Jürgen E.  Gschwend</span>, <span class="hlFld-ContribAuthor ">Christian  Wülfing</span>, <span class="hlFld-ContribAuthor ">Peter  Albers</span>, <span class="hlFld-ContribAuthor ">Jianguo  Li</span>, <span class="hlFld-ContribAuthor ">Anna  Osmukhina</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Skolnik</span>, <span class="hlFld-ContribAuthor ">Gary  Hudes</span>. </span><span class="cited-content_cbyCitation_article-title">Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2013,</strong> <em>31 </em>
                                    (4)
                                     , 1001-1007. <a href="https://doi.org/10.1007/s10637-013-9926-y" title="DOI URL">https://doi.org/10.1007/s10637-013-9926-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-013-9926-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-013-9926-y%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DPhase%252BII%252Bstudy%252Bto%252Bassess%252Bthe%252Befficacy%25252C%252Bsafety%252Band%252Btolerability%252Bof%252Bthe%252Bmitotic%252Bspindle%252Bkinesin%252Binhibitor%252BAZD4877%252Bin%252Bpatients%252Bwith%252Brecurrent%252Badvanced%252Burothelial%252Bcancer%26aulast%3DJones%26aufirst%3DRobert%26date%3D2013%26date%3D2013%26volume%3D31%26issue%3D4%26spage%3D1001%26epage%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Rongbao  Li</span>, <span class="hlFld-ContribAuthor ">Ronald  Shin</span>, <span class="hlFld-ContribAuthor ">Yimin  Wang</span>, <span class="hlFld-ContribAuthor ">Indira  Padmalayam</span>, <span class="hlFld-ContribAuthor ">Ling  Zhai</span>, <span class="hlFld-ContribAuthor ">N. Rama  Krishna</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the Binding Site of an Allosteric Ligand Using STD-NMR, Docking, and CORCEMA-ST Calculations. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>33 </em>, n/a-n/a. <a href="https://doi.org/10.1002/cmdc.201300267" title="DOI URL">https://doi.org/10.1002/cmdc.201300267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300267%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DIdentification%252Bof%252Bthe%252BBinding%252BSite%252Bof%252Ban%252BAllosteric%252BLigand%252BUsing%252BSTD-NMR%25252C%252BDocking%25252C%252Band%252BCORCEMA-ST%252BCalculations%26aulast%3DZhang%26aufirst%3DWei%26date%3D2013%26date%3D2013%26volume%3D33%26spage%3Dn%252Fa%26epage%3Dn%252Fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hala Bakr  El-Nassan</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>62 </em>, 614-631. <a href="https://doi.org/10.1016/j.ejmech.2013.01.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.01.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.01.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bkinesin%252Bspindle%252Bprotein%252B%252528Eg5%252529%252Binhibitors%252Bas%252Bantitumor%252Bagents%26aulast%3DEl-Nassan%26aufirst%3DHala%2BBakr%26date%3D2013%26volume%3D62%26spage%3D614%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wangqing  Kong</span>, <span class="hlFld-ContribAuthor ">Pascal  Feige</span>, <span class="hlFld-ContribAuthor ">Teresa  de Haro</span>, <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and Enantioselective Aminofluorination of Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2013,</strong> <em>125 </em>
                                    (9)
                                     , 2529-2533. <a href="https://doi.org/10.1002/ange.201208471" title="DOI URL">https://doi.org/10.1002/ange.201208471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201208471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201208471%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRegio-%252Band%252BEnantioselective%252BAminofluorination%252Bof%252BAlkenes%26aulast%3DKong%26aufirst%3DWangqing%26date%3D2013%26date%3D2013%26volume%3D125%26issue%3D9%26spage%3D2529%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wangqing  Kong</span>, <span class="hlFld-ContribAuthor ">Pascal  Feige</span>, <span class="hlFld-ContribAuthor ">Teresa  de Haro</span>, <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and Enantioselective Aminofluorination of Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2013,</strong> <em>52 </em>
                                    (9)
                                     , 2469-2473. <a href="https://doi.org/10.1002/anie.201208471" title="DOI URL">https://doi.org/10.1002/anie.201208471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201208471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201208471%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRegio-%252Band%252BEnantioselective%252BAminofluorination%252Bof%252BAlkenes%26aulast%3DKong%26aufirst%3DWangqing%26date%3D2013%26date%3D2013%26volume%3D52%26issue%3D9%26spage%3D2469%26epage%3D2473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuele  Marra</span>, <span class="hlFld-ContribAuthor ">Fabio  Palombo</span>, <span class="hlFld-ContribAuthor ">Gennaro  Ciliberto</span>, <span class="hlFld-ContribAuthor ">Luigi  Aurisicchio</span>. </span><span class="cited-content_cbyCitation_article-title">Kinesin spindle protein SiRNA slows tumor progression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2013,</strong> <em>228 </em>
                                    (1)
                                     , 58-64. <a href="https://doi.org/10.1002/jcp.24103" title="DOI URL">https://doi.org/10.1002/jcp.24103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.24103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.24103%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DKinesin%252Bspindle%252Bprotein%252BSiRNA%252Bslows%252Btumor%252Bprogression%26aulast%3DMarra%26aufirst%3DEmanuele%26date%3D2013%26date%3D2012%26volume%3D228%26issue%3D1%26spage%3D58%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 283-381. <a href="https://doi.org/10.1007/7355_2013_29" title="DOI URL">https://doi.org/10.1007/7355_2013_29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_29%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInfluence%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%25253A%252BTactical%252BApplications%252Bto%252BAddress%252BDevelopability%252BProblems%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2014%26spage%3D283%26epage%3D381%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adeline  Goulet</span>, <span class="hlFld-ContribAuthor ">Carolyn  Moores</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights into the Mechanism of Force Generation by Kinesin-5 Molecular Motors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 419-466. <a href="https://doi.org/10.1016/B978-0-12-407696-9.00008-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-407696-9.00008-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-407696-9.00008-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-407696-9.00008-7%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BInsights%252Binto%252Bthe%252BMechanism%252Bof%252BForce%252BGeneration%252Bby%252BKinesin-5%252BMolecular%252BMotors%26aulast%3DGoulet%26aufirst%3DAdeline%26date%3D2013%26spage%3D419%26epage%3D466%26pub%3DElsevier%26date%3D2013%26volume%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">Vincent  Mascitti</span>, <span class="hlFld-ContribAuthor ">Kevin  Beaumont</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism-guided drug design. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (4)
                                     , 631. <a href="https://doi.org/10.1039/c2md20317k" title="DOI URL">https://doi.org/10.1039/c2md20317k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md20317k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md20317k%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DMetabolism-guided%252Bdrug%252Bdesign%26aulast%3DStepan%26aufirst%3DAntonia%2BF.%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashant V.  Desai</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Raub</span>, <span class="hlFld-ContribAuthor ">Maria-Jesus  Blanco</span>. </span><span class="cited-content_cbyCitation_article-title">How hydrogen bonds impact P-glycoprotein transport and permeability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (21)
                                     , 6540-6548. <a href="https://doi.org/10.1016/j.bmcl.2012.08.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.08.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.08.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.08.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHow%252Bhydrogen%252Bbonds%252Bimpact%252BP-glycoprotein%252Btransport%252Band%252Bpermeability%26aulast%3DDesai%26aufirst%3DPrashant%2BV.%26date%3D2012%26volume%3D22%26issue%3D21%26spage%3D6540%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric  Desmarchelier</span>, <span class="hlFld-ContribAuthor ">Vincent  Coeffard</span>, <span class="hlFld-ContribAuthor ">Xavier  Moreau</span>, <span class="hlFld-ContribAuthor ">Christine  Greck</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Organocatalytic One-Pot Amination/aza-Michael/Aldol Condensation Reaction Sequence: Synthesis of 3-Pyrrolines with a Quaternary Stereocenter. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2012,</strong> <em>18 </em>
                                    (41)
                                     , 13222-13225. <a href="https://doi.org/10.1002/chem.201202024" title="DOI URL">https://doi.org/10.1002/chem.201202024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201202024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201202024%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DEnantioselective%252BOrganocatalytic%252BOne-Pot%252BAmination%25252Faza-Michael%25252FAldol%252BCondensation%252BReaction%252BSequence%25253A%252BSynthesis%252Bof%252B3-Pyrrolines%252Bwith%252Ba%252BQuaternary%252BStereocenter%26aulast%3DDesmarchelier%26aufirst%3DAlaric%26date%3D2012%26date%3D2012%26volume%3D18%26issue%3D41%26spage%3D13222%26epage%3D13225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. K.  Talapatra</span>, <span class="hlFld-ContribAuthor ">A. W.  Schüttelkopf</span>, <span class="hlFld-ContribAuthor ">F.  Kozielski</span>. </span><span class="cited-content_cbyCitation_article-title">The structure of the ternary Eg5–ADP–ispinesib complex. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Biological Crystallography</span><span> <strong>2012,</strong> <em>68 </em>
                                    (10)
                                     , 1311-1319. <a href="https://doi.org/10.1107/S0907444912027965" title="DOI URL">https://doi.org/10.1107/S0907444912027965</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S0907444912027965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS0907444912027965%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Biological%2520Crystallography%26atitle%3DThe%252Bstructure%252Bof%252Bthe%252Bternary%252BEg5%2525E2%252580%252593ADP%2525E2%252580%252593ispinesib%252Bcomplex%26aulast%3DTalapatra%26aufirst%3DS.%2BK.%26date%3D2012%26date%3D2012%26volume%3D68%26issue%3D10%26spage%3D1311%26epage%3D1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm800386y&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm800386y%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=124&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0007.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0008.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Previously Reported KSP Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0001.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClCH<sub>2</sub>C(CH<sub>2</sub>)CH<sub>2</sub>Cl, Bu<sub>4</sub>NHSO<sub>4</sub>, 10 M NaOH, DCM; (b) 1 M HCl; (c) Na<sub>2</sub>CO<sub>2</sub>/H<sub>2</sub>O; (d) LAH, THF, 0°C to room temp; (e) CDI, TEA, DCM; (f) O<sub>3</sub>, DCM, −78 °C, then DMS (15% yield from <b>3</b>); (g) NaHMDS, THF, −78 °C, then PhN(Tf)<sub>2</sub>; (h) 2,5-difluoroboronic acid, Na<sub>2</sub>CO<sub>3</sub>, LiCl, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME (69% for two steps); (i) 10 M NaOH, EtOH, 60°C; (j) TBSCl, imidazole, 5% DMF in DCM (83% for two steps); (k) Chiralpak AD, 1% <sup><i>i</i></sup>PrOH in hexanes (0.1% DEA as modifier), first isomer to elute is the desired (<i>S</i>)-isomer; (l) triphosgene, TEA, THF; (m) NHMe<sub>2</sub>; (n) HF−TEA, CH<sub>3</sub>CN (78% for three steps).</p></p></figure><figure data-id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0009.jpeg" id="rightTab-gc2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Relevant Properties of KSP Inhibitors <b>10</b> and <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0002.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TMSCl, TEA, DMF, 80°C; (b) Selectfluor, CH<sub>3</sub>CN, 0°C (90% for two steps); (c) MeNH<sub>2</sub>, AcOH, NaBH<sub>3</sub>CN, MeOH (1.3:1 ratio of 19:20, 62% combined yield); (d)Boc<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>; (e) Chiralpak AD, 15% IPA/hexanes (45% yield of <b>21</b> and 49% of <b>22</b> from <b>19</b>); (f) 1,4-cyclohexadiene, 10% Pd/C, EtOH; (g) CH2O, AcOH, NaBH<sub>3</sub>CN, MeOH; (h) HCl(g),EtOAc, workup with Na<sub>2</sub>CO<sub>3</sub> (>90% yield for three steps); (i) Chiralpak AD, 20% IPA/hexanes (45% yield of <b>23</b> and 41% of <b>24</b> from <b>20</b>).</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0003.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triphosgene, TEA, THF, 0°C (100%); (b) <b>28</b>, TEA, DMAP, THF; (c) TEA−HF, CH<sub>3</sub>CN, 37°C (63% yield over two steps).</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Induction of mitotic block by <b>30</b> in tumors from a mouse xenograft assay at doses of 2.5, 5, 10, 20, and 40 (mg/kg)/day. Levels of phosphohistone H3 were measured in the tumor 22 h postdose and plotted relative to vehicle and a known KSPi positive control. Steady-state plasma concentrations were determined at the time of sacrifice by cardiac puncture and also showed a dose dependent increase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0011.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of A2780 tumor growth in mice. Both paclitaxel and <b>30</b> were dosed at their MTD on the schedule indicated. The data are plotted as the change in tumor volume relative to its starting volume, versus days following initial dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0012.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of growth in PTX10 tumors that are paclitaxel-resistant because of a tubulin mutation. Both paclitaxel and <b>30</b> were dosed at their MTD on the schedule indicated. The data are plotted as the change in tumor volume relative to its starting volume, versus days following initial dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0013.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of growth in KB-v tumors that are paclitaxel-resistant because of Pgp overexpression. Both paclitaxel and <b>30</b> were dosed at their MTD on the schedule indicated. The data are plotted as the change in tumor volume relative to its starting volume, versus days following initial dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0014.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure of the active site of the KSP−<b>30</b>−ADP ternary complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/medium/jm-2008-00386y_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0015.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Immunofluorescence pictures of A2780 ovarian carcinoma cells treated with vehicle (left) or 50 nM of <b>30</b> (right) for 16 h (blue = DNA, green = microtubules). In the vehicle control image, cells in interphase, metaphase, and anaphase/telophase are visible.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-14/jm800386y/production/images/large/jm-2008-00386y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800386y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Chabner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. G.,  Jr</span><span> </span><span class="NLM_article-title">Chemotherapy and the war on cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1038%2Fnrc1529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=15630416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVek" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=65-72&author=B.+A.+Chabnerauthor=T.+G.+Roberts&title=Chemotherapy+and+the+war+on+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy and the war on cancer</span></div><div class="casAuthors">Chabner, Bruce A.; Roberts, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-72</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The era of chemotherapy began in the 1940s with the first uses of nitrogen mustards and antifolate drugs.  Cancer drug development since then has transformed from a low-budget, government-supported research effort to a high-stakes, multi-billion dollar industry.  The targeted-therapy revolution has arrived, but the principles and limitations of chemotherapy discovered by the early researchers still apply.  This article chronicles the history of modern chemotherapy and identifies remaining challenges for the next generation of researchers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrszgbuDuTBobVg90H21EOLACvtfcHk0lhHBJQoXtNcLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVek&md5=d5c8b3dba59b9d6dcca473552525fa14</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1529%26sid%3Dliteratum%253Aachs%26aulast%3DChabner%26aufirst%3DB.%2BA.%26aulast%3DRoberts%26aufirst%3DT.%2BG.%26atitle%3DChemotherapy%2520and%2520the%2520war%2520on%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nadal, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olavarria, E.</span><span> </span><span class="NLM_article-title">Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies</span> <span class="citation_source-journal">J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1111%2Fj.1368-5031.2004.00173.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=15206509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslGksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2004&pages=511-516&author=E.+Nadalauthor=E.+Olavarria&title=Imatinib+mesylate+%28Gleevec%2FGlivec%29+a+molecular-targeted+therapy+for+chronic+myeloid+leukaemia+and+other+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies</span></div><div class="casAuthors">Nadal, E.; Olavarria, E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-516</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Imatinib mesylate (Gleevec/Glivec, Novartis, Basel, Switzerland), formerly called STI571, is a specific and potent inhibitor of the BCR-ABL tyrosine kinase, the mol. hallmark of chronic myeloid leukemia.  Several clin. trials have demonstrated the efficacy of imatinib in different phases of this disease.  On the other hand, imatinib is also active against other tyrosine kinases, such as ABL, the stem cell factor receptor (c-kit) and the platelet-derived growth factor receptor, whose inhibition might have potential implications for the treatment of several malignancies.  In this regard, imatinib has already shown a remarkable activity in patients with hypereosinophilic syndrome and gastrointestinal stromal tumors.  Imatinib is an example of how a better understanding of the pathogenetic mechanisms of a neoplastic disease can lead to the development of a mol.-targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlEoJuXQeoUbVg90H21EOLACvtfcHk0lhHBJQoXtNcLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslGksLo%253D&md5=6cbc6128a640d2835fa5640942e02d1d</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1111%2Fj.1368-5031.2004.00173.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1368-5031.2004.00173.x%26sid%3Dliteratum%253Aachs%26aulast%3DNadal%26aufirst%3DE.%26aulast%3DOlavarria%26aufirst%3DE.%26atitle%3DImatinib%2520mesylate%2520%2528Gleevec%252FGlivec%2529%2520a%2520molecular-targeted%2520therapy%2520for%2520chronic%2520myeloid%2520leukaemia%2520and%2520other%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Pract.%26date%3D2004%26volume%3D58%26spage%3D511%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hussain, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D. W.</span><span> </span><span class="NLM_article-title">Molecularly targeted therapeutics for breast cancer</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=215-224&author=S.+A.+Hussainauthor=D.+H.+Palmerauthor=D.+Spoonerauthor=D.+W.+Rea&title=Molecularly+targeted+therapeutics+for+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DS.%2BA.%26aulast%3DPalmer%26aufirst%3DD.%2BH.%26aulast%3DSpooner%26aufirst%3DD.%26aulast%3DRea%26aufirst%3DD.%2BW.%26atitle%3DMolecularly%2520targeted%2520therapeutics%2520for%2520breast%2520cancer%26jtitle%3DBioDrugs%26date%3D2007%26volume%3D21%26spage%3D215%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span> </span><span class="NLM_article-title">New molecularly targeted therapies for lung cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2740</span><span class="NLM_x">–</span> <span class="NLM_lpage">2750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=2740-2750&author=S.+Sunauthor=J.+H.+Schillerauthor=M.+Spinolaauthor=J.+D.+Minna&title=New+molecularly+targeted+therapies+for+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DSchiller%26aufirst%3DJ.%2BH.%26aulast%3DSpinola%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26atitle%3DNew%2520molecularly%2520targeted%2520therapies%2520for%2520lung%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D2740%26epage%3D2750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Grandinetti, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldspiel, B. R.</span><span> </span><span class="NLM_article-title">Sorafenib and sunitinib: novel targeted therapies for renal cell cancer</span> <span class="citation_source-journal">Pharmacotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1125-1144&author=C.+A.+Grandinettiauthor=B.+R.+Goldspiel&title=Sorafenib+and+sunitinib%3A+novel+targeted+therapies+for+renal+cell+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrandinetti%26aufirst%3DC.%2BA.%26aulast%3DGoldspiel%26aufirst%3DB.%2BR.%26atitle%3DSorafenib%2520and%2520sunitinib%253A%2520novel%2520targeted%2520therapies%2520for%2520renal%2520cell%2520cancer%26jtitle%3DPharmacotherapy%26date%3D2007%26volume%3D27%26spage%3D1125%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Conlin, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidman, A. D.</span><span> </span><span class="NLM_article-title">Taxanes in breast cancer: An update</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1007%2FBF02951422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=17164044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Grur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=22-30&author=A.+K.+Conlinauthor=A.+D.+Seidman&title=Taxanes+in+breast+cancer%3A+An+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Taxanes in breast cancer: an update</span></div><div class="casAuthors">Conlin, Alison K.; Seidman, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-30</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1523-3790</span>.
    
            (<span class="NLM_cas:orgname">Current Science Inc.</span>)
        </div><div class="casAbstract">A review.  Over the past decade the taxanes have proved to be fundamental in the treatment of breast cancer.  Initially found to have efficacy in metastatic breast cancer, the taxanes are now vital components in the treatment of early-stage disease, in which their addn. to adjuvant treatment of early breast cancer has been shown to improve overall survival.  In addn., the taxanes have demonstrated a role in first-line therapy for metastatic disease, with some of the highest efficacy of any class of chemotherapy.  Targeted therapies in combination with the taxanes have further improved survival for both early and metastatic disease.  New formulations of taxanes may both improve antitumor activity and reduce toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkK9pmS9I3abVg90H21EOLACvtfcHk0ljF38Vm6Xc5nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Grur4%253D&md5=ded53533f64d08320ec1cb79c5ec2fbb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2FBF02951422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02951422%26sid%3Dliteratum%253Aachs%26aulast%3DConlin%26aufirst%3DA.%2BK.%26aulast%3DSeidman%26aufirst%3DA.%2BD.%26atitle%3DTaxanes%2520in%2520breast%2520cancer%253A%2520An%2520update%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2007%26volume%3D9%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Miglarese, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span> </span><span class="NLM_article-title">Development of new cancer therapeutic agents targeting mitosis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1517%2F13543784.15.11.1411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=17040200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyiurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=1411-1425&author=M.+R.+Miglareseauthor=R.+O.+Carlson&title=Development+of+new+cancer+therapeutic+agents+targeting+mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of new cancer therapeutic agents targeting mitosis</span></div><div class="casAuthors">Miglarese, Mark R.; Carlson, Robert O.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1411-1425</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Targeting cellular proliferation persists as a mainstay of cancer therapeutic strategy.  Although microtubule-targeting drugs (such as taxanes and vinca alkaloids) have been used successfully in the clinic to treat a variety of cancers, they carry substantial liabilities that have spurred drug companies to aggressively pursue new tubulin-targeting drug candidates with improved efficacy and toxicity profiles.  The recent discoveries of new mitotic targets for cancer therapy (such as kinesin spindle protein, Aurora kinases and Polo-like kinase-1) have also stimulated intense work focused on identifying novel antimitotic drugs directed at these new targets.  A no. of novel antimitotic drugs have demonstrated encouraging activity in preclin. models and have progressed into clin. development.  This review focuses on selected new antimitotic drugs under evaluation in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHZfWZQOMN27Vg90H21EOLACvtfcHk0ljF38Vm6Xc5nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyiurvL&md5=3cfb8468b30b5206fe3f0413f9c8ec9f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1517%2F13543784.15.11.1411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.15.11.1411%26sid%3Dliteratum%253Aachs%26aulast%3DMiglarese%26aufirst%3DM.%2BR.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26atitle%3DDevelopment%2520of%2520new%2520cancer%2520therapeutic%2520agents%2520targeting%2520mitosis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D15%26spage%3D1411%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastians, H.</span><span> </span><span class="NLM_article-title">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1016%2Fj.drup.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=17669681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=162-181&author=M.+Schmidtauthor=H.+Bastians&title=Mitotic+drug+targets+and+the+development+of+novel+anti-mitotic+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span></div><div class="casAuthors">Schmidt, Mathias; Bastians, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">162-181</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that interfere with the normal progression of mitosis belong to the most successful chemotherapeutic compds. currently used for anti-cancer treatment.  Classically, these drugs are represented by microtubule binding drugs that inhibit the function of the mitotic spindle in order to halt the cell cycle in mitosis and to induce apoptosis in tumor cells.  However, these compds. act not only on proliferating tumor cells, but exhibit significant side effects on non-proliferating cells including neurons that are highly dependent on intracellular transport processes mediated by microtubules.  Therefore, there is a particular interest in developing novel anti-mitotic drugs that target non-microtubule structures.  In fact, recently several novel drugs that target mitotic kinesins or the Aurora and polo-like kinases have been developed and are currently tested in clin. trials.  In addn., approaches of cell cycle checkpoint abrogation during mitosis and at the G2/M transition inducing mitosis-assocd. tumor cell death are promising new strategies for anti-cancer therapy.  It is expected that this "next generation" of anti-mitotic drugs will be as successful as the classical anti-microtubule drugs, while avoiding some of the adverse side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOJi9lDecBLVg90H21EOLACvtfcHk0lhkNMTQqiqYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N&md5=b7262b3578e6daaad41412780d022937</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DBastians%26aufirst%3DH.%26atitle%3DMitotic%2520drug%2520targets%2520and%2520the%2520development%2520of%2520novel%2520anti-mitotic%2520anticancer%2520drugs%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2007%26volume%3D10%26spage%3D162%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Wood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwell, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span> </span><span class="NLM_article-title">Past and future of the mitotic spindle as an oncology target</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1016%2FS1471-4892%2801%2900064-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=11710735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVelsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=370-377&author=K.+W.+Woodauthor=W.+D.+Cornwellauthor=J.+R.+Jackson&title=Past+and+future+of+the+mitotic+spindle+as+an+oncology+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Past and future of the mitotic spindle as an oncology target</span></div><div class="casAuthors">Wood, Kenneth W.; Cornwell, William D.; Jackson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-377</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Tubulin poisons were first discovered decades ago, but the recent clin. and com. success of Taxol has led to a renaissance in the search for novel mitotic spindle poisons to treat cancer.  Many tubulin poisons have been identified, but few have demonstrated clin. utility.  Recent studies have begun to identify the factors that differentiate the efficacy of these agents.  In addn., promising alternative approaches to targeting the mitotic spindle have been identified from detailed studies of mitotic regulation and mechanics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLTbni6UbogrVg90H21EOLACvtfcHk0lhkNMTQqiqYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVelsrk%253D&md5=1e7120d622f29b6d89d5127eaa72f61b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2801%2900064-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252801%252900064-9%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DK.%2BW.%26aulast%3DCornwell%26aufirst%3DW.%2BD.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26atitle%3DPast%2520and%2520future%2520of%2520the%2520mitotic%2520spindle%2520as%2520an%2520oncology%2520target%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2001%26volume%3D1%26spage%3D370%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0lhkNMTQqiqYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goldstein, L. S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philp, A. V.</span><span> </span><span class="NLM_article-title">The road less traveled: emerging principles of kinesin motor utilization</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1146%2Fannurev.cellbio.15.1.141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=10611960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVSnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1999&pages=141-183&author=L.+S.+B.+Goldsteinauthor=A.+V.+Philp&title=The+road+less+traveled%3A+emerging+principles+of+kinesin+motor+utilization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">The road less traveled: emerging principles of kinesin motor utilization</span></div><div class="casAuthors">Goldstein, Lawrence S. B.; Philp, Alastair Valentine</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-183</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with approx. 220 refs.  Proteins of the kinesin superfamily utilize a conserved catalytic motor domain to generate movements in a wide variety of cellular processes.  In this review, we discuss the rapid expansion in our understanding of how eukaryotic cells take advantage of these proteins to generate force and movement in diverse functional contexts.  We summarize several recent examples revealing that the simplest view of a kinesin motor protein binding to and translocating a cargo along a microtubule track is inadequate.  In fact, this paradigm captures only a small subset of the many ways in which cells harness force prodn. to the generation of intracellular movements and functions.  We also highlight several situations where the catalytic kinesin motor domain may not be used to generate movement, but instead may be used in other biochem. and functional contexts.  Finally, we review some recent ideas about kinesin motor regulation, redundancy, and cargo attachment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoBQ1ujISDnrVg90H21EOLACvtfcHk0lhkNMTQqiqYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVSnur8%253D&md5=27625ad8c431a03f616e8f4c24f83c9e</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.15.1.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.15.1.141%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DL.%2BS.%2BB.%26aulast%3DPhilp%26aufirst%3DA.%2BV.%26atitle%3DThe%2520road%2520less%2520traveled%253A%2520emerging%2520principles%2520of%2520kinesin%2520motor%2520utilization%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D1999%26volume%3D15%26spage%3D141%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span> </span><span class="NLM_article-title">Kinesin motors and disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1016%2FS0962-8924%2802%2902400-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=12495847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsV2msbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=585-591&author=E.+Mandelkowauthor=E.-M.+Mandelkow&title=Kinesin+motors+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Kinesin motors and disease</span></div><div class="casAuthors">Mandelkow, Eckhard; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">585-591</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinesins are motor proteins that move cargoes such as vesicles, organelles and chromosomes along microtubules.  They are best known for their role in axonal transport and in mitosis.  There is a diverse family of kinesins, members of which differ in compn. and functions.  Roles of kinesins in diseases typically involve defective transport of cell components, transport of pathogens, or cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ptPoI2iRarVg90H21EOLACvtfcHk0lglbsnCaZi_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsV2msbc%253D&md5=02ebe22982a81292c0a7ba93a7019712</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2802%2902400-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252802%252902400-5%26sid%3Dliteratum%253Aachs%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26atitle%3DKinesin%2520motors%2520and%2520disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2002%26volume%3D12%26spage%3D585%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sharp, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholey, J. M.</span><span> </span><span class="NLM_article-title">Microtubule motors in mitosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1038%2F35024000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=10993066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslSiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=41-47&author=D.+J.+Sharpauthor=G.+C.+Rogersauthor=J.+M.+Scholey&title=Microtubule+motors+in+mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule motors in mitosis</span></div><div class="casAuthors">Sharp, David J.; Rogers, Gregory C.; Scholey, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6800</span>),
    <span class="NLM_cas:pages">41-47</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 78 refs.  The mitotic spindle uses microtubule-based motor proteins to assemble itself and to segregate sister chromatids.  It is becoming clear that motors invoke several distinct mechanisms to generate the forces that drive mitosis.  Moreover, in carrying out its function, the spindle appears to pass through a series of transient steady-state structures, each established by a delicate balance of forces generated by multiple complementary and antagonistic motors.  Transitions from one steady state to the next can occur when a change in the activity of a subset of mitotic motors tips the balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSPtTwoWbhM7Vg90H21EOLACvtfcHk0lglbsnCaZi_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslSiu7s%253D&md5=4cbeb9651ad5b8389ffd2fe8b8eb3b31</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2F35024000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35024000%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DD.%2BJ.%26aulast%3DRogers%26aufirst%3DG.%2BC.%26aulast%3DScholey%26aufirst%3DJ.%2BM.%26atitle%3DMicrotubule%2520motors%2520in%2520mitosis%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D41%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Heald, R.</span><span> </span><span class="NLM_article-title">Motor function in the mitotic spindle</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=399-402&author=R.+Heald&title=Motor+function+in+the+mitotic+spindle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeald%26aufirst%3DR.%26atitle%3DMotor%2520function%2520in%2520the%2520mitotic%2520spindle%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D399%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bergnes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brejc, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belmont, L.</span><span> </span><span class="NLM_article-title">Mitotic kinesins: prospects for antimitotic drug discovery</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.2174%2F1568026053507697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=15853642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=127-145&author=G.+Bergnesauthor=K.+Brejcauthor=L.+Belmont&title=Mitotic+kinesins%3A+prospects+for+antimitotic+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic kinesins: prospects for antimitotic drug discovery</span></div><div class="casAuthors">Bergnes, Gustave; Brejc, Katjusa; Belmont, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-145</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinesins, mechanochem. enzymes that utilize the energy of ATP to translocate along or destabilize microtubules, are essential for accurate completion of cell division.  Recently, small mol. inhibitors of one kinesin, kinesin spindle protein (KSP/Eg5/kinesin 5), were shown to be efficacious in pre-clin. studies, with one quinazolinone-based inhibitor advancing to Phase II clin. trials as a potential anticancer chemotherapeutic agent.  This highlights the potential of KSP and other mitotic kinesins as targets for chemotherapeutic intervention.  Ten other kinesins were shown to play essential roles in cell division and thus may provide addnl. therapeutic opportunities.  In this review, the biol. roles of these proteins are described with emphasis on their importance to cell proliferation.  In addn., kinesin motor domain structure and mechanism are described with particular attention given to the conformational changes that offer opportunities for chem. inhibition.  Finally, a current list of KSP inhibitor classes is described in the context of their potential as clin. leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDH2W_-_N1cLVg90H21EOLACvtfcHk0lglbsnCaZi_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksLc%253D&md5=a9ce236f5aea736bfbbbe2638584b34c</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.2174%2F1568026053507697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507697%26sid%3Dliteratum%253Aachs%26aulast%3DBergnes%26aufirst%3DG.%26aulast%3DBrejc%26aufirst%3DK.%26aulast%3DBelmont%26aufirst%3DL.%26atitle%3DMitotic%2520kinesins%253A%2520prospects%2520for%2520antimitotic%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D127%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mayer, T. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, T. J.</span><span> </span><span class="NLM_article-title">Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1126%2Fscience.286.5441.971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=10542155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADyaK1MXntFaqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=971-974&author=T.+U.+Mayerauthor=T.+M.+Kapoorauthor=S.+J.+Haggartyauthor=R.+W.+Kingauthor=S.+L.+Schreiberauthor=T.+J.+Mitchison&title=Small+molecule+inhibitor+of+mitotic+spindle+bipolarity+identified+in+a+phenotype-based+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen</span></div><div class="casAuthors">Mayer, Thomas U.; Kapoor, Tarun M.; Haggarty, Stephen J.; King, Randall W.; Schreiber, Stuart L.; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5441</span>),
    <span class="NLM_cas:pages">971-974</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Small mols. that perturb specific protein functions are valuable tools for dissecting complex processes in mammalian cells.  A combination of two phenotype-based screens, one based on a specific posttranslational modification, the other visualizing microtubules and chromatin, was used to identify compds. that affect mitosis.  One compd., here named monastrol, arrested mammalian cells in mitosis with monopolar spindles.  In vitro, monastrol specifically inhibited the motility of the mitotic kinesin Eg5, a motor protein required for spindle bipolarity.  All previously known small mols. that specifically affect the mitotic machinery target tubulin.  Monastrol will therefore be a particularly useful tool for studying mitotic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogQtim1hvM_LVg90H21EOLACvtfcHk0lhQGWwiDMIaPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFaqu7o%253D&md5=d1c47a3e2af49f229e5bf618ca2835f5</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5441.971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5441.971%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DT.%2BU.%26aulast%3DKapoor%26aufirst%3DT.%2BM.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibitor%2520of%2520mitotic%2520spindle%2520bipolarity%2520identified%2520in%2520a%2520phenotype-based%2520screen%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D971%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sakowicz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beraud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crompton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turincio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabala, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. W.</span><span> </span><span class="NLM_article-title">Antitumor activity of a kinesin inhibitor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3276</span><span class="NLM_x">–</span> <span class="NLM_lpage">3280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3276-3280&author=R.+Sakowiczauthor=J.+T.+Finerauthor=C.+Beraudauthor=A.+Cromptonauthor=E.+Lewisauthor=A.+Fritschauthor=Y.+Leeauthor=J.+Makauthor=R.+Moodyauthor=R.+Turincioauthor=J.+C.+Chabalaauthor=P.+Gonzalesauthor=S.+Rothauthor=S.+Weitmanauthor=K.+W.+Wood&title=Antitumor+activity+of+a+kinesin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakowicz%26aufirst%3DR.%26aulast%3DFiner%26aufirst%3DJ.%2BT.%26aulast%3DBeraud%26aufirst%3DC.%26aulast%3DCrompton%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DE.%26aulast%3DFritsch%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DMak%26aufirst%3DJ.%26aulast%3DMoody%26aufirst%3DR.%26aulast%3DTurincio%26aufirst%3DR.%26aulast%3DChabala%26aufirst%3DJ.%2BC.%26aulast%3DGonzales%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DS.%26aulast%3DWeitman%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DK.%2BW.%26atitle%3DAntitumor%2520activity%2520of%2520a%2520kinesin%2520inhibitor%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3276%26epage%3D3280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein inhibitors as anticancer agents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1517%2F13543776.16.11.1517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFems7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1517-1532&author=C.+Jiangauthor=Q.+Youauthor=Z.+Liauthor=Q.+Guo&title=Kinesin+spindle+protein+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Kinesin spindle protein inhibitors as anticancer agents</span></div><div class="casAuthors">Jiang, Cheng; You, Qidong; Li, Zhiyu; Guo, Qinglong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1517-1532</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Kinesin spindle protein (KSP), or Hs Eg5, is a member of the kinesin superfamily of mol. motor proteins that utilize the energy generated from the hydrolysis of ATP to transport vesicles, organelles and microtubules.  KSP plays essential roles in mitotic spindle function and its inhibition prevents normal bipolar spindle formation, leading to mitotic arrest and subsequently to apoptosis of cells.  Therefore, KSP inhibitors have potential as novel anticancer therapeutics.  Since the discovery of monastrol in 1999, many types of KSP inhibitors were reported.  This review describes the mechanism of action and development of different types of KSP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqah-wXCZWf6bVg90H21EOLACvtfcHk0lhQGWwiDMIaPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFems7jK&md5=dd6d0bb463788d201533de28696f5554</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.11.1517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.11.1517%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DQ.%26atitle%3DKinesin%2520spindle%2520protein%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D1517%26epage%3D1532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marcus, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelnak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannakakou, P.</span><span> </span><span class="NLM_article-title">Mitotic kinesin inhibitors induce mitotic arrest and cell death in paclitaxel-resistant and -sensitive cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">11569</span><span class="NLM_x">–</span> <span class="NLM_lpage">11577</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=11569-11577&author=A.+I.+Marcusauthor=U.+Petersauthor=S.+L.+Thomasauthor=S.+Garrettauthor=A.+Zelnakauthor=T.+M.+Kapoorauthor=P.+Giannakakou&title=Mitotic+kinesin+inhibitors+induce+mitotic+arrest+and+cell+death+in+paclitaxel-resistant+and+-sensitive+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarcus%26aufirst%3DA.%2BI.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DThomas%26aufirst%3DS.%2BL.%26aulast%3DGarrett%26aufirst%3DS.%26aulast%3DZelnak%26aufirst%3DA.%26aulast%3DKapoor%26aufirst%3DT.%2BM.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3DMitotic%2520kinesin%2520inhibitors%2520induce%2520mitotic%2520arrest%2520and%2520cell%2520death%2520in%2520paclitaxel-resistant%2520and%2520-sensitive%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D11569%26epage%3D11577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dutcher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novik, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcoullis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiernik, P. H.</span><span> </span><span class="NLM_article-title">20th-Century advances in drug therapy in oncology. Part II</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=11028247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Kmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2000&pages=1079-1092&author=J.+P.+Dutcherauthor=Y.+Novikauthor=K.+O%E2%80%99Boyleauthor=G.+Marcoullisauthor=C.+Seccoauthor=P.+H.+Wiernik&title=20th-Century+advances+in+drug+therapy+in+oncology.+Part+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">20th-century advances in drug therapy in oncology-part II</span></div><div class="casAuthors">Dutcher, Janice P.; Novik, Yelena; O'Boyle, Kevin; Marcoullis, George; Secco, Christiane; Wiernik, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1079-1092</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review with 180 refs.  Ongoing research in cancer therapy has led to the development of antineoplastic agents which target specific components of the cell cycle.  In Part II of this series, we discuss agents which target the mitotic mechanism by inhibiting microtubules.  Although many of these agents are being shown to have multiple effects, the Vinca alkaloids and the taxanes are known as antimitotic drugs.  They are among the most important anticancer agents currently available, and because of their unique mechanisms, can be combined with a wide variety of other antineoplastic agents in a spectrum of diseases.  In addn., in part II, we are discussing agents that target DNA and prevent replication and thus cell growth by inhibiting the enzymes which protect DNA during replication, the topoisomerases.  These drugs, too, have unique mechanisms of action and have become major components of combination regimens.  The topoisomerase I inhibitors are new drugs derived from an older parent drug, and their full possibilities are still being explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY9ROGkNmSNrVg90H21EOLACvtfcHk0lhQGWwiDMIaPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Kmt7Y%253D&md5=a919ccc80fd767d7da6e99173c5e8d85</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDutcher%26aufirst%3DJ.%2BP.%26aulast%3DNovik%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DK.%26aulast%3DMarcoullis%26aufirst%3DG.%26aulast%3DSecco%26aufirst%3DC.%26aulast%3DWiernik%26aufirst%3DP.%2BH.%26atitle%3D20th-Century%2520advances%2520in%2520drug%2520therapy%2520in%2520oncology.%2520Part%2520II%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D40%26spage%3D1079%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sorbera, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradell, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayés, M.</span><span> </span><span class="NLM_article-title">Ispinesib mesilate</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1358%2Fdof.2006.031.09.1034213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=778-787&author=L.+A.+Sorberaauthor=J.+Bolosauthor=N.+Serradellauthor=M.+Bay%C3%A9s&title=Ispinesib+mesilate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ispinesib mesilate</span></div><div class="casAuthors">Sorbera, L. A.; Bolos, J.; Serradell, N.; Bayes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">778-787</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  In the search for novel mitotic targets for the development of antineoplastic agents, Homo sapiens Eg5 kinesin spindle protein (KSP, HsEg5/KSP) was identified.  KSP is a member of a subfamily of kinesins that are involved in centrosome sepn. and bipolar spindle formation during mitosis.  It has been shown to function exclusively in mitosis and is preferentially over-expressed in malignant cells.  Inhibition of KSP interferes with the formation of the bipolar spindle required for proper sepn. and lining of chromosomes during mitosis, which ultimately leads to cell death.  KSP inhibitors may therefore effectively interfere with mitosis while showing an improved therapeutic index.  Ispinesib mesylate (715992, SB-715992, formerly CK-0238273) is one such KSP inhibitor that was found to be more selective for KSP over other members of the kinesin family.  It effectively induced tumor regression in several preclin. models.  Ispinesib was chosen for further development as an antimitotic agent and has shown efficacy in phase I and II trials in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeq9wPJpd0uLVg90H21EOLACvtfcHk0lgv9WR1Vf_28w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKntw%253D%253D&md5=eee2df5eb9a47ce3c2882d2d150ae28a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.09.1034213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.09.1034213%26sid%3Dliteratum%253Aachs%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26aulast%3DBolos%26aufirst%3DJ.%26aulast%3DSerradell%26aufirst%3DN.%26aulast%3DBay%25C3%25A9s%26aufirst%3DM.%26atitle%3DIspinesib%2520mesilate%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D778%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><div class="note"><p class="first last">It is tempting to speculate that antimitotic agents designed to overcome known mechanisms of resistance, such as Pgp-overexpression and tubulin mutations, will lead to improved efficacy in the clinic against refractory tumors. Indeed, some recent studies have provided evidence in support of this hypothesis. See, for example, the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=It+is+tempting+to+speculate+that+antimitotic+agents+designed+to+overcome+known+mechanisms+of+resistance%2C+such+as+Pgp-overexpression+and+tubulin+mutations%2C+will+lead+to+improved+efficacy+in+the+clinic+against+refractory+tumors.+Indeed%2C+some+recent+studies+have+provided+evidence+in+support+of+this+hypothesis.+See%2C+for+example%2C+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Toppmeyer, D.; Seidman, A. D.; Pollak, M.; Russell, C.; Tkaczuk, K.; Verma, S.; Overmoyer, B.; Garg, V.; Ette, E.; Harding, M. W.; Demetri, G. D.</span><span> </span><span class="NLM_article-title">Safety and efficacy of the multidrug resistance inhibitor Incel (Biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel</span>.  <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span>− <span class="NLM_lpage">678</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=11895894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD38XislOqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=670-678&author=D.+Toppmeyer&author=A.+D.+Seidman&author=M.+Pollak&author=C.+Russell&author=K.+Tkaczuk&author=S.+Verma&author=B.+Overmoyer&author=V.+Garg&author=E.+Ette&author=M.+W.+Harding&author=G.+D.+Demetri&title=Safety+and+efficacy+of+the+multidrug+resistance+inhibitor+Incel+%28Biricodar%3B+VX-710%29+in+combination+with+paclitaxel+for+advanced+breast+cancer+refractory+to+paclitaxel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of the multidrug resistance inhibitor incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel</span></div><div class="casAuthors">Toppmeyer, Deborah; Seidman, Andrew D.; Pollak, Michael; Russell, Christy; Tkaczuk, Katherine; Verma, Shailendra; Overmoyer, Beth; Garg, Varun; Ette, Ene; Harding, Matthew W.; Demetri, George D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">670-678</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">VX-710 (biricodar, Incel) restores drug sensitivity to P-glycoprotein (MDR1) and multidrug resistance-assocd. protein (MRP1)-expressing cells.  This Phase II study evaluated the safety/tolerability, pharmacokinetics, and efficacy of VX-710 plus paclitaxel in women with locally advanced or metastatic breast cancer who were refractory to prior paclitaxel therapy.  Eligible patients had paclitaxel-refractory disease defined as progressive disease after a min. of two cycles of paclitaxel (weekly or 3-wk schedule) or relapsed/progressive disease within 6 mo of prior paclitaxel therapy.  Patients received 80 mg/m2 paclitaxel over 3 h starting 4 h after initiation of a 24-h continuous i.v. infusion of 120 mg/m2/h VX-710.  Cycles were repeated every 3 wk.  Thirty-seven patients received study treatment and 35 were evaluable for response.  VX-710 + paclitaxel therapy was generally well tolerated.  Myelosuppression was the principal toxicity, with a median nadir ANC cycle 1 of 0.76×109 cells/L and a 40% overall incidence of Grade 4 neutropenia.  Nonhematol. side effects (asthenia, paresthesia, headache, myalgia, nausea, and diarrhea) were generally mild to moderate and reversible.  Paclitaxel AUC (16.8±5.0 μg × h/mL) and clearance (5.1±1.3 L/h/m2) during the first treatment cycle were comparable with std. 175 mg/m2 paclitaxel administered in a 3-h schedule.  Four patients achieved partial responses (three of the four had progressive disease on prior paclitaxel) with a mean response duration of 5.5 mo.  The 11.4% (4 of 35) objective response rate obsd. in this study suggests that VX-710 can resensitize a subgroup of paclitaxel-refractory patients to paclitaxel.  The safety and pharmacokinetics of the VX-710/paclitaxel regimen support further evaluation in breast cancer patients with initial paclitaxel therapy to prevent emergence of the MDR phenotype in recurrent disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzLY_9EP6ep7Vg90H21EOLACvtfcHk0lgv9WR1Vf_28w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislOqt7s%253D&md5=9fe5847597a8d38e98ba54b592def218</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToppmeyer%26aufirst%3DD.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520the%2520multidrug%2520resistance%2520inhibitor%2520Incel%2520%2528Biricodar%253B%2520VX-710%2529%2520in%2520combination%2520with%2520paclitaxel%2520for%2520advanced%2520breast%2520cancer%2520refractory%2520to%2520paclitaxel%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D670%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goodin, S.; Kane, M. P.; Rubin, E. H.</span><span> </span><span class="NLM_article-title">Epothilones: mechanism of action and biologic activity</span>.  <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span>− <span class="NLM_lpage">2025</span>.<div class="note"><p class="first last">However, results from these clinical trials, though positive, have been less than stellar, and the validity of this rationale is still often questioned. See the following:</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1200%2FJCO.2004.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=15143095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlCks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=2015-2025&author=S.+Goodin&author=M.+P.+Kane&author=E.+H.+Rubin&title=Epothilones%3A+mechanism+of+action+and+biologic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Epothilones: Mechanism of action and biologic activity</span></div><div class="casAuthors">Goodin, Susan; Kane, Michael P.; Rubin, Eric H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2015-2025</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Drugs that target microtubules are among the most commonly prescribed anticancer therapies.  Although the mechanisms by which perturbation of microtubule function leads to selective death of cancer cells remain unclear, several new microtubule-targeting compds. are undergoing clin. testing.  In part, these efforts focus on overcoming some of the problems assocd. with taxane-based therapies, including formulation and administration difficulties and susceptibility to resistance conferred by P-glycoprotein.  Epothilones have emerged from these efforts as a promising new class of anticancer drugs.  Preclin. studies indicate that epothilones bind to and stabilize microtubules in a manner similar but not identical to that of paclitaxel and that epothilones are effective in paclitaxel-resistant tumor models.  Clin. phase I and early phase II data are available for BMS-247550, BMS-310705, EPO906, and KOS-862.  The results suggest that these compds. have a broad range of antitumor activity at doses and schedules assocd. with tolerable side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9nGTh_uHrDrVg90H21EOLACvtfcHk0lgv9WR1Vf_28w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlCks7w%253D&md5=97203c9109a4719c8395e46ffdd8683c</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DGoodin%26aufirst%3DS.%26atitle%3DEpothilones%253A%2520mechanism%2520of%2520action%2520and%2520biologic%2520activity%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D2015%26epage%3D2025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Greenberger, L. M.; Sampath, D.</span><span> </span><span class="NLM_article-title">Resistance to Taxanes</span>. In  <span class="citation_source-book">Cancer Drug Discovery and Development: Cancer Drug Resistance</span>; <span class="NLM_contrib-group">Teicher, B.</span>, Ed.; <span class="NLM_publisher-name">Humana Press Inc.</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">329</span>− <span class="NLM_lpage">357</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=329-357&author=L.+M.+Greenberger&author=D.+Sampathauthor=B.+Teicher&title=Cancer+Drug+Discovery+and+Development%3A+Cancer+Drug+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26atitle%3DResistance%2520to%2520Taxanes%26btitle%3DCancer%2520Drug%2520Discovery%2520and%2520Development%253A%2520Cancer%2520Drug%2520Resistance%26aulast%3DTeicher%26aufirst%3DB.%26pub%3DHumana%2520Press%2520Inc%26date%3D2006%26spage%3D329%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ferlini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raspaglio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicchillitti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozzetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prislei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartollino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, G.</span><span> </span><span class="NLM_article-title">Looking at drug resistance mechanisms for microtubule interacting drugs: Does TUBB3 work?</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.2174%2F156800907783220453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=18220531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFOnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=704-712&author=C.+Ferliniauthor=G.+Raspaglioauthor=L.+Cicchillittiauthor=S.+Mozzettiauthor=S.+Prisleiauthor=S.+Bartollinoauthor=G.+Scambia&title=Looking+at+drug+resistance+mechanisms+for+microtubule+interacting+drugs%3A+Does+TUBB3+work%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12dR"><div class="casContent"><span class="casTitleNuber">12d</span><div class="casTitle"><span class="NLM_cas:atitle">Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?</span></div><div class="casAuthors">Ferlini, Cristiano; Raspaglio, Giuseppina; Cicchillitti, Lucia; Mozzetti, Simona; Prislei, Silvia; Bartollino, Silvia; Scambia, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">704-712</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Vinca alkaloids and taxanes represent the mainstay of medical treatment of hematol. and solid tumors.  Unfortunately, a major clin. problem with these agents is drug resistance.  Although a plethora of mechanisms of drug resistance have been described, only a few of them have been validated in clin. trials.  Among these, the one involving the protein TUBB3 seems to represent a promising target for studying drug resistance.  In fact, it seems that this protein is a factor promoting cell survival and represents an endogenous element of an inherent drug-resistance program built into cells to counteract the activity of microtubule-interacting drugs.  Its pivotal role has been ascertained in clin. trials in lung, breast, and ovarian cancer, three diseases that can be successfully treated with microtubule-interacting drugs.  Although TUBB3 is probably not a unique factor in drug resistance, the hope is that direct targeting of this protein will increase the response to microtubule-interacting drugs, thereby overcoming an important element in the growth of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrWfd2bj6X67Vg90H21EOLACvtfcHk0ljdTyyOKSL-tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFOnsbo%253D&md5=42f53ae398eeeca0726f36dc32aaa37d</span></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.2174%2F156800907783220453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800907783220453%26sid%3Dliteratum%253Aachs%26aulast%3DFerlini%26aufirst%3DC.%26aulast%3DRaspaglio%26aufirst%3DG.%26aulast%3DCicchillitti%26aufirst%3DL.%26aulast%3DMozzetti%26aufirst%3DS.%26aulast%3DPrislei%26aufirst%3DS.%26aulast%3DBartollino%26aufirst%3DS.%26aulast%3DScambia%26aufirst%3DG.%26atitle%3DLooking%2520at%2520drug%2520resistance%2520mechanisms%2520for%2520microtubule%2520interacting%2520drugs%253A%2520Does%2520TUBB3%2520work%253F%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2007%26volume%3D7%26spage%3D704%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2041</span><span class="NLM_x">–</span> <span class="NLM_lpage">2045</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2041-2045&author=C.+D.+Coxauthor=M.+J.+Breslinauthor=B.+J.+Marianoauthor=P.+J.+Colemanauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=H.+E.+Huberauthor=N.+E.+Kohlauthor=M.+Torrentauthor=Y.+Yanauthor=L.+C.+Kuoauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+1%3A+The+discovery+of+3%2C5-dihydropyrazoles+as+potent+and+selective+inhibitors+of+the+mitotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DMariano%26aufirst%3DB.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25201%253A%2520The%2520discovery%2520of%25203%252C5-dihydropyrazoles%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520mitotic%2520kinesin%2520KSP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2041%26epage%3D2045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasber, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1779</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1775-1779&author=M.+E.+Fraleyauthor=R.+M.+Garbaccioauthor=K.+L.+Arringtonauthor=W.+F.+Hoffmanauthor=E.+S.+Tasberauthor=P.+J.+Colemanauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+Fernandezauthor=M.+D.+Schaberauthor=R.+B.+Lobellauthor=W.+Taoauthor=V.+J.+Southauthor=Y.+Yanauthor=L.+C.+Kuoauthor=T.+Prueksaritanontauthor=C.+Shuauthor=M.+Torrentauthor=D.+C.+Heimbrookauthor=N.+E.+Kohlauthor=H.+E.+Huberauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+2%3A+The+design%2C+synthesis%2C+and+characterization+of+2%2C4-diaryl-2%2C5-dihydropyrrole+inhibitors+of+the+mitotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DTasber%26aufirst%3DE.%2BS.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DSchaber%26aufirst%3DM.%2BD.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DShu%26aufirst%3DC.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25202%253A%2520The%2520design%252C%2520synthesis%252C%2520and%2520characterization%2520of%25202%252C4-diaryl-2%252C5-dihydropyrrole%2520inhibitors%2520of%2520the%2520mitotic%2520kinesin%2520KSP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1775%26epage%3D1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the miotic kinesin KSP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3175&author=C.+D.+Coxauthor=M.+Torrentauthor=M.+J.+Breslinauthor=B.+J.+Marianoauthor=D.+B.+Whitmanauthor=P.+J.+Colemanauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=M.+D.+Schaberauthor=R.+B.+Lobellauthor=W.+Taoauthor=V.+J.+Southauthor=N.+E.+Kohlauthor=Y.+Yanauthor=L.+C.+Kuoauthor=T.+Prueksaritanontauthor=D.+E.+Slaughterauthor=C.+Liauthor=E.+Mahanauthor=B.+Luauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+4%3A+Structure-based+design+of+5-alkylamino-3%2C5-diaryl-4%2C5-dihydropyrazoles+as+potent%2C+water-soluble+inhibitors+of+the+miotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DMariano%26aufirst%3DB.%2BJ.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DSchaber%26aufirst%3DM.%2BD.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DSlaughter%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMahan%26aufirst%3DE.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25204%253A%2520Structure-based%2520design%2520of%25205-alkylamino-3%252C5-diaryl-4%252C5-dihydropyrazoles%2520as%2520potent%252C%2520water-soluble%2520inhibitors%2520of%2520the%2520miotic%2520kinesin%2520KSP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zrada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 5: Discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by β-fluorination to overcome cellular efflux by P-glycoprotein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2697</span><span class="NLM_x">–</span> <span class="NLM_lpage">2702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2697-2702&author=C.+D.+Coxauthor=M.+J.+Breslinauthor=D.+B.+Whitmanauthor=P.+J.+Colemanauthor=R.+M.+Garbaccioauthor=M.+E.+Fraleyauthor=M.+M.+Zradaauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=R.+B.+Lobellauthor=W.+Taoauthor=M.+T.+Abramsauthor=V.+J.+Southauthor=H.+E.+Huberauthor=N.+E.+Kohlauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+5%3A+Discovery+of+2-propylamino-2%2C4-diaryl-2%2C5-dihydropyrroles+as+potent%2C+water-soluble+KSP+inhibitors%2C+and+modulation+of+their+basicity+by+%CE%B2-fluorination+to+overcome+cellular+efflux+by+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DZrada%26aufirst%3DM.%2BM.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DAbrams%26aufirst%3DM.%2BT.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25205%253A%2520Discovery%2520of%25202-propylamino-2%252C4-diaryl-2%252C5-dihydropyrroles%2520as%2520potent%252C%2520water-soluble%2520KSP%2520inhibitors%252C%2520and%2520modulation%2520of%2520their%2520basicity%2520by%2520%25CE%25B2-fluorination%2520to%2520overcome%2520cellular%2520efflux%2520by%2520P-glycoprotein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2697%26epage%3D2702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davide, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahan, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Metzler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salata, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5390</span><span class="NLM_x">–</span> <span class="NLM_lpage">5395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5390-5395&author=P.+J.+Colemanauthor=J.+D.+Schreierauthor=C.+D.+Coxauthor=M.+E.+Fraleyauthor=R.+M.+Garbaccioauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=R.+B.+Lobellauthor=K.+Rickertauthor=W.+Taoauthor=R.+E.+Diehlauthor=V.+J.+Southauthor=J.+P.+Davideauthor=N.+E.+Kohlauthor=Y.+Yanauthor=L.+Kuoauthor=T.+Prueksaritanontauthor=C.+Liauthor=E.+A.+Mahanauthor=C.+Fernandez-Metzlerauthor=J.+J.+Salataauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+6%3A+Design+and+synthesis+of+3%2C5-diaryl-4%2C5-dihydropyrazole+amides+as+potent+inhibitors+of+the+mitotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DDiehl%26aufirst%3DR.%2BE.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DDavide%26aufirst%3DJ.%2BP.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMahan%26aufirst%3DE.%2BA.%26aulast%3DFernandez-Metzler%26aufirst%3DC.%26aulast%3DSalata%26aufirst%3DJ.%2BJ.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25206%253A%2520Design%2520and%2520synthesis%2520of%25203%252C5-diaryl-4%252C5-dihydropyrazole%2520amides%2520as%2520potent%2520inhibitors%2520of%2520the%2520mitotic%2520kinesin%2520KSP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5390%26epage%3D5395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Roden, D. M.</span><span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0liRQzw7F-jYfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasber, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaughter, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Kinesin spindle protein (KSP) inhibitors. Part 3: Synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1780</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1780-1783&author=R.+M.+Garbaccioauthor=M.+E.+Fraleyauthor=E.+S.+Tasberauthor=C.+M.+Olsonauthor=W.+F.+Hoffmanauthor=K.+L.+Arringtonauthor=M.+Torrentauthor=C.+A.+Buserauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=M.+D.+Schaberauthor=C.+Fernandezauthor=R.+B.+Lobellauthor=W.+Taoauthor=V.+J.+Southauthor=Y.+Yanauthor=L.+C.+Kuoauthor=T.+Prueksaritanontauthor=D.+E.+Slaughterauthor=C.+Shuauthor=D.+C.+Heimbrookauthor=N+E.+Kohlauthor=H.+E.+Huberauthor=G.+D.+Hartman&title=Kinesin+spindle+protein+%28KSP%29+inhibitors.+Part+3%3A+Synthesis+and+evaluation+of+phenolic+2%2C4-diaryl-2%2C5-dihydropyrroles+with+reduced+hERG+binding+and+employment+of+a+phosphate+prodrug+strategy+for+aqueous+solubility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DTasber%26aufirst%3DE.%2BS.%26aulast%3DOlson%26aufirst%3DC.%2BM.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DSchaber%26aufirst%3DM.%2BD.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DSlaughter%26aufirst%3DD.%2BE.%26aulast%3DShu%26aufirst%3DC.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DKohl%26aufirst%3DN%2BE.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DKinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitors.%2520Part%25203%253A%2520Synthesis%2520and%2520evaluation%2520of%2520phenolic%25202%252C4-diaryl-2%252C5-dihydropyrroles%2520with%2520reduced%2520hERG%2520binding%2520and%2520employment%2520of%2520a%2520phosphate%2520prodrug%2520strategy%2520for%2520aqueous%2520solubility%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1780%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0ljxQI8gON60Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><div class="note"><p class="first last">By comparison, <b>2</b> had an MDR ratio of 4.6 with an EC<sub>50</sub> of 26.4 nM in the overexpressing cell line.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=By+comparison%2C+2+had+an+MDR+ratio+of+4.6+with+an+EC50+of+26.4+nM+in+the+overexpressing+cell+line."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">For a review of the relevance of Pgp to drug discovery, see the following:</p></div><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, M.</span><span> </span><span class="NLM_article-title">Clinical relevance of P-glycoprotein in drug therapy</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1081%2FDMR-120026871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=14705869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1ygsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=417-454&author=J.+H.+Linauthor=M.+Yamazaki&title=Clinical+relevance+of+P-glycoprotein+in+drug+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Relevance of P-Glycoprotein in Drug Therapy</span></div><div class="casAuthors">Lin, Jiunn H.; Yamazaki, Masayo</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">417-454</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  The drug efflux transporter P-glycoprotein (P-gp) is known to confer multidrug resistance in cancer chemotherapy.  The P-gp is highly expressed in many types of tumor cells, as well as many normal tissues, including the apical surface of intestinal epithelial cells, and the luminal surface of capillary endothelial cells in the brain.  Because of its expression and localization, it has been suggested that P-gp plays an important role in cancer chemotherapy, intestinal absorption, and brain uptake.  This review addresses the significance of the role of P-gp in cancer chemotherapy, drug absorption, and brain uptake.  Based on the clin. and animal studies with P-gp modulators, it has become apparent that the role of P-gp in multidrug resistance is far less important compared to other biol. factors.  Although P-gp is highly expressed in both intestinal epithelial cells and endothelial cells of brain capillaries and functions as an efflux transporter in both organs, the magnitude of P-gp's impact on intestinal absorption and brain uptake of drugs is quant. very different.  From animal and clin. studies, it is evident that P-gp plays a very important role in CNS penetration of drugs, whereas the effect of P-gp on drug absorption is not as important as generally believed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyF-MM7RjqZLVg90H21EOLACvtfcHk0ljxQI8gON60Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1ygsLw%253D&md5=22c8b47bccd0f577ca0f8589d442402f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1081%2FDMR-120026871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120026871%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DYamazaki%26aufirst%3DM.%26atitle%3DClinical%2520relevance%2520of%2520P-glycoprotein%2520in%2520drug%2520therapy%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2003%26volume%3D35%26spage%3D417%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">How does P-glycoprotein recognize its substrates?</span> <span class="citation_source-journal">Int. J. Clin. Pharmacol Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=9476149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1KntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1998&pages=50-54&author=A.+Seelig&title=How+does+P-glycoprotein+recognize+its+substrates%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">How does P-glycoprotein recognize its substrates?</span></div><div class="casAuthors">Seelig, A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-54</span>CODEN:
                <span class="NLM_cas:coden">ICTHEK</span>;
        ISSN:<span class="NLM_cas:issn">0946-1965</span>.
    
            (<span class="NLM_cas:orgname">Dustri-Verlag Dr. Karl Feistle</span>)
        </div><div class="casAbstract">The structures of 100 compds. previously tested as P-glycoprotein (Pgp) substrates were screened to find potential elements responsible for substrate-Pgp interaction and for Pgp overexpression.  It is suggested that a set of well-defined structural elements is required for an interaction with Pgp.  The recognition elements are formed by 2 (type I unit) or 3 electron donor groups (type II unit) with a fixed spatial sepn.  Type I units consist of 2 electron donor groups with a spatial sepn. of 2.5 ←.  Type II units contain either 2 electron donor groups with a spatial sepn. of 4.6 ← or 3 electron donor groups with a spatial sepn. of the outer 2 groups of 4.6 ←.  All mols. which contain at least 1 type I or 1 type II unit are predicted to be Pgp substrates.  The binding to Pgp increases with the strength and the no. of electron donor or H-bonding acceptor groups forming the type I and type II units.  Correspondingly a high percentage of amino acids with H-bonding donor side chains is found in the transmembrane sequences of Pgp relevant for substrate interaction.  Mols. which minimally contain 1 type II unit are predicted to be inducers of Pgp overexpression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAcqpuaufbjbVg90H21EOLACvtfcHk0ljxQI8gON60Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1KntA%253D%253D&md5=bf372aacf6a4015c2d60be921438daed</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DHow%2520does%2520P-glycoprotein%2520recognize%2520its%2520substrates%253F%26jtitle%3DInt.%2520J.%2520Clin.%2520Pharmacol%2520Ther.%26date%3D1998%26volume%3D36%26spage%3D50%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stouch, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, O.</span><span> </span><span class="NLM_article-title">Progress in understanding the structure−activity relationships of P-glycoproetin</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=315-328&author=T.+R.+Stouchauthor=O.+Gudmundsson&title=Progress+in+understanding+the+structure%E2%88%92activity+relationships+of+P-glycoproetin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStouch%26aufirst%3DT.%2BR.%26aulast%3DGudmundsson%26aufirst%3DO.%26atitle%3DProgress%2520in%2520understanding%2520the%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520P-glycoproetin%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D315%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Raub, T. J.</span><span> </span><span class="NLM_article-title">P-Glycoprotein recognition of substrates and circumvention through rational drug design</span> <span class="citation_source-journal">Mol. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp0500871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=3-25&author=T.+J.+Raub&title=P-Glycoprotein+recognition+of+substrates+and+circumvention+through+rational+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design</span></div><div class="casAuthors">Raub, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is now well recognized that membrane efflux transporters, esp. P-glycoprotein (P-gp; ABCB1), play a role in detg. the absorption, distribution, metab., excretion, and toxicol. behaviors of some drugs and mols. in development.  An investment in screening structure-activity relation (SAR) is warranted in early discovery when exposure and/or target activity in an in vivo efficacy model is not achieved and P-gp efflux is identified as a rate-limiting factor.  However, the amt. of investment in SAR must be placed into perspective by assessing the risks assocd. with the intended therapeutic target, the potency and margin of safety of the compd., the intended patient population(s), and the market competition.  The task of rationally designing a chem. strategy for circumventing a limiting P-gp interaction can be daunting.  The necessity of retaining biol. potency and metabolic stability places restrictions on what can be done, and the factors for P-gp recognition of substrates are complicated and poorly understood.  The parameters within the assays that affect overall pump efficiency or net efflux, such as passive diffusion, membrane partitioning, and mol. interaction between pump and substrate, should be understood when interpreting data sets assocd. with chem. around a scaffold.  No single, functional group alone is often the cause, but one group can accentuate the recognition points existing within a scaffold.  This can be likened to a rheostat, rather than an on/off switch, where addn. or removal of a key group can increase or decrease the pumping efficiency.  The most practical approach to de-emphasize the limiting effects of P-gp on a particular scaffold is to increase passive diffusion.  Efflux pumping efficiency may be overcome when passive diffusion is fast enough.  Eliminating, or substituting with fewer, groups that solvate in water, or decreasing their hydrogen bonding capacity, and adding halogen groups can increase passive diffusion.  Reducing mol. size, replacing electroneg. atoms, blocking or masking H-bond donors with N-alkylation or bulky flanking groups, introducing constrained conformation, or by promoting intramol. hydrogen bonds are all examples of steps to take.  This review discusses our understanding of how P-gp recognizes and pumps compds. as substrates and describes cases where structural changes were made in a chem. scaffold to circumvent the effects of P-gp interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRbEgPosNnxrVg90H21EOLACvtfcHk0lh0Z0Mx3ewsMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP&md5=cc89be920dfa0e32edb994be94626aa5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fmp0500871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp0500871%26sid%3Dliteratum%253Aachs%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DP-Glycoprotein%2520recognition%2520of%2520substrates%2520and%2520circumvention%2520through%2520rational%2520drug%2520design%26jtitle%3DMol.%2520Pharm.%26date%3D2006%26volume%3D3%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Yates, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearbey, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuetz, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaan, P. W.</span><span> </span><span class="NLM_article-title">Structural determinants of P-glycoprotein-mediated transport of glucocorticoids</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1794</span><span class="NLM_x">–</span> <span class="NLM_lpage">1803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=1794-1803&author=C.+R.+Yatesauthor=C.+Changauthor=J.+D.+Kearbeyauthor=K.+Yasudaauthor=E.+G.+Schuetzauthor=D.+D.+Millerauthor=J.+T.+Daltonauthor=P.+W.+Swaan&title=Structural+determinants+of+P-glycoprotein-mediated+transport+of+glucocorticoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DC.%2BR.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DKearbey%26aufirst%3DJ.%2BD.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DSchuetz%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26atitle%3DStructural%2520determinants%2520of%2520P-glycoprotein-mediated%2520transport%2520of%2520glucocorticoids%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26spage%3D1794%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cerny, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzlik, R. P.</span><span> </span><span class="NLM_article-title">Cyclopropylamine inactivation of cytochromes P450: role of metabolic intermediate complexes</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2005&pages=265-275&author=M.+A.+Cernyauthor=R.+P.+Hanzlik&title=Cyclopropylamine+inactivation+of+cytochromes+P450%3A+role+of+metabolic+intermediate+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCerny%26aufirst%3DM.%2BA.%26aulast%3DHanzlik%26aufirst%3DR.%2BP.%26atitle%3DCyclopropylamine%2520inactivation%2520of%2520cytochromes%2520P450%253A%2520role%2520of%2520metabolic%2520intermediate%2520complexes%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2005%26volume%3D426%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Goncharov, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radilov, A. S.</span><span> </span><span class="NLM_article-title">Toxicology of fluoroacetate: a review, with possible directions for therapy research</span> <span class="citation_source-journal">J. Appl. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1002%2Fjat.1118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=16252258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFerurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=148-161&author=N.+V.+Goncharovauthor=R.+O.+Jenkinsauthor=A.+S.+Radilov&title=Toxicology+of+fluoroacetate%3A+a+review%2C+with+possible+directions+for+therapy+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicology of fluoroacetate: a review, with possible directions for therapy research</span></div><div class="casAuthors">Goncharov, Nikolay V.; Jenkins, Richard O.; Radilov, Andrey S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-161</span>CODEN:
                <span class="NLM_cas:coden">JJATDK</span>;
        ISSN:<span class="NLM_cas:issn">0260-437X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Fluoroacetate (FA; CH2FCOOR) is highly toxic towards humans and other mammals through inhibition of the enzyme aconitase in the tricarboxylic acid cycle, caused by 'lethal synthesis' of an isomer of fluorocitrate (FC).  FA is found in a range of plant species and their ingestion can cause the death of ruminant animals.  Some fluorinated compds. used as anticancer agents, narcotic analgesics, pesticides or industrial chems. metabolize to FA as intermediate products.  The chem. characteristics of FA and the clin. signs of intoxication warrant the re-evaluation of the toxic danger of FA and renewed efforts in the search for effective therapeutic means.  Antidotal therapy for FA intoxication was aimed at preventing fluorocitrate synthesis and aconitase blockade in mitochondria, and at providing citrate outflow from this organelle.  Despite a greatly improved understanding of the biochem. mechanism of FA toxicity, ethanol, if taken immediately after the poisoning, was the most acceptable antidote for the past 6 decades.  This review deals with the clin. signs and physiol. and biochem. mechanisms of FA intoxication to provide an explanation of why, even after decades of investigation, has no effective therapy to FA intoxication been elaborated.  An apparent lack of integrated toxicol. studies is viewed as a limiter of progress in this regard.  Two principal ways of developing effective therapies for FA intoxication are considered.  Firstly, competitive inhibition of FA interaction with CoA and of FC interaction with aconitase.  Secondly, channeling the alternative metabolic pathways by orienting the fate of citrate via cytosolic aconitase, and by maintaining the flux of reducing equiv. into the TCA cycle via glutamate dehydrogenase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmt9jcqnW8rVg90H21EOLACvtfcHk0lh0Z0Mx3ewsMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFerurs%253D&md5=d2e2b695c218a75c93b6a0c779e0bebb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fjat.1118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjat.1118%26sid%3Dliteratum%253Aachs%26aulast%3DGoncharov%26aufirst%3DN.%2BV.%26aulast%3DJenkins%26aufirst%3DR.%2BO.%26aulast%3DRadilov%26aufirst%3DA.%2BS.%26atitle%3DToxicology%2520of%2520fluoroacetate%253A%2520a%2520review%252C%2520with%2520possible%2520directions%2520for%2520therapy%2520research%26jtitle%3DJ.%2520Appl.%2520Toxicol.%26date%3D2006%26volume%3D26%26spage%3D148%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">van Niel, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broughton, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locker, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyes, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. L.</span><span> </span><span class="NLM_article-title">Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT<sub>1D</sub> receptor ligands with improved pharmacokinetic profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2087</span><span class="NLM_x">–</span> <span class="NLM_lpage">2104</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981133m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2087-2104&author=M.+B.+van+Nielauthor=I.+Collinsauthor=M.+S.+Beerauthor=H.+B.+Broughtonauthor=S.+K.+F.+Chengauthor=S.+C.+Goodacreauthor=A.+Healdauthor=K.+L.+Lockerauthor=A.+M.+MacLeodauthor=D.+Morrisonauthor=C.+R.+Moyesauthor=D.+O.+O%E2%80%99Connorauthor=A.+Pikeauthor=M.+Rowleyauthor=M.+G.+N.+Russellauthor=B.+Sohalauthor=J.+A.+Stantonauthor=S.+Thomasauthor=H.+Verrierauthor=A.+P.+Wattauthor=J.+L.+Castro&title=Fluorination+of+3-%283-%28piperidin-1-yl%29propyl%29indoles+and+3-%283-%28piperazin-1-yl%29propyl%29indoles+gives+selective+human+5-HT1D+receptor+ligands+with+improved+pharmacokinetic+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm981133m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981133m%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BNiel%26aufirst%3DM.%2BB.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DBeer%26aufirst%3DM.%2BS.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DCheng%26aufirst%3DS.%2BK.%2BF.%26aulast%3DGoodacre%26aufirst%3DS.%2BC.%26aulast%3DHeald%26aufirst%3DA.%26aulast%3DLocker%26aufirst%3DK.%2BL.%26aulast%3DMacLeod%26aufirst%3DA.%2BM.%26aulast%3DMorrison%26aufirst%3DD.%26aulast%3DMoyes%26aufirst%3DC.%2BR.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%2BO.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DRussell%26aufirst%3DM.%2BG.%2BN.%26aulast%3DSohal%26aufirst%3DB.%26aulast%3DStanton%26aufirst%3DJ.%2BA.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DVerrier%26aufirst%3DH.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26atitle%3DFluorination%2520of%25203-%25283-%2528piperidin-1-yl%2529propyl%2529indoles%2520and%25203-%25283-%2528piperazin-1-yl%2529propyl%2529indoles%2520gives%2520selective%2520human%25205-HT1D%2520receptor%2520ligands%2520with%2520improved%2520pharmacokinetic%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2087%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><div class="note"><p class="first last">The absolute stereochemistry of <b>30</b> was proven by X-ray analysis, whereas the absolute stereochemistry at C3 and C4 of the piperidine ring in <b>31</b> is not known but is drawn as such to simplify visualization of the relative stereochemistry. See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a> for full details and characterization of all four isomers.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+absolute+stereochemistry+of+30+was+proven+by+X-ray+analysis%2C+whereas+the+absolute+stereochemistry+at+C3+and+C4+of+the+piperidine+ring+in+31+is+not+known+but+is+drawn+as+such+to+simplify+visualization+of+the+relative+stereochemistry.+See+Experimental+Section+and+Supporting+Information+for+full+details+and+characterization+of+all+four+isomers."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Crosio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fimia, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loury, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassone-Corsi, P.</span><span> </span><span class="NLM_article-title">Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian aurora kinases</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">874</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm800386y&amp;key=10.1128%2FMCB.22.3.874-885.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=11784863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt12nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=874-885&author=C.+Crosioauthor=G.+M.+Fimiaauthor=R.+Louryauthor=M.+Kimuraauthor=Y.+Okanoauthor=H.+Zhouauthor=S.+Senauthor=C.+D.+Allisauthor=P.+Sassone-Corsi&title=Mitotic+phosphorylation+of+histone+H3%3A+spatio-temporal+regulation+by+mammalian+aurora+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian aurora kinases</span></div><div class="casAuthors">Crosio, Claudia; Fimia, Gian Maria; Loury, Romain; Kimura, Masashi; Okano, Yukio; Zhou, Hongyi; Sen, Subrata; Allis, C. David; Sassone-Corsi, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-885</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Phosphorylation at a highly conserved serine residue (Ser-10) in the histone H3 tail is considered to be a crucial event for the onset of mitosis.  This modification appears early in the G2 phase within pericentromeric heterochromatin and spreads in an ordered fashion coincident with mitotic chromosome condensation.  Mutation of Ser-10 is essential in Tetrahymena, since it results in abnormal chromosome segregation and extensive chromosome loss during mitosis and meiosis, establishing a strong link between signaling and chromosome dynamics.  Although mitotic H3 phosphorylation has been long recognized, the transduction routes and the identity of the protein kinases involved have been elusive.  Here we show that the expression of Aurora-A and Aurora-B, two kinases of the Aurora/AIK family, is tightly coordinated with H3 phosphorylation during the G2/M transition.  During the G2 phase, the Aurora-A kinase is coexpressed while the Aurora-B kinase colocalizes with phosphorylated histone H3.  At prophase and metaphase, Aurora-A is highly localized in the centrosomic region and in the spindle poles while Aurora-B is present in the centromeric region concurrent with H3 phosphorylation, to then translocate by cytokinesis to the midbody region.  Both Aurora-A and Aurora-B proteins phys. interact with the H3 tail and efficiently phosphorylate Ser10 both in vitro and in vivo, even if Aurora-A appears to be a better H3 kinase than Aurora-B.  Since Aurora-A and Aurora-B are known to be overexpressed in a variety of human cancers, our findings provide an attractive link between cell transformation, chromatin modifications and a specific kinase system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOtyPtqNysDbVg90H21EOLACvtfcHk0lgqarqswfcGXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt12nsA%253D%253D&md5=8e455152fc5b3244d07110ebcbfa0d0a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.3.874-885.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.3.874-885.2002%26sid%3Dliteratum%253Aachs%26aulast%3DCrosio%26aufirst%3DC.%26aulast%3DFimia%26aufirst%3DG.%2BM.%26aulast%3DLoury%26aufirst%3DR.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DSen%26aufirst%3DS.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26aulast%3DSassone-Corsi%26aufirst%3DP.%26atitle%3DMitotic%2520phosphorylation%2520of%2520histone%2520H3%253A%2520spatio-temporal%2520regulation%2520by%2520mammalian%2520aurora%2520kinases%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D874%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davide, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R. B.</span><span> </span><span class="NLM_article-title">Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=49-59&author=W.+Taoauthor=V.+J.+Southauthor=Y.+Zhangauthor=J.+P.+Davideauthor=L.+Farrellauthor=N.+E.+Kohlauthor=L.+Sepp-Lorenzinoauthor=R.+B.+Lobell&title=Induction+of+apoptosis+by+an+inhibitor+of+the+mitotic+kinesin+KSP+requires+both+activation+of+the+spindle+assembly+checkpoint+and+mitotic+slippage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DW.%26aulast%3DSouth%26aufirst%3DV.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDavide%26aufirst%3DJ.%2BP.%26aulast%3DFarrell%26aufirst%3DL.%26aulast%3DKohl%26aufirst%3DN.%2BE.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26atitle%3DInduction%2520of%2520apoptosis%2520by%2520an%2520inhibitor%2520of%2520the%2520mitotic%2520kinesin%2520KSP%2520requires%2520both%2520activation%2520of%2520the%2520spindle%2520assembly%2520checkpoint%2520and%2520mitotic%2520slippage%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26spage%3D49%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><div class="note"><p class="first last">In mouse models, MTD is typically defined as ≤10% deaths due to mechanism-based toxicity. In studies with <b>30</b> infused at 12 (mg/kg)/day, there was 1 death out of 34 mice dosed, providing a 3% rate of death for this cohort</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+mouse+models%2C+MTD+is+typically+defined+as+%E2%89%A410%25+deaths+due+to+mechanism-based+toxicity.+In+studies+with+30+infused+at+12+%28mg%2Fkg%29%2Fday%2C+there+was+1+death+out+of+34+mice+dosed%2C+providing+a+3%25+rate+of+death+for+this+cohort."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">The sequence of KSP is highly conserved across species, and the IC<sub>50</sub> of <b>30</b> was found to be 2.2 ± 1.2 nM and 4.8 ± 1.0 nM against human and mouse KSP, respectively. Therefore, we expect little difference in therapeutic index across species due to differences in KSP potency</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+sequence+of+KSP+is+highly+conserved+across+species%2C+and+the+IC50+of+30+was+found+to+be+2.2+%C2%B1+1.2+nM+and+4.8+%C2%B1+1.0+nM+against+human+and+mouse+KSP%2C+respectively.+Therefore%2C+we+expect+little+difference+in+therapeutic+index+across+species+due+to+differences+in+KSP+potency."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><div class="note"><p class="first last">For instance, compound <b>24</b> in ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a> has cell potency and serum shift numbers of 3.4 and 6.6 nM, respectively, and its in vivo EC<sub>90</sub> is 38 nM</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+instance%2C+compound+24+in+ref+14+has+cell+potency+and+serum+shift+numbers+of+3.4+and+6.6+nM%2C+respectively%2C+and+its+in+vivo+EC90+is+38+nM."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><div class="note"><p class="first last">Because mice become neutropenic and recover more quickly than humans, a once per week for 3 weeks schedule in humans (q7d × 3) is mimicked by a once every 4 days for 12 days cycle in mouse (q4d × 3). Minipumps were not used in this protocol to allow for dosing on multiple days</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Because+mice+become+neutropenic+and+recover+more+quickly+than+humans%2C+a+once+per+week+for+3+weeks+schedule+in+humans+%28q7d+%C3%97+3%29+is+mimicked+by+a+once+every+4+days+for+12+days+cycle+in+mouse+%28q4d+%C3%97+3%29.+Minipumps+were+not+used+in+this+protocol+to+allow+for+dosing+on+multiple+days."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Giannakakou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sackett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buters, J. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poruchynsky, M. S.</span><span> </span><span class="NLM_article-title">Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">17118</span><span class="NLM_x">–</span> <span class="NLM_lpage">17125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=17118-17125&author=P.+Giannakakouauthor=D.+L.+Sackettauthor=Y.-K.+Kangauthor=Z.+Zhanauthor=J.+T.+M.+Butersauthor=T.+Fojoauthor=M.+S.+Poruchynsky&title=Paclitaxel-resistant+human+ovarian+cancer+cells+have+mutant+%CE%B2-tubulins+that+exhibit+impaired+paclitaxel-driven+polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiannakakou%26aufirst%3DP.%26aulast%3DSackett%26aufirst%3DD.%2BL.%26aulast%3DKang%26aufirst%3DY.-K.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DButers%26aufirst%3DJ.%2BT.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DPoruchynsky%26aufirst%3DM.%2BS.%26atitle%3DPaclitaxel-resistant%2520human%2520ovarian%2520cancer%2520cells%2520have%2520mutant%2520%25CE%25B2-tubulins%2520that%2520exhibit%2520impaired%2520paclitaxel-driven%2520polymerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D17118%26epage%3D17125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><div class="note"><p class="first last">The data shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> for efficacy in the KB-v cell line were generated by dosing <b>30</b> on a qd × 1 schedule at 40 mpk as a suspension in methylcellulose. This represents the MTD for this schedule, and this dosing paradigm has shown good efficacy in a number of experiments. The data from the q4d × 3 schedule in the KB-v cell line are not shown because in this experiment (run only once), the vehicle control group displayed much less tumor progression than expected, similar to that of the group treated with <b>30</b>. However, as expected, the mice treated with paclitaxel in this study experienced significant tumor growth. The reason for the low rate of tumor progression in the vehicle group from this experiment is not known</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+data+shown+in+Figure+4+for+efficacy+in+the+KB-v+cell+line+were+generated+by+dosing+30+on+a+qd+%C3%97+1+schedule+at+40+mpk+as+a+suspension+in+methylcellulose.+This+represents+the+MTD+for+this+schedule%2C+and+this+dosing+paradigm+has+shown+good+efficacy+in+a+number+of+experiments.+The+data+from+the+q4d+%C3%97+3+schedule+in+the+KB-v+cell+line+are+not+shown+because+in+this+experiment+%28run+only+once%29%2C+the+vehicle+control+group+displayed+much+less+tumor+progression+than+expected%2C+similar+to+that+of+the+group+treated+with+30.+However%2C+as+expected%2C+the+mice+treated+with+paclitaxel+in+this+study+experienced+significant+tumor+growth.+The+reason+for+the+low+rate+of+tumor+progression+in+the+vehicle+group+from+this+experiment+is+not+known."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halczenko, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span> </span><span class="NLM_article-title">Inhibition of a mitotic motor protein: where, how, and conformational consequences</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2004&pages=547-554&author=Y.+Yanauthor=V.+Sardanaauthor=B.+Xuauthor=C.+Homnickauthor=W.+Halczenkoauthor=C.+A.+Buserauthor=M.+Schaberauthor=G.+D.+Hartmanauthor=H.+E.+Huberauthor=L.+C.+Kuo&title=Inhibition+of+a+mitotic+motor+protein%3A+where%2C+how%2C+and+conformational+consequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DHomnick%26aufirst%3DC.%26aulast%3DHalczenko%26aufirst%3DW.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DSchaber%26aufirst%3DM.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26atitle%3DInhibition%2520of%2520a%2520mitotic%2520motor%2520protein%253A%2520where%252C%2520how%252C%2520and%2520conformational%2520consequences%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D335%26spage%3D547%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Parish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucete, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugger, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakowicz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.-M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Novel ATP-competitive kinesin spindle protein inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4939</span><span class="NLM_x">–</span> <span class="NLM_lpage">4952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4939-4952&author=C.+A.+Parishauthor=N.+D.+Adamsauthor=K.+R.+Augerauthor=J.+L.+Burgessauthor=J.+D.+Carsonauthor=A.+M.+Chaudhariauthor=R.+A.+Copelandauthor=M.+A.+Diamondauthor=C.+A.+Donatelliauthor=K.+J.+Duffyauthor=L.+F.+Fauceteauthor=J.+T.+Finerauthor=W.+F.+Huffmanauthor=E.+D.+Huggerauthor=J.+R.+Jacksonauthor=S.+D.+Knightauthor=L.+Luoauthor=M.+L.+Mooreauthor=K.+A.+Newlanderauthor=L.+H.+Ridgersauthor=R.+Sakowiczauthor=A.+N.+Shawauthor=C.-M.+M.+Sungauthor=D.+Suttonauthor=K.+W.+Woodauthor=S.-Y.+Zhangauthor=M.+N.+Zimmermanauthor=D.+Dhanak&title=Novel+ATP-competitive+kinesin+spindle+protein+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParish%26aufirst%3DC.%2BA.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26aulast%3DFaucete%26aufirst%3DL.%2BF.%26aulast%3DFiner%26aufirst%3DJ.%2BT.%26aulast%3DHuffman%26aufirst%3DW.%2BF.%26aulast%3DHugger%26aufirst%3DE.%2BD.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%2BH.%26aulast%3DSakowicz%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DA.%2BN.%26aulast%3DSung%26aufirst%3DC.-M.%2BM.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DWood%26aufirst%3DK.%2BW.%26aulast%3DZhang%26aufirst%3DS.-Y.%26aulast%3DZimmerman%26aufirst%3DM.%2BN.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DNovel%2520ATP-competitive%2520kinesin%2520spindle%2520protein%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4939%26epage%3D4952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rickert, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasber, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span> </span><span class="NLM_article-title">Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2008&pages=220-231&author=K.+W.+Rickertauthor=M.+Schaberauthor=M.+Torrentauthor=L.+A.+Neilsonauthor=E.+S.+Tasberauthor=R.+M.+Garbaccioauthor=P.+J.+Colemanauthor=D.+Harveyauthor=Y.+Zhangauthor=Y.+Yangauthor=G.+Marshallauthor=L.+Leeauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buser&title=Discovery+and+biochemical+characterization+of+selective+ATP+competitive+inhibitors+of+the+human+mitotic+kinesin+KSP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRickert%26aufirst%3DK.%2BW.%26aulast%3DSchaber%26aufirst%3DM.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DNeilson%26aufirst%3DL.%2BA.%26aulast%3DTasber%26aufirst%3DE.%2BS.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHarvey%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMarshall%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26atitle%3DDiscovery%2520and%2520biochemical%2520characterization%2520of%2520selective%2520ATP%2520competitive%2520inhibitors%2520of%2520the%2520human%2520mitotic%2520kinesin%2520KSP%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2008%26volume%3D469%26spage%3D220%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><div class="note"><p class="first last">The coordinates have been deposited with the RCSB Protein Data Bank under the accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CJO">3CJO</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+coordinates+have+been+deposited+with+the+RCSB+Protein+Data+Bank+under+the+accession+code+3CJO."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Stein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, N. G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandrendreis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooley, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, G.</span><span> </span><span class="NLM_article-title">Phase I clinical and pharmacokinetic (PK) trial of the kinesin spindle protein (KSP) inhibitor MK-0731 in patients with solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">18S</span><span class="NLM_x">) </span> <span class="NLM_fpage">2548</span><div class="note"><p class="first last">(ASCO Annual Meeting Proceedings Part I)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=2548&issue=18S&author=M.+N.+Steinauthor=E.+H.+Rubinauthor=K.+Taberauthor=R.+C.+Fernandezauthor=N.+G.+B.+Agrawalauthor=E.+Vandrendreisauthor=K.+Hsuauthor=A.+Walkerauthor=K.+Holenauthor=L.+Xueauthor=P.+C.+Cooleyauthor=G.+Wilding&title=Phase+I+clinical+and+pharmacokinetic+%28PK%29+trial+of+the+kinesin+spindle+protein+%28KSP%29+inhibitor+MK-0731+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DM.%2BN.%26aulast%3DRubin%26aufirst%3DE.%2BH.%26aulast%3DTaber%26aufirst%3DK.%26aulast%3DFernandez%26aufirst%3DR.%2BC.%26aulast%3DAgrawal%26aufirst%3DN.%2BG.%2BB.%26aulast%3DVandrendreis%26aufirst%3DE.%26aulast%3DHsu%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DA.%26aulast%3DHolen%26aufirst%3DK.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DCooley%26aufirst%3DP.%2BC.%26aulast%3DWilding%26aufirst%3DG.%26atitle%3DPhase%2520I%2520clinical%2520and%2520pharmacokinetic%2520%2528PK%2529%2520trial%2520of%2520the%2520kinesin%2520spindle%2520protein%2520%2528KSP%2529%2520inhibitor%2520MK-0731%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26issue%3D18S%26spage%3D2548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Shen, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardarelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">261</span><span class="NLM_x">, </span> <span class="NLM_fpage">7762</span><span class="NLM_x">–</span> <span class="NLM_lpage">7770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm800386y&amp;key=3711108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm800386y&amp;key=1%3ACAS%3A528%3ADyaL28XksFChs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=7762-7770&author=D.+W.+Shenauthor=C.+Cardarelliauthor=J.+Hwangauthor=M.+Cornwellauthor=N.+Richertauthor=S.+Ishiiauthor=I.+Pastanauthor=M.+M.+Gottesman&title=Multiple+drug-resistant+human+KB+carcinoma+cells+independently+selected+for+high-level+resistance+to+colchicine%2C+adriamycin%2C+or+vinblastine+show+changes+in+expression+of+specific+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins</span></div><div class="casAuthors">Shen, Ding Wu; Cardarelli, Carol; Hwang, Jaulang; Cornwell, Marilyn; Richert, Nancy; Ishii, Shunsuke; Pastan, Ira; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7762-70</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Four cell lines derived from the human KB carcinoma cell line which express high-level multiple drug resistance were established.  One of these lines was selected for resistance to colchicine  [64-86-8], one was selected for resistance to colchicine in the presence of the tumor promoter, mezerein  [34807-41-5], one for resistance to vinblastine  [865-21-4], and one for resistance to adriamycin  [25316-40-9].  All of these cell lines were cross-resistant to the other selective agents.  The development of multidrug resistance in these cultured human carcinoma cells was assocd. with a limited no. of specific protein alterations revealed by high-resoln., 2-dimensional gel electrophoresis and Western blot anal.  These protein alterations in multidrug-resistant lines included the decreased prevalence of members of a family of proteins of mol. mass 70,000 to 80,000 daltons, pI 4.8-5.0, the increased synthesis of a protein of mol. mass 21,000 daltons, pI 5.0, in the colchicine-resistant cell lines only, and the increased expression of a 170,000-dalton protein in membrane prepns. from all of the resistant cells.  The loss of the 70,000- to 80,000-dalton proteins in the multidrug-resistant lines, which was also be demonstrated by immunopptn. of these proteins with specific antisera, was assocd. with a loss of translatable mRNA for these proteins.  Apparently, only a limited no. of protein changes occur in multidrug-resistant cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24ZiGUZbjD7Vg90H21EOLACvtfcHk0lg_ZGX6qVmaKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFChs7w%253D&md5=b8fc5057559ea644506e76b643733a90</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DD.%2BW.%26aulast%3DCardarelli%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DJ.%26aulast%3DCornwell%26aufirst%3DM.%26aulast%3DRichert%26aufirst%3DN.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DMultiple%2520drug-resistant%2520human%2520KB%2520carcinoma%2520cells%2520independently%2520selected%2520for%2520high-level%2520resistance%2520to%2520colchicine%252C%2520adriamycin%252C%2520or%2520vinblastine%2520show%2520changes%2520in%2520expression%2520of%2520specific%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D7762%26epage%3D7770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CJO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CJO','PDB','3CJO'); return false;">PDB: 3CJO</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a href="/doi/suppl/10.1021/jm800386y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08428"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for compounds <b>12</b>−<b>16</b>, potency data for the epimers of <b>30</b> and <b>31</b>, and proton NMR spectra of all new compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800386y/suppl_file/jm800386y-file001.pdf">jm800386y-file001.pdf (605.87 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800386y&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm800386y%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800386y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1010KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ab5d7e063d2a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
